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General Introduction 
Part of this chapter will be published in: 
Roel Schaapveld, Bé Wieringa, and Wiljan Hendriks 
Receptor-like protein tyrosine phosphatases: Alike and yet so different 
Molecular Biology Reports, in press (1997) 
Chapter ¡ 
GENERAL INTRODUCTION 
Protein tyrosine phosphatases 
Protein tyrosine phosphatases (PTPases, protein-tyrosine-phosphate phosphohydrolase, EC 
3 1 3 48) are a family of proteins of which the first one, PTP1B, was discovered in 1988 
by Tonks and coworkers (Tonks et al , 1988a) PTPases obtained their name from the 
enzymatic role they perform inside cells, namely the removal of phosphate groups from 
phosphotyrosine residues of specific target proteins The phosphorylation of these tyrosine 
residues, catalyzed by the protein tyrosine kinases (PTKs), is known to regulate important 
cellular processes like metabolism, gene expression, division and differentiation, 
development, transport, and locomotion (Barford et al , 1995) Since PTPases act on the 
same kind of biochemical switches as the PTKs, they are thought to play an equally 
important biological role (Sun and Tonks, 1994, Figure 1) In support with this 
contention, Klarlund, already in 1985, showed that addition of the PTPase inhibitor 
vanadate to cells in culture leads to increased amounts of phosphotyrosine-containing 
proteins and cellular transformation Thus, a delicate balance between PTK and PTPase 
action is essential for normal functioning of cells 
Next to the PTPases, two other protein families are capable as well to dephosphorylate 
tyrosine-phosphorylated proteins the structurally distinct low molecular weight PTPases 
and the structurally related dual specificity phosphatases which catalyze the 
dephosphorylation of phospho-tyrosine, threonine and -serine residues (Barford et al , 
1995) To date, the protein family of PTPases comprises some 50 members (Barford et 
al , 1995) which display a bewildering variety of amino acid motifs, fused to the catalytic 
PTPase domains (Brady Kalnay and Tonks, 1995) The PTPase family can be divided in 
two main classes based on their subcellular localization, namely (ι) intracellular, cytosohc 
or nuclear, PTPases that contain only one PTPase domain, and (n) receptor like, 
transmembrane PTPases that have one or two tandemly repeated catalytic domains 
The catalytic PTPase domain 
All PTPase family members possess at least one -230-280 amino acid catalytic domain 
with a mean sequence identity of -35% among all pairs of sequences (Barford et al , 
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1995; Streuli, 1996). Each domain contains a highly conserved active-site region with the 
consensus motif [I/V]HCXAGXXR[S/T]G (where X is any amino acid). Site-directed 
mutagenesis studies showed that the cysteine residue within this motif is absolutely 
essential for activity (Guan and Dixon, 1991; Pot and Dixon, 1992). Trapping 
experiments showed that the cysteine forms a thiol-intermediate during the catalytic 
turnover in which the cleavage of the phosphoenzyme intermediate is the rate-limiting 
step (Cho et ai, 1992a, 1992b; Guan and Dixon, 1991; Pot and Dixon, 1992). The 
hydroxyl group of the conserved threonine residue in the signature motif is important in 
facilitating the breakdown of this intermediate (Zhang et al., 1995). The invariant 
cysteine is adjacent to another conserved residue, histidine, which is significantly involved 
in catalysis, but not essential for PTPase activity Its role appears to be predominantly 
structural, in defining the positioning of the cysteine residue and the conformation of the 
phosphate binding loop (Barford et al., 1994) The arginine residue at position +6 is also 
essential for catalytic activity (Streuli et al., 1990) by having an important role in 
substrate binding and transition state stabilization (Zhang et al., 1994a). 
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Figure 1. The concerted action of PTPases and PTKs in cell signalling. 
(A) PTPases may aci as antagonists ot PTKs by dephosphorylaling the PTKs' autophosphorylalion sites, 
thereby inactivating the kinases itself, or by dephosphorylating their target substrates (S) (B) PTPases may 
act in cooperation with PTKs in the case of the Src-hke PTKs, by dephosphorylating the C-tenrunal 
inhibitory phosphorylation site, thereby activating the kinase and promoting the signalling cascade (adapted 
trom Sun and Tonks, 1994) 
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All amino acids in between the arginine and histidine residues form the base of the 
catalytic site cleft (Barford et al , 1994) The PTPases' specificity for phosphotyrosine 
containing residues probably results from the depth of this active-site cleft the shorter 
phosphosenne and phosphothreonine side chains would not reach the phosphate-binding 
site (Barford et al , 1994) Obviously, this structure has been well conserved as the three 
dimensional structure of PTP1B (Barford et al 1994) and the Yersinia dual-specificity 
PTPase (Stuckey et al , 1994), which share only twenty percent sequence homology, 
revealed an almost similar conformation of the phosphate-binding site Interestingly, the 
structure of the active-site cleft bears much more resemblance to Src homology 2 (SH2) 
domains, which also recognize phosphorylated tyrosines (Jia et al , 1995) than to the 
catalytic domains of the serine/threonine phosphatases or of the alkaline or acid 
phosphatases (Mauro and Dixon, 1994) The sequence context in which the 
phosphorylated tyrosine residue(s) must be recognized may be a crucial determinant in 
this property In contrast to the SH2 domains which contain binding sites C-terminal to 
the phosphorylated tyrosine (reviewed in Jia et al , 1995), PTPases display a subtle 
preference for multiple acidic side chains within five amino acids N-terminal to the 
phosphotyrosine residue (Zhang et al , 1993, 1994b) 
Regulation of PTPase activity 
Strikingly, intrinsic PTPase enzymatic activity is generally two to three orders of 
magnitude greater than that of the PTKs (Hunter, 1995) This can account for the low 
level of tyrosine-phosphorylated proteins, only 0 01-0 05% of all phosphorylated proteins 
and for the transient nature of tyrosine phosphorylation of cellular proteins (Hunter and 
Sefton, 1980, Hunter, 1995) Also, considering the large family of potentially redundant 
PTPases, the enzymatic activity must be highly regulated and restricted to prevent non 
specific dephosphorylation of proteins and to make PTK signalling effective (Hunter, 
1995, Mauro and Dixon, 1994, Tonks et al , 1992) This can be accomplished in various 
ways (1) by modulating the steady state levels of the enzyme, (2) by post-translational 
modification (e g serine/threonine and/or tyrosine phosphorylation, proteolytic cleavage, 
etc ), (3) by interaction with as yet not identified activator/inhibitor molecules, and (4) by 
discrete subcellular localization in further restricting the substrate specificity (Hunter, 
1995, Lammers et al , 1993, Mauro and Dixon, 1994, Tonks et al , 1992) The latter 
regulatory principle is quite evident for the non receptor, intracellular PTPases 
16 
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Intracellular PTPases 
The intracellular PTPases show a great diversity of protein modules outside the conserved 
catalytic domain These modules serve as 'zip codes' to target the PTPase to a particular 
subcellular localization, thereby defining and restricting its substrate specificity (Mauro 
and Dixon, 1994, Tonks et al , 1992) Examples of these flanking modules are (1) a short 
hydrophobic segment for targeting to the cytoplasmic face of intracellular membranes, (n) 
a nuclear localization signal, (ui) SH2 domains, which target the PTPases to 
phosphotyrosine-containing proteins, (ìv) a motif with homology to the actin-binding 
proteins band 4 1, ezrin, and talin, that directs the protein to the interfaces between the 
plasma membrane and the cytoskeleton, (v) domains related to retinal binding proteins, 
and (vi) PDZ-motifs as present in many proteins involved in submembranous signalling at 
specialized cell cell junctions (Barford et al , 1995, Hendriks, 1995, Kennedy, 1995, 
Mauro and Dixon, 1994, Ponting and Phillips, 1995) In addition, several PTPases 
contain sequences rich in proline, glutamic acid, serine, and threonine residues, so-called 
PEST sequences, which may serve as signals for proteolytic degradation and are 
characteristic of proteins with a short intracellular half life (for review see Rechsteiner 
and Rogers, 1996) 
Despite extensive data on their structure and subcellular localization, the signalling role 
of the cytosolic PTPases is not understood completely Recent findings gave more insight 
in the essential role they may play as terminators or as positive regulators of multiple 
signalling pathways (reviewed by Streuli, 1996) 
Receptor-like protein tyrosine phosphatases 
A database search with the peptide sequence of the intracellular PTPase PTP1B led to the 
identification of the first transmembrane, receptor-like PTPase (RPTPase), the leukocyte 
common antigen CD45 (Charbonneau et al , 1988) which was cloned already three years 
earlier (Thomas et al , 1985) In 1988 it was then quickly shown that CD45 indeed could 
catalyze the dephosphorylation of phosphotyrosine-containing proteins (Tonks et al , 
1988b), designating CD45 as the prototype of the RPTPase subfamily (Figure 2) All 
members possess an intracellular part containing one or two homologous PTPase 
domains, a single membrane-spanning region, and variable extracellular segments with 
potential ligand binding capacity Therefore, they have the potential to trigger signalling 
events at the cell membrane through ligand mediated dephosphorylation of tyrosine-
17 
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phosphorylated proteins (Tonks et al, 1992) In this context, the binding of a ligand to 
the extracellular segment may modulate the cytoplasmic PTPase activity (Mauro and 
Dixon, 1994), but experimental proof for this mechanism is lacking thus far 
The RPTPases can be classified in seven subtypes based on their extracellular motifs 
(Figure 2). The diversity of this subfamily is further increased by the existence of 
multiple isoforms resulting from alternative splicing and post-translational modifications 
(for review see Mourey & Dixon, 1994). In the following sections a detailed description 
on the distinct structural features and structure-function relationships of members of each 
of these subclasses will be given. The order of appearance of the different types largely 
follows the order as shown in Figure 2. An exception is made for the type II (A and B) 
and type III RPTPases, which are the cell adhesion molecule-like RPTPases and will be 
discussed in more detail at the end of this chapter. 
Figure 2. The family of receptor-like protein tyrosine phosphatases 
The ligure shows the distinct subtypes of RPTPases based on their extracellular motils. The classifkalion is 
according to Brady-Kalnay and Tonks (1995) except for ChPTPX, which we regard as a CD45-hke 
RPTPasc Only the largest isoform of each member is shown The identified structural features are indicated 
in the open box Fn-Ill, fibronectin type Ill-like repeat. Ig, lmmunoglobulin-hke domain; MAM, domain 
with homology to meprin, the A5 glycoprotein, and RPTP/x; CA, carbonic anhydrase-like domain, PTP, 
tyrosine phosphatase domain References are indicated in the text. 
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The RPTPase prototype CD45 
The type I RPTPase CD45 (also known as LCA, T200 in Τ cells, and B220 in В cells, 
the mouse homolog is denoted Ly 5) is expressed on the surface of all haematopoietic 
cells and their precursors except mature erythrocytes and platelets (for review see Chan et 
al , 1994, Okumura and Thomas, 1995, Yakura, 1994) Its extracellular domain is highly 
glycosylated, is rich in cysteine residues, and shows alternative splicing of exons 4, 5, 
and 6, and in rat and mouse also of exon 7 The expression of the different isoforms, 
ranging in molecular mass from 180 to 235 kDa, is cell type specific and depends on the 
activation state of lymphoid cells (Kishihara et al , 1993) 
The generation of different CD45 knock-out mice revealed that CD45 is not required 
for the proper development of В lymphocytes, but instead has a role in the regulation of 
certain subpopulations of В cells, ι e in the negative and positive selection of В 
lymphocytes (Byth et al , 1996, Cyster et al , 1996, Kishihara et al , 1993) 
Furthermore, an important regulatory role for CD45 in the signal transduction via the Τ 
cell receptor (TCR) at multiple stages during Τ cell development has been demonstrated 
(Byth et al , 1996, Klaus et al , 1996) The catalytic activity of the first, membrane 
proximal PTPase domain is necessary and sufficient to rescue the TCR signalling in 
CD45-negative cells (Desai et al , 1993, 1994), but requires membrane anchoring close to 
the membrane-associated substrates (Niklinska et al , 1994) 
It remains a point of controversy whether both PTPase domains of CD45 are 
enzymatically active (Streuli et al , 1990, Tan et al , 1993) because the in vitro data can 
be explained in various ways Inactivation of the first, membrane proximal domain, for 
example, might suppress the activity of the second domain, whereas partial or complete 
deletion of the structural integrity of the first domain may enable the second domain to 
become active (Pallen, 1993, Tan et al , 1993) Vice versa, the complete second domain 
may be necessary for the PTPase activity of the first domain (Johnson et al , 1992, Ng et 
al , 1995) This dispute on the enzymatic activity does not alter the fact that CD45 is the 
only RPTPase for which substrates have been identified (for review see Chan et al , 
1994, Okumura and Thomas, 1995) CD45 is able to activate the Src family kinases p56'ck 
and p59ly", important in antigen-induced receptor signalling, by specifically 
dephosphorylating the negative regulatory tyrosine phosphorylation site in their С termini 
In this mechanism, another cytoplasmic tyrosine kinase, p50csk, is able to phosphorylate 
both the C-terminal tyrosine in p56'ck and a site in the second PTPase domain of CD45 
This activates CD45 and provides a binding-site for the SH2 domain of p56lck (Autero et 
20 
general introduction 
al , 1994) Others argue that the mechanism is more complex Burns et al (1994) found 
a hyperphosphorylation of the C-termmus and increased enzymatic activity for p56kk 
tyrosine kinase in CD45-negative Τ cells Ostergaard and Trowbridge (1990) showed that 
co-clustenng of CD45 by CD4 decreases the CD4-associated p56lck autophosphorylation 
and enzymatic activity This would suggest that the interaction with CD45 inhibits rather 
than enhances p56lck activity Furthermore, Ng et al (1996) claimed that p56lck is able to 
interact with CD45 in the absence of any detectable tyrosine phosphorylation of CD45, 
suggesting a nonconvential SH2 domain interaction However, this interaction might not 
be direct in vivo In Τ cells, p56lck always co-precipitates with CD45 in the presence of a 
newly identified 30 32 kDa lymphocyte phosphatase-associated phosphoprotein, called 
LPAP or CD45AP (Koretzky et al , 1993, Ross et al , 1994, Schraven et al , 1991, 
1992, 1994, Takeda et al , 1992, 1994) In contrast, LPAP/CD45AP can be co-
precipitated with CD45 in the absence of p56'ck (Koretzky et al , 1993) and the 
transmembrane domains of CD45 and LPAP are essential for this interaction (Bruyns et 
al , 1996, Cahir McFarland and Thomas, 1995, Kitamura et al , 1995) It has been 
suggested that LPAP is protected from degradation through its interaction with CD45 
(Bruyns et al , 1996) but it is still not known what the function of LPAP is and also its 
requirement for the association of CD45 and p56Lk is not understood Since tyrosine 
phosphorylation of LPAP is not detectable in the presence of enzymatically active CD45, 
LPAP might also be a substrate of CD45 in lymphocytes (Schraven et al , 1994) and 
important for the initiation of Τ cell signalling The identification of the CD3 ζ chain as 
another substrate of CD45 suggests in addition a role for CD45 in termination of the TCR 
signalling for which a dephosphorylated ζ chain is essential (Furukawa et al , 1994) 
Phosphorylation on serine residues in CD45 may modulate the activity of the enzyme 
itself but the effects of this modification are still being disputed (Ostergaard and 
Trowbridge, 1991, Stover and Walsh, 1994, Tonks et al , 1990, Trowbridge et al , 1992, 
Valentine et al , 1991, Yamada et al , 1990) Another regulatory mechanism for CD45 
enzyme activity might be the association to cytoskeletal proteins Binding to fodnn (non 
erythroid spectrin) or the structurally related cytoskeletal protein, spectrin, increases 
PTPase activity (Lokeshwar and Bourguignon, 1992) The fodnn binding site of CD45 
was mapped to the N-terminal region of the second PTPase domain (Iida et al , 1994) 
Different isoforms of CD45 also specifically associate with an as yet unidentified widely 
expressed 116 kDa tyrosme-phosphorylated glycoprotein (Arendt and Ostergaard, 1995) 
The efficacy of Τ and В cell activation through antigen recognition and the regulation 
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of intracellular signals generated via other surface receptors might be determined by 
CD45 receptor-ligand interactions Unfortunately, the identity of the ligand(s) of CD45 
remains unclear although two candidates have been put forward Binding of CD22, a В 
cell surface protein of the Ig superfamily, blocks TCR-generated effects, suggesting that 
interaction with the extracellular domain may modulate CD45's PTPase activity (Aruffo et 
al , 1992, Sgroi et al , 1995, Stamenkovic et al , 1991) The other candidate-ligand is 
heparan sulfate on stromal cells suggesting a role for CD45 in adhesion of haematopoietic 
precursors to the bone marrow stroma (Coombe et al , 1994) The recently identified 
fibronectin type III (Fn-III)-hke repeat in the extracellular domain (Bork and Doolittle, 
1993) may mediate CD45's role in cell adhesion Moreover, also carbohydrate groups 
may be important in cell-cell interactions since the extracellular domain is heavily 
glycosylated and the CD45 isoforms differ in O-glycosylation Antibodies against the 
extracellular domain can influence the cell binding avidity Depending on the type of anti-
CD45 monoclonal antibody used, some antibodies induce the adhesion between peripheral 
Τ cells and monocytes via lymphocyte function-associated antigen (LFA)-l, while others 
inhibit the LFA-1/intercellular adhesion molecule (ICAM)-l or LFA-l/ICAM-3 dependent 
adhesion (reviewed in Okumura and Thomas, 1995) In addition, homotypic adhesion via 
LFA-1 of activated Τ cells, but not resting Τ cells, is induced by the engagement of 
CD45 (Spertim et al , 1994) 
Whatever the mechanisms involved in CD45 binding, it is becoming increasingly clear 
that CD45 is part of a larger molecular assembly which may have a cell-type dependent 
composition Clearly, completion of the inventory of cell physiological hgand(s) of CD45 
is needed in order to understand how CD45 activity is regulated and to define its role in 
cell-cell interaction processes 
The second member of this subclass, ChPTPX, was cloned from chicken and, quite 
surprisingly, was found to contain a spectnn-like repeat in its extracellular domain (Fang 
et al , 1994a) This repeat, present in many actin binding proteins, such as a- and /3-
spectrins, a-fodrin, α-actinin, and dystrophin, was subsequently also detected in CD45 
Next to the spectnn-like repeat, the extracellular domain of ChPTPX contains a 
Ser/Thr/Pro-nch region with many potential O-glycosylation sites, and a Fn-III-hke 
repeat Also, the alternative splicing that affects the N-terminal part and the 70% 
similarity in the intracellular domains suggest that ChPTPX may be regarded as the 
chicken homologue of CD45 Although it has been shown that ChPTPX can 
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dephosphorylate pp60c src at the С terminal tyrosine residue at position 527 m vitro (Fang 
et al , 1994b), more studies will be necessary to verify or disclaim further overlap in the 
physiological roles of ChPTPX and CD45 in vivo 
RPTPases with short extracellular extrusions 
The type IV RPTPases RPTPa (the mouse homolog is known as LRP) and RPTPe have 
two tandem cytoplasmic PTPase domains and short, highly glycosylated extracellular 
segments of only 123 or 27 residues, respectively (Jink et al , 1990, Kaplan et al , 1990, 
Knieger et al , 1990, Matthews et al , 1990, Monyama et al , 1992, Ohagi et al , 1990, 
Sap et al , 1990) In the case of RPTPa both cytoplasmic domains are enzymatically 
functional in vitro, but show distinct enzymatic activities and substrate specificities (Wang 
and Pallen, 1991, Pallen 1993) Interestingly, an enzymatically inactive alternatively 
spliced isoform that has an insertion within the first PTPase domain has been identified 
(Matthews et al , 1990, Wong et al , 1993), suggesting that activity of the first domain is 
required to uncover the cryptic intrinsic activity of the second domain giving rise to a 
fully active form of RPTPa (Pallen, 1993) RPTPa isoforms also arise from differences 
in glycosylation (Daum et al , 1991, 1994) Pulse chase experiments showed that a 100 
kDa protein is the precursor of a 130 kDa protein which contains both N and О linked 
carbohydrates This translational modification might contribute to specificity in ligand 
binding Ligands, however, have not been identified sofar Both the 100 and 130 kDa 
isoenzymes are simultaneously expressed on the same cell and may form dimers, as has 
also been suggested for CD45 (Daum et al , 1994, Desai et al , 1993) 
Recently, some progress has been made in elucidating the cellular role(s) and 
substrate(s) of RPTPa which is prominently expressed in brain and kidney but also 
present in a variety of other tissues (Kaneko et al , 1995, Matthews et al , 1990, Sap et 
al , 1990) Evidence is accumulating that RPTPa induces or acts in the signalling leading 
to neuronal differentiation possibly via dephosphorylating the regulatory tyrosine ìesidue 
at position 527 in the C-terminus of ррбО^ tyrosine kinase (den Hertog et al , 1993, 
Tsuneizumi et al , 1994, van Inzen et al , 1996) Overexpression of RPTPa in rat 
embryo fibroblasts also leads to persistent activation of ρρ60"Γί concomitant with cellular 
transformation, possibly via activation and translocation to the nucleus of mitogen 
activated protein (MAP) kinase and subsequent activation of the transcription factor c-Jun 
(Zheng et al , 1992, 1994) This makes RPTPa the only known PTPase to behave as an 
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oncogene in experimental systems, and also in vivo a role in the neoplastic transformation 
of colonic epithelial cells has been suggested (Tabm et al , 1995, Zheng at al , 1992) 
Next to its possible function as a positive regulator of cell proliferation, RPTPa, and 
RPTPe as well, may have a role as a negative regulator of insulin receptor tyrosine kinase 
(IRTK) activity in baby hamster kidney cells overexpressing the insulin receptor (IR) 
(Moller et al , 1995) 
Clearly, not only the cellular environment in proliferating and differentiating cells but 
also proper regulation of RPTPa activity is of critical importance for its biological role 
As already mentioned for CD45, phosphorylation on serine residues may be a mechanism 
for regulation of RPTPa PTPase activity Treatment of RPTPa transfected cells with the 
phorbol ester phorbol 12 mynstate 13 acetate (PMA) resulted in enhanced PTPase 
activity This is parallelled by an increase m serine phosphorylation, probably mediated 
via activation of protein kinase С (PKC) (den Hertog et al , 1995, Tracy et al , 1995) As 
the position of the phosphorylated serine residues is close to the dimer interface they may 
have a role in RPTPa oligomenzation (Bilwes et al , 1996) A model in which 
dimenzation and consequent active site blockage prevents binding of phosphotyrosine 
containing substrates and subsequently downregulates RPTPa activity was proposed on 
the basis of the crystal structure of the membrane proximal PTPase domain (Bilwes et al , 
1996) 
RPTPa may also be regulated by tyrosine phosphorylation It has been shown that 
RPTPa is constitutively phosphorylated on tyrosine residue 789 which serves as a binding 
site for the adaptor growth factor receptor binding (GRB-2) protein (den Hertog et al , 
1994, Su et al , 1994) This may provide a link to the Ras signal transduction pathway 
although the Ras guanine nucleotide exchange factor Son of Sevenless (Sos) was not 
detectable in this complex Recently, den Hertog and Hunter (1996) showed that not only 
the SH2 domain but also the C-terminal SH3 domain of GRB-2 is, most likely indirectly, 
involved in the binding to RPTPa This second RPTPa binding region is localized close 
to the catalytic site cleft of the N-terminal PTPase domain This suggests that binding of 
the GRB-2 C-terminal SH3 domain may block access to the catalytic site, and thereby 
inhibit RPTPa PTPase activity As a second consequence, the N-terminal SH3 domain of 
GRB-2 might not be able to bind to Sos due to stenc hindrance (den Hertog and Hunter, 
1996) 
For the second type IV RPTPase, RPTPe, two major mRNAs were found that show 
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distinct tissue specificity the larger lsoform being expressed in brain, heart, testes, and 
lung, and the slightly smaller mRNA in lymph nodes, thymus, spleen, and lung (Elson 
and Leder, 1995a) The larger mRNA specifies a molecule which undergoes tissue-
specific N glycosylation of the extracellular domain (Elson and Leder, 1995a) The 
smaller isoform lacks the signal peptide, the extracellular domain and the transmembrane 
segment, making it the first known cytoplasmic PTPase with two PTPase domains (Elson 
and Leder, 1995b, Nakamura et al , 1996) The mam regulation of expression of the 
distinct isoforms takes place at the level of transcription Presumably there is also 
regulation at the translational level because RPTPe mRNA expression is not invariably 
followed by RPTPc protein expression The cytoplasmic isoform is regarded as a delayed 
early response gene the transcription of which is regulated through a pathway that 
requires PKC For example, expression is upregulated in HL-60 cells upon addition of the 
phorbol ester 12 tetradecanoate 13 acetate (TPA) (Elson and Leder, 1995b) 
The larger, transmembrane RPTPe isoform may play a role in v-Ha-raj- and с леи-
mediated transformation of mammary epithelium The expression level of this isoform is 
low in normal mammary glands but is highly increased in mammary tumors initiated by 
ν Ha ras or с neu, and not in mammary tumors initiated by c-myc or int 2 (Elson and 
Leder, 1995a) It remains to be established whether RPTPe indeed plays an active role in 
the actual transformation mechanism of the mammary epithelial cells Another possible 
role for RPTPe may be in osteoclast formation as Schmidt et al (1996) found expression 
of RPTPe in osteoclasts and regulation of its PTPase activity by biphosphonates, potent 
inhibitors of bone resorption 
RPTPases with an extracellular carbonic anhydrasc-like motif 
The RPTPases RPTP^/ß (Krueger et al , 1990) and RPTPY (Kaplan et al , 1990, Barnea 
et al , 1993) have been classified as type V RPTPases Together with Drosophila 
DPTP99A, they are the only RPTPases, that have an aspartic acid residue instead of the 
conserved cysteine in their second PTPase domain (Hanharan et al , 1991, Kaplan et al , 
1990, Krueger et al , 1990, Tian et al , 1991, Yang et al , 1991) Presumably this 
renders the second domain inactive In addition, both RPTPf//? and RPTP7 possess a 
unique insert of 15 amino acids in the second PTPase domain that harbours a potential 
tyrosine phosphorylation site (Barnea et al , 1993, Kaplan et al , 1990) that may function 
in regulating their PTPase activity Extracellularly, they possess a single amino-terminal 
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motif with homology to carbonic anhydrase (CA), a Fn-III-like repeat, and a long 
cysteine-free spacer region (Barnea et al , 1993, Krueger and Saito, 1992, Levy et al , 
1993) CAs catalyze the reversible hydration of a C02 molecule to a bicarbonate ion, and 
their physiological functions include C02 transport by blood, pH regulation in the kidney, 
and C02 exchange in mitochondria and chloroplasts (reviewed m Tashian, 1989) All CAs 
are zinc metalloenzymes but in the CA-hke domains of RPTP¿7/3 and RPTPY two 
conserved histidine residues are lacking This prevents binding of zinc and renders the 
CA-like domain catalytically inactive In contrast, many other amino acid residues are 
conserved, including two cysteine residues that are thought to form a disulfide bridge 
The CA-like domain may therefore have a three-dimensional structure quite similar to 
CAs and provide an ideal interface for the binding of small soluble ligands (Krueger and 
Saito, 1992) 
RPTP¿"//3 exists in three isoforms, one secreted and two membrane-bound, that differ 
by the absence of 860 amino acid residues from the spacer region (Levy et al 1993, 
Maurel et al , 1994) All three isoforms are exclusively expressed in the central and 
peripheral nervous system and restricted to cells of neuroectodermal origin Changes in 
expression of the different isoforms appear to be correlated with glial cell differentiation, 
suggesting a role in morphogenesis of the nervous system (Canoll et al , 1993, 1996, 
Levy et al , 1993, Sakurai et al , 1996) In line with this, the CA like domain of 
RPTPf//3 was shown to bind to contactin, a glycosylphosphatidylinositol (GPI) anchored 
neuronal cell adhesion molecule of the immunoglobulin superfamily (also known as Fl 1 
in man, the mouse homolog is denoted F3) (Peles et al , 1995) Interestingly, contactin is 
also expressed as a soluble protein due to cleavage from the membrane (Brummendorf 
and Rathjen, 1993) enabling a unique mode of bidirectional signalling That is, contactin 
can function as the neuronal receptor for RPTP£7j3 and vice versa, the soluble form of 
contactin can act as the functional ligand of the transmembrane RPTPf//3 isoforms (Peles 
et al , 1995) 
An additional mechanism by which RPTPf//3 may modulate neuronal migration was 
revealed by the identification of the extracellular domain of RPTP¿7/3 as being the 
chondroitin sulphate proteoglycan called 6B4 proteoglycan or phosphacan (Barnea et al , 
1994b Maeda et al , 1994, Maurel et al , 1994, Shitara et al , 1994) Both the large 
RPTPf/0 transmembrane isoform and the soluble isoform, but not the short 
transmembrane isoform (denoted as dvRPTPf//3), are expressed as chondroitin sulfate 
proteoglycans (Barnea et al , 1994b, Sakurai et al , 1996) that interact heterophilically 
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with the extracellular matrix (ECM) protein tenascin and the adhesion molecules neural 
cell adhesion molecule (N-CAM), neuron-ghal cell adhesion molecule (Ng-CAM/Ll), and 
TAG-l/axonin-1 (Barnea et al , 1994a Milev et al , 1994, 1996) It was found that these 
interactions, in contrast to the RPTP¿7/3-contactin interaction mentioned above, inhibit cell 
adhesion and neunte outgrowth of chick brain neurons and are mediated by asparagine-
linked oligosaccharides present in the CA like and Fn-III like domains (Milev et al , 
1994, 1995, Peles et al , 1995) It is difficult to explain the different selective effects of 
phosphacan on neunte outgrowth and glial cell adhesion that have been reported (Maeda 
et al , 1995, 1996, Sakurai et al , 1996) Curently, the most attractive hypothesis is that 
phosphacan is likely to act as a competitor for ligand binding to the membrane bound 
forms of RPTP¿7/3 and all three isoforms may interfere with the interactions of contactin 
with its natural ligand tenascin, or N-CAM and Ng-CAM/Ll Taking into account that 
TAG-l/axonin-1 is also a ligand of N-CAM and able to interact with tenascin, the 
existence of higly complex interactive processes for formation of neuronal networks is 
evident (Milev et al , 1996), but this may not come as a surprise 
The biological significance of the other type V RPTPase, RPTPy, is only poorly 
understood Гог quite some time RPTP7 was considered as a candidate tumor suppressor 
due to the location of its gene (PTPRG) on human chromosome 3pl4 2 (in first instance 
on 3p21), in a region found to be frequently deleted in certain types of renal and lung 
carcinoma (Barnea et al , 1993, LaForgia et al , 1991, 1993) Yet, although a 
homozygous deletion within the CA-hke domain has been detected in a mouse tumor cell 
line (Wary et al , 1993), direct evidence that RPTP7 is the product of a tumor suppressor 
gene is lacking sofar Moreover, d search for mutations in the PTPRG gene from tumors 
and tumor-derived cell lines failed to identify any abnormalities in all known exons 
(Druck et al , 1995, Tsukamoto et al , 1992) As with many other RPTPase genes, the 
observed distinctly sized mRNAs may represent normal isoforms of RPTP7 which are 
generated by alternative splicing (Kastury et al , 1996, Tsukamoto et al , 1992) For 
instance, the most predominant transcript lacks a 87-bp juxtamembrane exon (Kastury et 
al , 1996), but the significance of the splicing out of this small exon is again elusive 
RPTPases with only one cytoplasmic PTPase domain 
PTP BR7 (also known as PC12-PTP) and PTP-SL together make up a new subfamily of 
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type VI RPTPases with only one cytoplasmic PTPase domain (Hendriks et al , 1995, 
Ogata et al , 1995, Sharma and Lombroso, 1995) These proteins display the highest 
homology to cytosohc PTPases, namely HePTP/LC-PTP and STEP Their extracellular 
domain does not show any structural homology to known molecules PTP-SL represents 
an N-terminal truncated form of PTP-BR7, resulting from the use of alternative promoters 
(A van den Maagdenberg, D Bachner, and W Hendriks, unpublished results) In mouse 
embryonic tissue only the —4 1 kb transcript encoding PTP-BR7 is expressed whereas in 
the adult mouse brain both the ~4 1 kb PTP-BR7 transcript and a smaller, ~3 2 kb 
mRNA encoding PTP-SL are present 
Unfortunately, there are not many clues to the functional roles of these type of 
RPTPases RNA in situ hybridization revealed that the expression is restricted to neuronal 
cells within the spinal ganglia and to developing and mature Purkinje cells within the 
cerebellum (A van den Maagdenberg, D Bachner, and W Hendriks, unpublished 
results, Ogata et al , 1995) This might point to a role in cerebellar development Also, 
upon treatment of PC 12 cells with nerve growth factor (NGF) the expression of the PTP 
BR7 transcript is increased with a maximal induction after 8 hours, suggesting a possible 
involvement of PTP BR7 in the early stages of neuronal growth and differentiation 
(Sharma and Lombroso, 1995) Still, it remains to be shown that the increase in PTP-BR7 
mRNA level is followed by an increase in protein product and/or enzymatic activity If 
so, PTP-BR7 might represent one of the three biochemically identified PTPase activities 
that are induced in NGF treated PC 12 cells (Aparicio et al , 1992) 
RPTPases as autoantigens in insulin-dependent diabetes mellitus 
The type VII RPTPase-like proteins IA 2 (also known as PTPLP, ICA512, the mouse 
homolog is denoted as PTP35) (Kambayashi et al, 1995, Lan et al , 1994, Lu et al , 
1994, Magistrelh et al , 1995) and IA-2/3 (also known as PTP-NP, the rat homolog is 
denoted as Phogrin) (Chiang and Flanagan, 1996, Lu et al , 1996, Wasmeier and Hutton, 
1996) are both RPTPase-like molecules with an unusual cysteine-nch region at their N-
terminus in the extracellular domain and only a single PTPase domain intracellular^ 
Interestingly, in this PTPase domain the conserved alanine in the signature motif has been 
substituted for an aspartate residue and it is still a question whether IA-2 or IA-2/3 are 
enzymatically active For IA-2 it has been proposed it acts as a competitive inhibitor by 
protecting phosphotyrosine residues from the activity of genuine PTPases (Kambayashi et 
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al, 1995) The intracellular part of IA-2 is about 74% identical to the corresponding 
domain of IA-2/3 but the extracellular domain differs substantially (only 26% identity) (Lu 
et al , 1996) Clearly, IA-2/3 and IA-2 are encoded by different genes but whether they 
reside on different chromosomes or are arranged in tandem at the same locus still has to 
be investigated 
IA-2, encoded by a 4 kb mRNA, is mainly expressed in brain and pancreatic islets 
(Hendriks et al , 1995, Kambayashi et al , 1995, Lan et al , 1994, Lu et al , 1994, 
Magistrelli et al , 1995) It was originally isolated from an insulinoma subtraction library 
(Lan et al , 1994) but it is still elusive whether its expression has any relation to 
unrestricted growth of these cells Magistrelh and coworkers (1995) found that the mRNA 
and protein expression of the mouse homolog of IA-2 is regulated during cell growth and 
stimulated by mitogens in mouse fibroblasts Mouse IA-2/3 may have a function in neural 
development as an alternative spliced mRNA lacking the extracelllular region is expressed 
in early neural cell lineages At later stages of neurogenesis and in the adult brain the 
expression of the full-length mRNA is observed (Chiang and Flanagan, 1996) 
IA-2 and IA-2/3 have now been identified as the precursors of the 40 kDA and 37 kDA 
insulin-dependent diabetes mellitus (IDDM)-specific major autoantigens, respectively 
(Bonifacio et al , 1995, Lan et al , 1996, Lu et al , 1996, Magistrelh et al , 1995, 
Passim et al , 1995, Payton et al , 1995, Rabin et al , 1994) Autoantibodies recognize 
both common and distinct determinants on IA-2 and IA 2/3 (Lu et al , 1996) Recently, 
IA-2 was identified as an intrinsic membrane protein of secretory granules which 
undergoes proteolytic cleavage at its luminal domain and that recycles to the Golgi 
complex to be sorted into newly formed secretory granules making IA-2 the first 
RPTPase residing in an intracellular compartment (Solimena et al , 1996) Also IA-2/3 is 
localized to the secretory granule membranes in pancreatic islets and the precursors of 
pancreatic endocrine cells (Chiang and Flanagan, 1996, Lu et al , 1996, Wasmeier and 
Hutton, 1996) These findings suggest that a subset of the autoantibodies in IDDM is 
directed against proteins associated with secretory vesicles (Solimena et al , 1996) 
Moreover, the human IA-2 gene maps to chromosome region 2q35-q36 1 (van den 
Maagdenberg et al , 1996) which is within the area where the IDDM7 or IDDM13 
susceptibility gene loci reside (Moraban et al , 1996), implying a direct role for IA-2 in 
autoimmune diabetes 
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Cell adhesion molecule-like RPTPases 
Cell-cell and cell matrix interactions play an important role during development, for 
example in cell migration, tissue morphogenesis, and axonal growth in the nervous 
system (Doherty and Walsh, 1994, Parons, 1996) It has now been well established that 
protein tyrosine phosphorylation is a key event in these interactions Hence, RPTPases are 
considered good candidates to function as direct signal transducers upon cell surface 
recognition in cell-cell and cell-matrix interactions (Brady-Kalnay and Tonks, 1995) 
The RPTPase that is subject of this thesis, the Leukocyte common Antigen-Related 
molecule LAR, belongs to a particular subset of RPTPases with a presumed role in these 
kind of interactions The extracellular part of these so-called cell-adhesion molecule 
(CAM)-like RPTPases contain multiple Fn-III-like repeats alone or in combination with 
immunoglubulin (Ig)-like domains They share these features with ECM proteins like 
fibronectin and tenascin, cell surface receptors such as the N-CAMs, the growth 
hormone-prolactin receptor family, and certain RPTKs like Axl and the Eph-subfamily 
These molecules are all involved m cell-cell or cell-matrix interactions The remaining 
part of this introduction will be dedicated to these CAM-like RPTPases that are classified 
as type II (A and B) and type III RPTPases (see Figure 1) 
The type III RPTPases: a function in contact inhibition? 
The type III RPTPases bear in their extracellular segment exclusively multiple Fn Ill-like 
repeats but can have either one or two cytosohc PTPase domains RPTP/3, and its 
homolog in Drosophila, DPTP10D (discussed below) were the first RPTPases identified 
with only one cytoplasmic PTPase domain They bear sixteen or twelve Fn-III-like 
repeats in their extracellular segment, respectively (Krueger et al , 1990, Tian et al , 
1991, Yang et al , 1991) This group has now been extended with the cloning of DEP 1 
(also known as PTPTJ, the mouse homolog is denoted Byp) (Honda et al , 1994, 
Kuramochi et al , 1996, Ostman et al , 1994), GLEPP1 (also known as РТР U2, the 
mouse homolog is denoted as РТРф) (Pixley et al , 1995, Seimiya et al , 1995, Thomas 
et al , 1994, Wiggins et al , 1995), and SAP-1 (Matozaki et al , 1994), all with eight Fn-
Ill-hke repeats extracellularly, and DPTP4E in Drosophila which contains eleven Fn-III-
like repeats in its extracellular domain (Oon et al , 1993) Also DPTP99A in Drososphila 
and OST-РТР which contain two cytoplasmic PTPase domains and two and ten Fn-III-like 
repeats extracellularly, respectively (Hanharan et al , 1991, Mauro et al , 1994), belong 
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to this class of RPTPases 
The type III RPTPases with only one catalytic PTPase domain contain specific amino 
acids within the PTPase domain, which are not present in either cytosolic PTPases or 
other RPTPases with tandem PTPase domains (Thomas et al , 1994, Wiggins et al , 
1995) Their mRNAs seem to come in many flavours, mainly due to alternative splicing 
Uniquely among RPTPases, for PTP0 two membrane spanning molecules and a cytosolic 
isoform with identical single PTPase domains have been found (Pixley et al , 1995) 
Alternative splicing might also be responsible for the existence of A3'-RPTP/3, an RPTP/3 
mRNA truncated near its catalytic site (de Vries et al , 1991), РТР-oc, an osteoclast-
specific 5'-truncated splice variant of GLEPP1 (Wu et al , 1996), and OB РТР, a rat 
olfactory bulb-specific GLEPPl isoform with only seven Fn-III-like repeats in its 
extracellular domain (Yahagi et al , 1996) 
There has been much speculation on the physiological role and regulation of the type 
III RPTPases For example, the intracellular domains of DEP-1, RPTP/3, and GLEPPl 
contain multiple tyrosine residues suggesting that tyrosine phosphorylation may regulate 
phosphatase activity Moreover, the С termini of these RPTPases contain a conserved 
YEN(LVV) amino acid motif which is a potential binding site for the SH2 domain of the 
Abl tyrosine kinase SH3-binding protein 3BP2, implying a role for 3BP2 in the signalling 
downstream of these RPTPases (Kuramochi et al , 1996, Mayer et al , 1992, Songyang et 
al , 1994) 
Compelling evidence for a specific function of these RPTPases was provided initially 
by Ostman et al (1994) They described that the expression of DEP-1 is dramatically 
increased in cell cultures at high density suggesting a role in contact inhibition of growth 
Earlier, Pallen and Tong (1991) had already found that PTPase activity is increased in 
cells harvested at high density Due to this increase, the levels of ligand-induced tyrosine 
phosphorylation of, for example, epidermal growth factor (EGF) and platelet-derived 
growth factor (PDGF) receptors decrease in cells at high density Thus, this mechanism 
serves to prevent cellular transformation (Sorby and Ostman, 1996) Indeed, density-
dependent growth inhibition can be overcome by treating cells with the a-specific PTPase 
inhibitor vanadate (reviewed in Brady-Kalnay and Tonks, 1994b) Conversely, upon 
stimulation of PTPase activity by О phospho-L-tyrosine, the growth of renal and breast 
carcinoma cell lines can be inhibited (Mishra and Hamburger, 1993) There is now 
accumulating evidence suggesting that individual type III RPTPases (e g DEP-1, RPTP/3, 
and OST РТР) might be candidates for mediating growth regulation by direct involvement 
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in density-dependent growth arrest (Gaits et al , 1994, 1995, Mauro et al , 1994, 1996, 
Southey et al , 1995) Still, for most members of this subclass this has to be 
experimentally verified 
The Drosophila RPTPases: essential in axon pathfinding 
Next to the two non-receptor PTPases DPTP61F (McLaughlin and Dixon, 1993) and 
corkscrew (Perkins et al , 1992), a family of five RPTPases has been identified in 
Drosophila (for review see Zinn, 1993) Of these five, the type III RPTPases DPTP4E 
and DPTP10D are the only ones that contain a single catalytic PTPase domain and eleven 
or twelve Fn Ill-like repeats in their extracellular segments, respectively In contrast, 
DPTP99A contains two tandemly repeated PTPase domains but only two Fn-III-like 
repeats in its extracellular part Finally, DLAR and DPTP69D (formerly DPTP) also 
contain two cytoplasmic PTPase domains, but extracellularly a combination of N terminal 
three Ig like and membrane-proximal nine Fn-III like repeats, or two Ig-hke plus two Fn-
Ill-like repeats, making them type IIA RPTPases (Desai et al , 1994, Hariharan et al , 
1991, Oon et al , 1993, Streuli et al , 1989, Tian et al , 1991, Yang et al , 1991) 
A transmembrane glycoprotein, gpl50, has been identified that selectively interacts 
with the active site in the catalytic domain of DPTP10D (Tian and Zinn, 1994) This 
substrate-enzyme interaction is unusual in that it is stable and does not require 
phosphorylation of the tyrosine residues in the short gpl50 cytoplasmic domain 
DPTP10D may therefore regulate the phosphorylation of gpl50 and thereby control the 
interactions with, as yet unknown, downstream effectors (Tian and Zinn, 1994) 
DPTP4E is expressed throughout many cell types in the fly whereas DLAR, 
DPTP10D, DPTP69D, and DPTP99A are much more selectively expressed on axons of 
the embryonic central nervous system (CNS) (for review see Chien, 1996, Desai et al , 
1994) Considering the structural similarity and the significant overlap in their expression, 
they may have redundant functions in the developing CNS (Desai et al , 1994, Tian el 
al , 1991, Yang et al , 1991) Indeed, flies lacking DPTP99A show no alterations in the 
embryonic CNS (Hamilton et al , 1995) In mutant embryos lacking DPTP69D, however, 
motor neuron growth cones stop growing before they reach their muscle targets or they 
bypass their muscle targets (Desai et al , 1996) This phenotype was more severe in 
double mutants lacking DPTP69D and DPTP99A (Desai et al , 1996) In flies lacking 
DLAR, motor axons fail to enter their appropiate targets and display bypass phenotypes 
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due to wrong navigation at specific choice points (Krueger et al , 1996) This phenotype 
was not 100% penetrant Interestingly, this restricted nature of the DLAR phenotype 
contrasts with the widespread neural expression of DLAR Taken together, the specific 
mutant phenotypes demonstrate specific roles for these three RPTPases in steering 
(DLAR) and defasciculation (DPTP69D, DPTP99A), important processes in motor axon 
guidance (Desai et al , 1996, Krueger et al , 1996) 
Type IIB RPTPases mediate cell-cell aggregation via homophilic interactions 
The closely related type IIB RPTPases RPTP/x (Gebbink et al , 1991) and RPTPK (Jiang 
et al , 1993), and the recently cloned PCP 2 (Wang et al , 1996) harbor intracellular^ 
the classical tandemly repeated PTPase domains, separated from the transmembrane 
segment by an unusually large juxtamembrane region The juxlamembrane region of 
RPTP i^ bears a potential binding site for 14-3-3 proteins, as is also found in RPTPe 
(Muslin et al , 1996) The multifunctional family of phosphosenne binding 14-3-3 
proteins play an important role in the formation of protein-protein complexes, and thus 
RPTPft's location and function may be regulated by serine phosphorylation In addition to 
an Ig like and four Fn-III like repeats, the extracellular part contains a MAM domain, 
which is a ~ 160 amino acids region including four cysteine residues that is also present in 
the unrelated membrane bound metalloendopeptidase mepnn and the Xenopus neuronal 
cell surface A5 glycoprotein (Beekman and Bork, 1993) Both RPTP/x and к can undergo 
postradiational cleavage at a site in the fourth Fn-III-like repeat by a member of the 
subtihsin family of endoproteases, most likely PC5 (Campan et al , 1996) This generates 
two subunits which remain associated in a noncovalent manner (Brady-Kalnay and Tonks, 
1994a, Gebbink el al , 1995, Jiang et al , 1993) The N terminal subunit which comprises 
almost the entire ectodomain can be shed from the surface of exponentially growing cells 
(Gebbink et al , 1995) 
RPTPμ and RPTPK can mediate cell cell aggregation via homophilic, but not 
heterophilic, interactions (Brady Kalnay et al , 1993, Gebbink et al , 1993, Sap et al , 
1994, Zondag et al , 1995) For these events to occur, the catalytic PTPase domains, 
proteolytic cleavage, or calcium are not required (Brady Kalnay et al , 1993, Gebbink et 
al , 1993, Sap et al , 1994) Using chimeric proteins it was found that the MAM domain 
might confer the homophilic binding specificity of RPTP^ (Zondag et al , 1995) 
However, another study pointed out that the Ig like domain is both necessary and 
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sufficient for the homophihc interaction of RPTP¿¿ (Brady-Kalnay and Tonks, 1994a) 
Perhaps, in analogy to the CAM-like RPTK Axl/Ark/tyro7/UFO (Bellosta et al , 1995, 
Stitt et al , 1995, Varnum et al , 1995), ΙΙΡΤΡμ might undergo a heterophils interaction, 
ι e binding a soluble ligand, at low cell density, and homophihc binding at high cell 
density (Brady-Kalnay and Tonis, 1995) 
Immunofluorescense studies revealed that the cell surface expression of ΙίΡΤΡμ and 
RPTPK is restricted to regions of cell-cell contact and increases with increasing cell 
density (Brady-Kalnay et al , 1995, Fuchs et al , 1996, Gebbink et al , 1995) This 
clustering at contact regions is accompanied by increased proteolytic cleavage of the 
protein (Campan et al , 1996) and may lead to tyrosine dephosphorylation of intracellular 
substrates at cell-cell contacts (Gebbink et al , 1995) Recently, members of the 
cadhenn/catenin complex were found to colocalize and associate with RPTP^ and RPTPK 
at adherens junctions (Brady-Kalnay et al , 1995, Fuchs et al , 1996) As /3-catenin has 
been suggested as a substrate for RPTPK PTPase activity, a functional role in the 
regulation of cell contact and adhesion controlled events is likely (Fuchs et al , 1996) 
Nevertheless, mice lacking RPTP^ (G Zondag and M Gebbink, personal 
communication) or RPTPK (Skarnes et al , 1995) show no apparent defects in embryonal 
development nor histological abnormalities at the adult stage 
LAR and the LAR-like RPTPases, RPTPô and RPTPa 
The type IIA RPTPases LAR, RPTPÔ, and RPTPa (also known as BPTP-1, ΡΤΡ-ΝΕ3, 
rPTP-2, LAR-PTP2, PTP-P1/-PS, PTP-NU3, CPTP-1/3, Crypa, and MPTP-H3/70 15) 
(Adachi et al , 1992, Boehm, 1993, Endo et al , 1996, Goldstein et al , 1992, Krueger et 
al , 1990, Mizuno et al , 1993, Ogata et al , 1994, Pan et al , 1993, Pot et al , 1991, 
Pulido et al , 1995a, 1995b, Sahin and Hockfield, 1993, Schaapveld et al , 1995, Stoker, 
1994, Streuli et al , 1988, Wagner et al , 1994, Walton et al , 1993, Yan et al , 1993, 
Zhang et al , 1994) bear an extracellular part existing of three tandemly arranged Ig-hke 
domains and eight Fn-III-like repeats with high homology to CAMs, like N-CAM, Ng-
CAM/L1, and fascichn II (Edelman and Crossin, 1991) 
All three RPTPases are expressed on the cell surface as a complex of two 
noncovalently-associated subunits (denoted as E- and P-subunit, see Figure 3) derived 
from a pro-protein Processing of this pro-protein by a subtihsin-hke endoprotease occurs 
intracellular^ at a paired basic amino acid-site located in the extracellular region (Streuh 
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et αι., 1992; Yu et al., 1992; Yan et al., 1993; Pulido et ai, 1995a, 1995b). The E-
subunit contains the CAM-like receptor-region, while the P-subunit contains a short 
segment of the extracellular region, the transmembrane peptide, and the cytoplasmic 
PTPase domains (see Figure 3) This arrangement is not only found for the type II 
RPTPases including ΚΡΤΡμ and к (as described above), but also, for example, for the 
cell-cell adhesion molecule Ng-CAM/Ll and the Drosophila PTK Sevenless (Burgoon et 
ai, 1991; Simonia/. , 1989). 
extracellular 
E-subunit(150kPa) 
intracellular 
P-subunit (85 kDa) 
mouse LAR N Г ^ ^ 1 і т т Ш ^ ! Ш ^ | 
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human LAR 
Drosophila LAR 
mouse RPTP5 
mouse RPTPo 
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Figure 3. LAR structure and conserved homology of the PTPase domains 
The 150 kDa E-subunit contains the CAM-like region, whereas the 85 kDa P-subunit contains a short 
segment oí the extracellular region, the transmembrane peptide, and the cytoplasmic PTPase domains a, 
site of proprotein processing resulting in the complex of two noncovalenlly-associated subunits, b, 
proteolytic cleavage at a second site within the P-subunil ectodomain near the transmembrane peptide 
necessary for shedding of the E-subunit, independent of the cleavage at a The same features have been 
reported tor RPTP5 Proteolytic cleavage has also been shown for RPTPa. 
Comparison of the amino acid sequences of the PTPase domains 1 and 2 shows the striking conservation (in 
% homology) tor the second PTPase domain not only between species, but also between the mouse 
homologs of the type IIA RPTPases For symbols see Figure 1 
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The E-subunit of LAR is shed during growth at high density (Streuli et al , 1992) 
This shedding results from a secondary proteolytic cleavage near the transmembrane 
peptide, is PMA-inducible, and independent of the first proteolytic cleavage (Serra-Pages, 
et al , 1994) This suggests that the protease(s) responsible for the shedding is regulated 
via activation of PKC, reminiscent of the PMA-inducible shedding of other receptors, like 
the leukocyte adhesion molecule L-selectin, the colony stimulating factor (CSF)-l 
receptor, and the tumor necrosis factor (TNF) receptor (Serra-Pagès et al , 1994) 
Shedding of the CAM-like ectodomain has also been reported for ΡΤΡδ, and is likely to 
be a common feature of the type II RPTPases (Pulido et al , 1995a, 1995b) It still 
remains to be established whether this shedding has an effect on the intracellular 
phosphatase activity and ligand reponsiveness The shed ectodomain might also have a 
distinct, cytokine-like function, thereby acting as a ligand itself or competing with the cell 
surface molecule for ligand binding More insight into the exact functional role of these 
features awaits characterization of the ligands and substrates 
LAR, RPTPô and RPTPa are overall 70% identical at the amino acid level, and up to 
-80-90% identical for both PTPase domains (Pulido et al , 1995b, Schaapveld et al , 
1995) Using bacterially expressed proteins and artificial substrates it was found that the 
first, membrane proximal domain of LAR is catalytically active Domain 2 may have only 
a regulatory role in controlling the substrate specificity of domain 1 (Itoh et al., 1992, 
Pot et ai, 1991, Streuli et al, 1990) In these assays, the catalytic activities of a 
recombinant LAR protein containing only the first domain or both domains were 
indistinguishable (Cho et al , 1992b, Itoh et al., 1992), argueing against the model for 
cooperativity in catalytic PTPase activity (Pallen, 1993) Strikingly, among species the 
second domain of LAR shows a slower mutation rate than the first (Streuli et al , 1990), 
and also sequence comparison with the LAR like RPTPases ΡΤΡδ and ΡΤΡσ revealed a 
higher homology (up to 90% at the protein level) for the second domain when compared 
with the first domain (Schaapveld et al., 1995, Figure 3) This is not seen for the type 
IIB RPTPases or for members of the other types of RPTPases (Schaapveld et al , 1995) 
Multiple isoforms of LAR, RPTPô, and RPTPa (as shown in Figure 4) appear to be 
generated by tissue-specific and developmentally regulated alternative splicing (Endo et 
al , 1996, Longo et al , 1993, Mizuno et al , 1993, 1994, Ogata et al , 1994, O'Grady et 
al , 1994, Pan et al , 1993, Pulido et al , 1995a, 1995b, Stoker, 1994, Wagner et al , 
1994, Walton et al , 1993, Yan et al , 1993, Zhang and Longo, 1995) In addition, 
alternative polyadenylation is involved in the formation of an RPTPa isoform with a 
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truncated cytoplasmic segment lacking the second PTPase domain (Pan et al , 1993) One 
tissue can express multiple isoforms with varieties in the number of Fn-III-like repeat 
units, Ig-hke domains, and presence or absence of mini-exon segments encoding small 
peptides This structural diversity might lead to functional diversity, ι e ligand 
specificity, as was shown for N-CAM, where splicing of a 10-amino acid peptide located 
within the fourth Ig-hke domain regulates the neunte outgrowth promoting activity of N-
CAM (Doherty et al., 1992) Within N-CAM, the Ig-like domains predominantly regulate 
cell adhesion and the Fn-III-like repeats contribute significantly to neunte outgrowth (Frei 
et al , 1992) Although the different isoforms are mainly found in brain, it is not known 
whether LAR, PTPô or ΡΤΡσ affect neunte outgrowth 
Yet, this would not be too surprising as many aspects of neural cell function are 
regulated via tyrosine phosphorylation For example the receptors for NGF and its related 
family of neurotrophins are all RPTKs of the Trk-family (for review see Barbacid, 1995) 
These receptors are expressed almost exclusively in neurons in a developmentally 
regulating pattern, and mutant animals have provided detailed information on the role they 
play in neuronal development The CAM-hke RPTPases are good candidates to 
participate in such processes RNA in situ hybridization experiments demonstrate complex 
spatial and developmental regulation of LAR, RPTPô, and RPTPCT expression during 
development in many areas of the brain For example, LAR is expressed in the forebrain, 
brainstem, dorsal root ganglia, and in hippocampal, pyramidal and dentate granule 
neurons, and cerebellar Purkinje cells (Longo et al , 1993, Schaapveld et al , unpublished 
results) Strikingly, high levels of RPTPa were observed in the same structures (Yan et 
al , 1993), and also RPTPô could be detected in the pyramidal cell layer of the 
hippocampus and the piriform cortex (Mizuno et al , 1993) In addition, LAR is 
expressed at high levels in the proliferative zone of the cortex, whereas RPTPa shows 
highest levels of expression during the period of corticogenesis, in the external granule 
cell layer of the developing cerebellum (Sahin and Hockfteld, 1993, Sahin et al , 1995, 
Yan et al , 1993) High levels of the brain-specific isoform of RPTPa lacking four Fn-III 
like repeats (AFn4-7, see Figure 4) were also observed in the immature neurons of the 
olfactory neuroepithehum (Walton et al , 1993) Wang et al (1995), however, showed 
that the signal in the immature neuroepithehum represented the full-lenght transcript, 
whereas the brain-specific ΔΡη4-7 isoform is expressed at the adult stage Comparison of 
the various expression data is, however, difficult because mostly different species or 
developmental stages were used Furthermore, due to the extensive alternative splicing, it 
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Figure 4. Comparison of ihe structures and alternative splicing patterns of LAR, RPTP6, and RPTPo 
A schematic representaion ot LAR, RPTP6, and RPTPff isoforms is depicted The lull lenght isolorms 
encode three Ig like domains, eight Fn-III-like repeats, the transmembrane peptide, and two cytoplasmic 
PTPase domains The positions of the mini-exon (me) A, meB, meC, and meD peptides are indicated by 
small arrows For LAR, meC represents the alternative spliced small exon 13 (O'Grady el al., 1994) 
Alternative usage for the meA-meD peptides may also occur in the truncated isoforms No LAR isoforms 
containing the meB sequence were isolated In addition, a LAR-AFn4-7 isotorm as reported by O'Grady el 
al (1994) was not found by others (Pulido et al , 1995b) Wagner el al (1994) reported the existence of a 
mouse RPTPa isotorm with nine Fn-III-like repeats due to a 132-bp insertion at the fourth Fn-III-like 
repeat The existence ot a rat RPTPo-AFn4 isoform has only been claimed by Ogata et al (1994) by 
sequence comparison with their mouse homolog The RPTPa-AExt/D2 and -lgl-2 isoforms have only been 
detected in chicken (Stoker, 1994). The RPTPa-AExl/D2 might be a partial clone of RPTPa-AFn4-7/D2 
Sequence errors or PCR artifacts might explain some of these discrepancies For abbrevations and symbols 
see Figure 1 D2, PTPase domain 2, Ext, extracellular region 
is hard to establish which isoform corresponds with a specific signal So, although a role 
in creating the neuronal architecture of the CNS is suggested, the precise physiological 
meaning of the isoform alteration during neuronal development as seen for all three 
RPTPases remains to be clarified 
The cell biological role of LAR? 
Alhough LAR was among the first PTPases to be identified and has been studied 
extensively at the cellular level, its physiological function remains unclear. Several 
possible physiological functions have been put forward Firstly, since PTPases may be 
involved in signals which inhibit cell growth upon cell-cell contact (Fischer et al., 1991), 
LAR may function as a tumor suppressor gene The single copy gene for LAR (PTPRF) 
is located on human chromosome lp32-34 1 (Disteche et al., 1989, Jink et al., 1992; 
Streuli et al., 1992; A. van den Maagdenberg, unpublished observation). This region is 
frequently deleted in tumors of neuroectodermal origin, as for example 
phaeochromocytoma, medullary thyroid carcinoma, and neuroblastoma (reviewed in 
Dracopoli et al., 1994). Also, aberrant transcripts of LAR lacking the cytoplasmic 
phosphatase domains have been found in colon and breast tumors (Weinstein et al., 
1993) Furthermore, the resemblance of the LAR extracellular part to the tumor 
suppressor gene Deleted in Colorectal Cancer (DCC) (Fearon et al., 1990) and other 
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CAM'S which play a role in metastasis, is evident A possible role in breast carcinoma 
came from studies showing increased LAR expression in RPTK pl85"eu transformed 
breast epithelial cells and that overexpression of LAR can reduce the tumor growth of 
these transformed cells (Zhai et al., 1993, 1995) It is still hypothetical whether LAR 
plays a suppressive regulatory role in tumor growth in these breast carcinoma cells as also 
candidate breast carcinoma tumor suppressor genes are located to the same chromosomal 
region as LAR (Genuardi et al , 1989, Weinberg, 1991) Furthermore, the involvement 
of other PTPases in the suppression of tumor growth of pl85neu induced human breast 
carcinoma cells (Brown-Shimer et al , 1992, Elson and Leder, 1995a, Wiener et al , 
1994) needs more clarification 
Secondly, a role for LAR in insulin signalling has been suggested based on several 
findings For example, LAR expression is increased in adipose tissue of obese human 
subjects (Ahmad et al , 1995, Ahmad and Goldstein, 1995) Also, LAR has been found to 
be active against the autophosphorylated insulin receptor (IR) m vitro, preferentially 
dephosphorylating the phosphotyrosine residues that have been implicated in the 
regulation of the receptor kinase (Hashimoto et al , 1992a) Moreover, antisense 
inhibition of LAR led to increased hgand-dependent IR activation and signalling (Kulas et 
al , 1995, 1996b), whereas overexpression of membrane-bound LAR decreased the 
tyrosine phosphorylation of the IR upon insulin stimulation (Zhang et al , 1996) In 
addition, the IR and LAR could be co-immunoprecipitated upon chemical cross linking on 
the surface of rat hepatoma cells (Zhang et al , 1996) In these cells LAR may influence 
the phosphorylation status of the IR and its substrates IRS-1 and 1RS 2 (Li and Goldstein, 
1996) However, not only LAR but various other PTPases, such as the cytosohc PTP1B 
and SHP2 and the RPTPases CD45, RPTPa, and RPTPe are also capable of 
dephosphorylating the IR (Goldstein, 1993, Kulas et al , 1996a М ііег et al , 1995) 
Also, the levels of LAR expression in the insulin sensitive tissues as liver and muscle are 
subject of debate (Hashimoto et al , 1992b, Longo et al , 1993, Pulido et al , 1995b, 
Streuh et al , 1992, Schaapveld et al , 1996, Zhang and Goldstein, 1991) Therefore, the 
identification of the PTPase family members that are critically involved in the in vivo 
regulation of insulin signalling needs further study 
Finally, as LAR is colocalized with a coiled-coil protein, termed LAR-interacting 
protein 1 (LIP 1) at the ends of focal adhesions (FAs) LAR may be involved in cell-
matrix interactions (Serra-Pages et al , 1995) Strikingly, also RPTPô and RPTPa are able 
to interact with LIP 1 (Pulido et al , 1995b) LIP 1 binds to the second phosphatase 
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domain of LAR, as does also a second protein, termed TRIO, which was also identified 
using the two-hybrid system (Debant et al , 1996) TRIO contains N-terminally four 
spectrin like repeats (involved in intracellular targeting) followed by two functional GEF 
domains, guanine nucleotide exchange factors which promote the exchange of GDP for 
GTP One domain is specific for the small GTP-binding protein Rac which is involved in 
the formation of lamellipodia and membrane ruffles The second domain activates Rho 
which is involved in the formation of stress fibers and focal contacts (for review see 
Zigmond, 1996) Both GEF domains are followed by a pleckstrin homology (PH) 
domain, implicated in membrane association by interacting with membrane-bound proteins 
or by binding directly to phospholipids (for review see Lemmon et al , 1996, Mayer et 
al , 1993, Shaw, 1996) At its С terminus, TRIO contains adjacent to an Ig-like domain a 
protein serine kinase (PSK) domain, which is most similar to smooth muscle myosin light 
chain kinase Thus, the apparently inactive second PTPase domain of LAR may play a 
role in placing LAR in the proper cellular environment close to cytoskeletal proteins in 
the cell cortex and FAs The role of tyrosine phosphorylation in the maintenance and 
modulation of cell cell and cell-substratum interactions indeed strongly suggests a 
potential catalytical role for LAR in these regions An example is the formation of FAs 
by the changes in tyrosine phosphorylation of associated proteins (for review see Craig 
and Johnson, 1996 Parsons, 1996) FAs contain transmembrane proteins known as 
integrins, which link the ECM to an intracellular plaque associated with actin bundles 
(stress fibers) Attachment of cells to the ECM results in tyrosine phosphorylation of 
multiple intracellular proteins associated with these adhesions including paxilhn, tensin, 
tahn, β íntegnn and focal adhesion kinase (FAK) Inhibition of cellular tyrosine kinases 
prevents the formation of FAs Taking into account that the expression of LAR is most 
widespread in epithelial cells, which are especially rich in FAs, and that LAR is also 
localized at other regions of association of cells and the basement membrane (Streuli et 
al , 1992), a functional role for LAR in integrin-mediated tyrosine phosphorylation and 
the formation of cellular structures like FAs is indeed most obvious 
Outline of this thesis 
The identification of many distinct RPTPase genes and the discovery of multiple isoforms 
resulting from alternative splicing and posttranslational modification has revealed a 
surprising complexity for this multiprotein family Studies on the biological significance 
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of the expression of RPTPase isoforms are hampered by the spatial and tissue regulation 
of isoform expression in vivo which can not be mimicked in individual cell lines m vitro 
Moreover, the study of structure-function relationships is intrinsically difficult because 
these genes and proteins are generally very large in size, and for most of the family 
members specific ligands and substrates are not at hand In addition, a direct read-out for 
activation or inhibition of RPTPases is not available The studies described in this thesis 
represent an approach that is independent of such knowledge, yet allows the study of the 
in vivo function of an individual RPTPase in signal transduction and growth regulation 
The isolation, cloning, and characterization of the relevant segments of the structural 
and genomic DNAs of the mouse homolog of the CAM-like RPTPase LAR (Chapter II) 
provided us with the necessary tools to construct a replacement type targeting vector to 
generate mouse embryonic stem (ES) cell lines by homologous recombination lacking 
LAR exon sequences encoding both cytoplasmic PTPase domains (Chapter III) These ES 
cell lines were subsequently used to generate mice with a loss of function mutation, ι e 
lacking LAR tyrosine phosphatase activity (Chapter IV) The observed effects of this 
mutation point to a role for LAR in mammary gland development and function (Chapter 
IV) In addition, in a collaborative effort the consequences ol the lack of LAR PTPase 
activity with respect to metabolic responses induced by insulin were investigated (Chapter 
V) The conclusions which can be drawn from these studies and future directions to better 
define the complex interactions and functions of the RPTPase LAR within the signal 
transduction network controlling development and differentiation are discussed in the final 
chapter (Chapter VI) 
42 
general introduction 
References 
Adachi, M , Sekiya, M., Arimura, Y., Takekawa, M., Itoh, F., Hinoda, Y., Imai, К., and Yachi, A 
(1992) Protein-tyrosine phosphatase expression in pre-B cell NALM-6. Cancer Res , 52:737-740 
Ahmad, F , Considine, R.V., and Goldstein, В J. (1995) Increased abundance of the receptor-type 
protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity 
in adipose tissues ot obese human subjects J. Clin Invest , 95:2806-2812 
Ahmad, F., and Goldstein, B.J (1995) Increased abundance of specific skeletal muscle protein-tyrosine 
phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus Metabolism, 44 1175-
1184 
Aparicio, L F., Ocrant, I., Boylan, J M , and Gruppuso, Ρ A (1992) Protein tyrosine phosphatase 
activation during nerve growth factor-induced neuronal differentiation of PC12 cells. Cell Growth Differ , 
3363-367 
Arendt, C.W , and Ostergaard, H.L. (1995). CD45 protein-tyrosine phosphatase is specifically associated 
with a 116-kDa tyrosine-phosphorylated glycoprotein J. Biol. Chem., 270:2313-2319 
Aruffo. A , Kanner, S.B., Sgroi, D., Ledbetter, J.A , and Stamenkovic, I (1992). CD22-mediated 
stimulation ot Τ cells regulates T-cell receptor/CD3-induced signalling. Proc Natl. Acad. Sci. USA, 
89.10242-10246. 
Autero, M , Sahannen, J , Pessa Monkawa, Τ , Soula-Rothhut, M , Oetken, С , Gassmann, M , Bergman, 
M , Alitalo, К , Bum, Ρ , Gahmberg, С G., and Mustelin, Τ (1994) Tyrosine phosphorylation of 
CD45 phosphotyrosine phosphatase by p50"' kinase creates a binding sue for p56'rt tyrosine kinase and 
activates the phosphatase Mol. Ceti Biol , 14:1308-1321 
Barbacid, M (1995) Neurotrophic factors and their receptors Сип. Орт Cell Biol , 7:148-155 
Barford, D , Flint, A J., and Tonks, Ν К (1994) Crystal structure of human protein tyrosine phosphatase 
IB Science, 263· 1397-1404 
Barford, D., Jia, Z., and Tonks, N K. (1995) Protein tyrosine phosphatases take oft. Nature Struct Biol., 
2:1043-1053 
Barnea, G , Silvermoinen, О , Shaanan, В., Honegger, A M , Canoll, P.D , D'Eustachio, Ρ , Morse, В , 
Levy, J.B , LaForgia, S., Huebner, К., Musacchio, J.M , Sap, J., and Schlessinger, J. (1993). 
Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP7 defines a new 
subfamily of receptor tyrosine phosphatases Mol Cell Biol , 13 1497-1506 
Bamea, G , Grumet, M , Milev, P., Silvermoinen, О , Levy, J В , Sap, J , and Schlessinger, J (1994a) 
Receptor tyrosine phosphatase β is expressed in the form of proteoglycan and binds to the extracellular 
matrix protein tenascin J Biol Chem , 269:14349-14352. 
Bamea, G , Gnimet, M , Sap, J , Margolis, R.U , and Schlessinger, J. (1994b) Close similarity between 
receptor-linked tyrosine phosphatase and rat brain proteoglycan Cell, 76 205 
Beekman, G, and Bork, Ρ (1993) An adhesive domain detected in functionally diverse receptors Trends 
Biochem. Sa , 18.40-41 
Bellosta, P., Costa, M., Lin, D Α., and Basilico, С. (1995). The receptor tyrosine kinase ARK mediates 
cell aggregation by homophilic binding. Mol Cell. Biol , 15:614-625 
43 
Chapter I 
Bilwes, A M , den Hertog, J , Hunter, Τ , and Noel, J Ρ (1996) Structural basis for inhibition of receptor 
protein tyrosine phosphatase-α by dimenzation Nature, 382 555 559 
Boehm, Τ (1993) Analysis of multigene families by DNA fingerprinting of conserved domains direct 
cloning of tissue-specific protein tyrosine phosphatases Oncogene, 8 1385-1390 
Bonifacio, E , Lampasona, V , Genovese, S , Ferrari, M , and Bosi, E (1995) Identification of protein 
tyrosine phosphatase-like 1A2 (islet cell antigen 512) as the insulin-dependent diabetes related 37/40K 
autoantigen and a target of islet cell antibodies J Immunol , 155 5419 5426 
Bork, Ρ , and Dooliltle, R F (1993) Fibronectin type-Ill modules in the receptor phosphatase CD45 and 
tapeworm antigens Protein Science, 2 1185-1187 
Brady-Kalnay, S M , Flint, A J , and Tonks, Ν К (1993) Homophilic binding ot ΡΤΡμ, a receptor type 
protein tyrosine phosphatase, can mediate cell cell aggregation J Cell Biol , 122 961-972 
Brady-Kalnay, S M , and Tonks, N К (1994a) Identification of the homophilic binding site of the receptor 
protein tyrosine phosphatase ΡΤΡμ J Biol Chem , 269 28472 28477 
Brady-Kalnay, S M , and Tonks, Ν К (1994b) Receptor protein tyrosine phosphatases, cell adhesion and 
signal transduction Adv Prot Phosphatases, 8 241-274 
Brady-Kalnay, S M , and Tonks, Ν К (1995) Protein tyrosine phosphatases as adhesion receptors Curr 
Op Cell Biol , 7 650 6657 
Brady-Kalnay, S M, Rimm, D L , and Tonks, Ν К (1995) Receptor protein tyrosine phosphatase ΡΤΡμ 
associates with Cadherins and catenins in vivo J Cell Biol , 130 977-986 
Brown-Shimer, S , Johnson, К A , Hill, D E , and Bruskin, A M (1992) Effect of protein tyrosine 
phosphatase IB expression on transformation by the human neu oncogene Cancer Res , 52 478 482 
Brummendorf, T, and Rathjen, F G (1993) Лхопаі glycoproteins with immunoglobulin and fibronectin 
type Ill-related domains in vertebrates Structural features, binding activities, and signal transduction J 
Neurochem , 61 1207 1219 
Bruyns, E , Hendricks-Taylor, L R , Meuer, S , Koretzky, G A , and Schraven, В (1996) Identification 
of sites of interaction between lymphocyte phosphatase associated phosphoprotein (LPAP) and CD45 
J Biol Chem , 270 31372-31376 
Burgoon, Μ Ρ , Grumet, M , Mauro, V , Edelman, G M , and Cunningham, В A (1991) Structure of the 
chicken neuron-glia cell adhesion molecule, Ng-CAM origin of the polypeptides and relation to the Ig 
superfamily J Cell Biol , 112 1017 1029 
Bums, C M , Sakaguchi, K, Appella, E , and Ashwell, J D (1994) CD45 regulation ot tyrosine 
phosphorylation and enzyme activity of scr family kinases J Biol Chem , 269 13594-13600 
Byth, К F , Conroy, L A , Howie«, S , Smith, A J Η May, J , Alexander, D S , and Holmes, N (1996) 
CD45 null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in 
the selection of CD4*CD8+ thymocytes, and in В cell maturation J Exp Med 183 1707 1718 
Cahir McFarland, E D , and Thomas, M L (1995) CD45 protein-tyrosine phosphatase associates with the 
WW domain containing protein CD45AP, through the transmembrane domain J Biol Chem 
270 28103-28107 
Campan, M , Yoshizumi, M , Seidah, Ν G , Lee, Μ E , Bianchi С , and Haber, E (1996) Increased 
proteolytic cleavage of protein tyrosine phosphatase μ in confluent vascular endothelial cells the role of 
44 
general introduction 
PC5, a member of the subtilisin family Biochemistry, 35 3797 3802 
Canoll, Ρ D , Barnea, G , Levy, J В , Sap, Ì , Ehrlich, M , Silvennoinen, О , Schlessinger, J , and 
Musacchio, J M (1993) The expression of a novel receptor-type tyrosine phosphatase suggests a role in 
morphogenesis and plasticity of the nervous system Dev Brain Res , 75 293-298 
Canoll, Ρ D , Petanceska, S , Schlessinger, J , and Musacchio, J M (1996) Three forms of RPTP-0 are 
differentially expressed during ghogenesis in the developing rat brain and during glial cell differentiation 
in culture J Neurosa Res, 44 199-215 
Chan, А С , Desai, D M , and Weiss, A (1994) The role of protein tyrosine kinases and protein tyrosine 
phosphatases in Τ cell antigen receptor signal transduction Annu Rev Immunol , 12 555 592 
Charbonneau, Η , Tonks, Ν К , Walsh, К A , and Fischer, Ε Η (1988) The leukocyte common antigen 
(CD45) A putative receptor-linked protein tyrosine phosphatase Proc Natl Acad Sci USA, 85 7182-
7186 
Chiang, M К , and Flanagan, J G (1996) PTP-NP, a new member of the receptor protein tyrosine 
phosphatase family, implicated in development of nervous system and pancreatic endocrine cells 
Development, 122 2239-2250 
Chien, С -В (1996) PY in the fly Receptor-like tyrosine phosphatases in axonal pathfindmg Neuron, 
16 1065 1068 
Cho Η , Krishnaraj, R , Kitas, E , Bannwarth, W , Walsh, С Τ , and Anderson, К S (1992a) Isolation 
and structural elucidation of a novel phosphocysteine intermediate in the LAR protein tyrosine 
phosphatase enzymatic pathway J Am Chem Soc , 114:7296 7298 
Cho H , Ramer, S E , Itoh, M , Kitas, E , Bannwarth, W , Bum, Ρ , Saito, Η , and Walsh, С Τ (1992b) 
Catalytic domains of the LAR and CD45 protein tyrosine phosphatases from Escherichia coll expression 
systems Purification and characterization for specificity and mechanism Biochemistry, 31 133-138 
Coombe D R , Watt, S M , and Parish, C R (1994) Mac 1 (CDII0/CDI8) and CD45 mediate the 
adhesion ot hematopoietic progenitor cells to stroma] cell elements via recognition ot stromal heparan 
sulfate Blood 84 739 752 
Craig, S W , and Johnson, R Ρ (1996) Assembly of focal adhesions progress, paradigms, and portents 
Curr Opm Cell Biol , 8 74-85 
Cysler, J G , Healy, J I , Kishihara, К , Мак, Τ W , Thomas, M L , and Goodnow, С С (1996) 
Regulation of B-lymphocyte negative and postive selection by tyrosine phosphatase CD45 Nature, 
381 325 328 
Daum, G , Zander, N F , Morse, R , Hurwitz, D , Schlessinger, J , and Fischer, Ε H (1991) 
Characterization of a human recombinant receptor linked prolein tyrosine phosphatase J Biol Chem , 
266 12211 12215 
Daum, G , Regenass, S , Sap, J , Schlessinger, J , and Fischer, Ε Η (1994) Multiple isoforms of the 
human tyrosine phosphatase RPTPa Isoenzymes and differences in glycosylation J Biol Chem 
269 10524-10528 
Debant, A , Serra-Pages, С , Seipel К , O'Brien, S , Tang, M , Park, S Η , and Streuli, M (1996) The 
multidomain protein Trio binds the LAR transmembrane tyrosine phosphatase, contains a protein kinase 
domain, and has separate rac-specific and rho-specific guanine nucleotide exhange factor domains Proc 
45 
Chapter I 
Nail Acad Sa USA, 93 5466 5471 
den Hertog, J , Pals, С E G M , Peppelenbosch, M Ρ , Tertoolen, L G J , de Laat, S W , and Kruijer, W 
(1993) Receptor protein tyrosine phosphatase a activates pp60c s" and is involved m neuronal 
differentiation EMBO J , 12 3789 3798 
den Hertog, J , Tracy, S , and Hunter, Τ (1994) Phosphorylation ot receptor protein-tyrosme phosphatase 
α on Tyr789, a binding site for the SH3-SH2-SH3 adaptor protein Grb-2 in vivo EMBO J , 13 3020 
3032 
den Hertog, J , Sap, J , Pals, С E G M , Schlessinger, J , and Kruijer, W (1995) Stimulation of receptor 
protein tyrosine phosphatase a activity and phosphorylation by phorbol ester Cell Growth Differ , 6 303 
307 
den Hertog, J , and Hunter, Τ (1996) Tight association of GRB2 with receptor protein tyrosine 
phosphatase α is mediated by the SH2 and C-terminal SH3 domains EMBO J , 15 3016-3027 
Desai, С J , Popova, E, and Zinn, К (1994) A Drosophila receptor tyrosine phosphatase expressed in the 
embryonic CNS and larval optic lobes is a member of the set of proteins bearing the "HRP 
carbohydrate epitope J Neurosa , 14 7272-7283 
Desai, С J , Gindhart Jr , J G , Goldstein, L S В , and Zinn, К (1996) Receptor tyrosine phosphatases are 
required for motor axon guidance in the Drosophila embryo Cell, 84 599 609 
Desai, D M , Sap, J , Silvennoinen, О , Schlessinger, J , and Weiss, A (1993) Ligand mediated negative 
regulation of a chimeric transmembrane receptor tyrosine phosphatase Cell 73 541-554 
Desai, D M , Sap, J , Silvennoinen, О , Schlessinger, J , and Weiss, A (1994) The catalytic activity of 
the CD45 membrane proximal phosphatase domain is required tor TCR signaling and regulation EMBO 
J , 13 4002 4010 
de Vnes, L , Li, R -Y , Ragab, A , Ragab-Thomas, J M F , and Chap, H (1991) Expression of a 
truncated protein tyrosine phosphatase mRNA in human lung FEBS Leti , 282 285-288 
Disteche, С M , Adler, D A , Tedder, Τ F , and Saito, Η (1989) Mapping of the genes LYAM1, a new 
lymphocyte adhesion molecule, and for LAR, a new receptor-linked protein tyrosine phosphatase to 
human chromosome 1 Tenth international workshop on human gene mapping Cytogenet Cell Genet , 
51 990 
Doherty, Ρ , Moolenaar, С E С К , Ashlon, S V , Michalides, R J A M , and Walsh, F S (1992) Use ot 
the VASE exon down regulates the neunte outgrowth promoting activity of NCAM 140 Nature 
356 791 793 
Doherty, Ρ and Walsh, F S (1994) Signal transduction events underlying neunte outgrowth stimulated by 
cell adhesion molecules Curr Opin Neurobwl , 4 49 55 
Dracopoli, N С , Bruns, G A P , Brodeur, G M , Landes, G M , Matise, Τ С , Seldin, M F , Vante, 
J M , and Weith, A (1994) Report of the first international workshop on human chromosome 1 
mapping 1994 Cytogenet Cell Genet , 67 144-165 
Druck, Τ , Kastury, К , Hadaczek, Ρ , Podolski, J , Toloczko, A , Sikorski, A , Ohta M , LaForgia, S , 
Lasota, J , McCue, Ρ , Lubinski, J , and Huebner, К (1995) Loss of heterozygosity at the familal RCC 
t(3,8) locus in most clear cell renal carcinomas Cancer Res , 55 5348 5353 
Edelman, G M , and Crossin, К L (1991) Cell adhesion molecules implications for a molecular histology 
46 
general introduction 
Annu Rev Biochem , 60 155-190 
Elson, A , and Leder, Ρ (1995a) Protein tyrosine phosphatase ε An isoform specifically expressed in 
mouse mammary tumors initiated by ν Ha ras or neu J Biol Chem , 270 26116-26122 
Elson, A , and Leder, Ρ (1995b) Identification of a cytoplasmic, phorbol ester inducible isoform of protein 
tyrosine phosphatase ε Proc Natl Acad Sa USA, 92 12235 12239 
Endo, N , Rutledge, S J , Opas, E E , Vogel, R , Rodan, G A , and Schmidt, A (1996) Human protein 
tyrosine phosphatase-σ alternative splicing and inhibition by biphosphonates J Bone Miner Res 
11 535 543 
Fang, К S , Barker, К , Sudol, M , and Hanatusa, H (1994a) A transmembrane protein tyrosine 
phosphatase contains spectrin like repeats in its extracellular domain J Biol Chem , 269 14056 14063 
Fang, К S , Sabe, Η , Sano, Η , and Hanafusa, Η (1994b) Comparative study ot three protein-tyrosine 
phosphatases Chicken protein-tyrosine phosphatase λ dephosphorylates с Src tyrosine 527 J Biol 
Chem , 269 20194 20200 
Fearon, E R , Cho, К R , Nigro, J M , Simons, J W , Ruppert, J M , Hamilton, S R , Preisinger, А С , 
Thomas, G , Kinzler, К W , and Vogelstein, В (1990) Identification of a chromosome 18q gene that is 
altered in colorectal cancers Science, 247 49 56 
Fischer, E H , Charbonneau, Η , Tonks, Ν К (1991) Protein tyrosine phosphatases a diverse family of 
intracellular and transmembrane enzymes Science, 253 401 406 
Frei Τ von Bohlen und Halbach, F , Wille, W , and Schachner, M (1992) Different extracellular 
domains ol the neural cell adhesion molecule (N CAM) are involved in different functions J Cell Biol , 
118 177 194 
Fuchs, M , Muller, Τ , Lerch, Μ Μ , and Ullrich, A (1996) Association of human protein tyrosine 
phosphatase к with members of the armadillo family J Biol Chem , 271 16712 16719 
Furukawa, Τ , Itoh, Μ , Krueger, Ν X , Streuli, Μ , and Sano, H (1994) Specific interaction ol the 
CD45 protein tyrosine phosphatase with tyrosine phosphorylated CD3 f chain Proc Natl Acad Sa 
USA 91 10928 10932 
Gaits, F , Li, R -Y , Ragab, A , Selves, J , Ragab Thomas, J M F , and Chap, Η (1994) Implication of a 
protein tyrosine phosphatase in human lung cancer Cell Mol Biol , 40 677 685 
Gans, F , Li, R Y , Ragab, A, Ragab-Thomas, J M F , and Chap, H (1995) Increase in receptor like 
protein tyrosine phosphatase activity and expression level on density dependent growth arrest of 
endothelial cells Biochem J , 311 97 103 
Gebbink, M F В G , van Etten, I , Hateboer, G , Suijkerbuijk, R , Beijersbergen, R L , Geurts van Kessel, 
A and Moolenaar, W H (1991) Cloning, expression and chromosomal localization of a new putative 
receptor like protein tyrosine phosphatase FEBS Lett , 290 123 130 
Gebbink, M F В G , Zondag G С M , Wubbolts, R W , Beijersbergen, R L , van Etten, I , and 
Moolenaar, W H (1993) Cell cell adhesion mediated by a receptor-like protein tyrosine phosphatase J 
Biol Chem , 268 16101 16104 
Gebbink M F В G , Zondag G С M Koningstein, G M , Feiken, Ε , Wubbolts, R W , and Moolenaar, 
W H (1995) Cell surface expression of receptor protein tyrosine phosphatase RPTPft is regulated by 
cell cell contact J Cell Biol , 131 251 260 
47 
Chapter I 
Genuardi, M , Tsihira, H , Anderson, D E , and Saunders, G F (1989) Disiai deletion of chromosome 1 ρ 
in ductal carcinoma of the breast Am J Hum Gen , 45 73 82 
Goldstein, В J , Zhang, W-R , Hashimoto, Η , and Kahn, С R (1992) Approaches to the molecular 
cloning of protein-tyrosine phosphatases in insulin sensitive tissues Mol Cell Biochem 109 107-113 
Goldstein, В J (1993) Regulation of insulin receptor signaling by protein-tyrosine dephosphorylation 
Receptor, 3 1-15 
Guan, К L , and Dixon, J E (1991) Evidence for protein tyrosine phosphatase catalysis proceeding via a 
cysteine-phosphate intermediate J Biol Chem , 266 17026 17030 
Hamilton, В A , Ho, A , and Zinn, К (1995) Targeted mutagenesis and genetic analysis of a Drosoplula 
receptor linked protein tyrosine phosphatase gene Roux's Arch Dev Biol , 204 187 192 
Hanharan, Ι К , Chuang, Ρ -Τ , and Rubin, G M (1991) Cloning and characterization of a receptor class 
phosphotyrosine phosphatase gene expressed on central nervous system axons in Drosophila 
melanogaster Proc Nail Acad Set USA, 88 11266 11270 
Hashimoto, N , Feener, Ε Ρ , Zhang, W -R , and Goldstein, В J (1992a) Insulin receptor protein 
phosphatases Leukocyte common antigen related phosphatase rapidly deactivates the insulin receptor 
kinase by preferential dephosphorylation of the receptor regulatory domain J Biol Chem , 267 13811 
13814 
Hashimoto, N , Zhang, W -R , and Goldstein В J (1992b) Insulin receptor and epidermal growth factor 
receptor dephosphorylation by three major rat liver protein tyrosine phosphatases expressed in a 
recombinant bacterial system Biochem J , 284 569 576 
Hendriks, W (1995) Neuronal nunc oxide synthase contains a discs large homologous region (DHR) 
sequence motif Biochem J , 305 687 688 
Hendriks, W , Schepens, J , Brugman, С , Zeeuwen Ρ , and Wiennga, В (1995) A novel receptor-type 
protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain 
Biochem J , 305 499-504 
Honda, Η , Inazawa J , Nishida, J , Yazaki, Y , and Hirai H (1994) Molecular cloning 
characterization, and chromosomal localization of a novel protein tyrosine phosphatase, HPTPTJ Blood 
84 4186 4194 
Hunter, Τ , and Sefton, Β M (1980) Transforming gene product of Rous sarcoma virus phosphorylales 
tyrosine Proc Natl Acad Set USA, 77 1311 1315 
Hunter, Τ (1995) Protein kinases and phosphatases The Yin and Yang of protein phosphorylation and 
signaling Cell, 80 225-236 
Iida, N , Lokeshwar, V Β , and Bourguignon, L Y W (1994) Mapping the fodnn binding domain of 
CD45, a leukocyte membrane-associated tyrosine phosphatase J Biol Chem 269 28576-28583 
Itoh, M , Streuli, M , Krueger, N X and Saito, H (1992) Purification and characterization ot the 
catalytic domains of the human receptor-linked protein tyrosine phosphatases НРТР/3, Leukocyte 
Common Antigen (LCA), and Leukocyte Common Antigen related molecule (LAR) J Biol Chem 
267 12356 12363 
Jia, Ζ , Barford, D , Flint, A J , and Tonks, Ν К (1995) Structural basis for phosphotyrosine peptide 
recognition by protein tyrosine phosphatase IB Science, 268 1754 1758 
48 
general introduction 
Jiang, Υ -Ρ , Wang, Η , D'Eustachio, Ρ , Musacchio, J M , Schlessinger, J , and Sap, J (1993) Cloning 
and characterization of R PTPx, a new member of the receptor proteint tyrosine phosphatase family with 
a proteolytically cleaved cellular adhesion molecule like extracellular region Mol Cell Biol , 13 2942 
2951 
Jink, F R , Janzen, Ν M , Melhado, I G , and Harder, К W (1990) Cloning and chromosomal assignment 
of a widely expressed human receptor like protein tyrosine phosphatase FEBS Leti , 273 239-242 
Jink, F R , Harder, К W , Melhado, 1 G , Anderson, L L , and Duncan, A M V (1992) The gene for 
leukocyte antigen related tyrosine phosphatase (LAR) is localized to human chromosome lp32, a region 
frequently deleted in tumors of neuroectodermal origin Cytogenet Cell Genet , 61 266 268 
Johnson, Ρ , Ostergaard, Η L , Wasden, С , and Trowbridge, 1 S (1992) Mutational analysis ot CD45 A 
leukocyte specific protein tyrosine phosphatase J Biol Chem , 267 8035 8041 
Kambayashi, Y , Takahashi, К , Bardhan, S , and Inagami, Τ (1995) Cloning and expression of protein 
tyrosine phosphatase like protein derived from a rat pheochromocyloma cell line Biochem J , 306 331 
335 
Kaneko, Τ , Monyama, Τ , Imai, E , Akagi, Y , Arai, M , lnoue, Τ , Xia, С , Noguchi, Τ , Kamada, Τ , 
and Ueda, Ν (1995) Expression of transmembrane type protein tyrosine phosphatase mRNA along rat 
nephron segment Am J Ph\swl , 269 Fl 102 Fl 108 
Kaplan, R , Morse, В , Huebner, К , Croce, С , Howk, R , Ravera, M , Ricca, G , Jaye, M , and 
Schlessinger, J (1990) Cloning of three human tyrosine phosphatases reveals a multigene family of 
receptor linked protein tyrosine phosphatases expressed in brain Proc Natl Acad Set USA, 87 7000 
7004 
Kastury, К , Ohta, M , Lasóla, J , Moir, D , Dormán, Τ , LaForgia, S , Druck, Τ , and Huebner, К 
(1996) Structure ot the human receptor tyrosine phosphatase gamma gene (PTPRG) and relation to the 
familial RCC 1(3,8) chromosome translocation Genomics, 32 225 235 
Kennedy, Μ В (1995) Origin of PDZ (DHR, GLGF) domains Trends Biochem Set , 20 350 
Kishihara, К , Penninger, J , Wallace, V A , Kundig, Τ M , Kawai, К , Wakeman, А , Timms, E , 
Pfeffer, К , Ohashi, Ρ S , Thomas, M L , Furlonger, С , Paige, С J , and Мак, Τ W (1993) Normal 
В lymphocyte development but impaired Τ cell maturation in CD45 exon 6 protein tyrosine phosphatase 
deficient mice Cell, 74 143 156 
Kitamura, К , Mam, A , Ng, D Η , Johnson, Ρ , Maizel, A L , and Takeda, A (1995) Characterization 
of the interaction between CD45 and CD45 AP J Biol Chem , 270 21151 21157 
Klarlund, J К (1985) Transformation of cells by an inhibitor of phosphatases acting on phopshotyrosine in 
proteins Cell, 41 707 717 
Klaus, J К Sidorenko S Ρ , and Clark, E A (1996) CD45 ligation induces programmed cell death in Τ 
and В lymphocytes J Immunol , 156 2743-2753 
Koretzky, G A , Kohmetscher, M , and Ross, S (1993) CD45 assoiated kinase activity requires lek but not 
Τ cell receptor expression in the Jurkat Τ cell line J Biol Chem , 268 8954 8964 
Krueger, N X , Streuli, M , and Saito, H (1990) Structural diversity and evolution of human receptor like 
protein tyrosine phosphatases EMBO J , 9 3241 3252 
Krueger, N X , and Saito, H (1992) A human transmembrane protein tyrosine phosphatase, PTPf, is 
49 
Chapter I 
expressed in brain and has an N-terrrunal receptor domain homologous io carbonic anhydrases Proc 
Natl Acad Sci 1/5Λ, 89 7417-7421 
Krueger, N X , Van Vactor, D , Wan, H I , Gelbart, W M , Goodman, С S , and Saito, Η (1995) The 
transmembrane tyrosine phosphatase DLAR controls motor axon guidance in Drosophila Cell, 84 611 
622 
Kulas, D Τ , Zhang, W R , Goldstein, В J , Furlanetto R W , and Mooney R A (1995) Insulin receptor 
signaling is augmented by antisense inhibition ot the protein tyrosine phosphatase LAR J Biol Chem , 
270 2435-2438 
Kulas, D Τ , Freund, G G , and Mooney, R A (1996a) The transmembrane protein tyrosine phosphatase 
CD45 is associated with decreased insulin receptor signalling J Biol Chem , 271 755 760 
Kulas, D Τ Goldstein, В J , and Mooney, R A (1996b) The transmembrane protein tyrosine phosphatase 
LAR modulates signaling by multiple receptor tyrosine kinases J Biol Chem , 271 748 754 
Kuramochi, S , Matsuda, S , Matsuda, Y , Saitoh, Τ , Ohsugi, Μ , and Yamamoto, Τ (1996) Molecular 
cloning and charactreization of Byp, a murine receptor-type tyrosine phosphatase similar to human DEP 
1 FEBS Lett , 378 7 14 
LaForgia, S , Morse, В , Levy, J , Bamea, G , Cannizzaro, L A , Li, F , Nowell, Ρ С , Boghosian-Sell, 
L , Glick, J , Weston, A , Harris, С С , Drabkin, Η , Patterson, D . Croce, С M , Schlessmger, J , and 
Huebner, К (1991) Receptor protein tyrosine phosphatase γ is a candidate tumor suppressor gene at 
human chromosome region 3p21 Proc Natl Acad Sci USA, 88 5036 5040 
LaForgia S , Lasota, J , Latif, F , Boghosian Sell, L , Kastury, К Ohta, M , Druck, Τ , Alchinson, 1 , 
Cannizzaro, L A Bamea, G , Schlessmger, J , Modi, W Kuzmin, I , Tory К Zbar Β , Croce 
С M , Lerman, M , and Huebner, К (199') Detailed genetic and physical map ot the 3p chromosome 
region surrounding the familial renal cell carcinoma chromosome translocation, t(3 8)(pl4 2,q24 1) 
Cancer Res , 53 3118-3124 
Lammers, R , Bossenmaier, В , Cool, D E , Tonks, N К , Schlessmger, J , Fischer E H , and Ullrich, A 
(1993) Differential activities ot protein tyrosine phosphatases in intact cells J Biol Chem , 268 22456 
22462 
Lan, M S , Lu, J , Goto, Y , and Notkins, A L (1994) Molecular cloning and identification of a receptor 
type protein tyrosine phosphatase, IA-2, from human insulinoma DNA Cell Biol , 13 505 514 
Lan, M S , Wasserfall, С , MacLaren, Ν К , and Notkins, A L (1996) IA-2, a transmembrane protein ot 
the protein tyrosine phosphatase family, is a major autoantigen m insulin-dependent diabetes mellitus 
Proc Natl Acad Sa USA, 93 6367-6370 
Lemmon, M A , Ferguson, Κ M , and Schlessmger, J (1996) PH domains diverse sequences with a 
common told recruit signaling molecules to the cell surface Cell, 85 621-624 
Levy, J В Canoll, Ρ D , Silvennoinen, О , Bamea, G , Morse, В , Honegger, A M Huang, J -Τ , 
Cannizzaro, L A , Park, S H , Druck, Τ , Huebner К , Sap, J , Ehrlich, M , Musacchio, J M , and 
Schlessmger, J (1993) The cloning ot a receptor-type protein tyrosine phosphatase expressed in the 
central nervous system J Biol Chem , 268 10573-10581 
Li, Ρ M , and Goldstein, В J (1996) Cell density-dependent changes in the insulin action pathway 
Evidence for involvement of protein-tyrosine phosphatases J Cell Biochem , 61 31-38 
50 
general introduction 
Lokeshwar V В , and Bourguignon, L YW (1992) Tyrosine phosphatase activity of lymphoma CD45 
(GP180) is regulated by a direct interaction with the cytoskeleton J Biol Chem , 267 21551-21557 
Longo, F M , Martignetti, J A , Le Beau, J M , Zhang, J S , Barnes, J Ρ , and Brosius, J (1993) 
Leukocyte common antigen-related receptor linked tyrosine phosphatase Regulation of mRNA 
expression J Biol Chem , 268 26503-26511 
Lu, J Notkins, A L , and Lan, M S (1994) Isolation, sequence and expression of a novel mouse brain 
cDNA, mlA 2, and its relatedness to members of the protein tyrosine phosphatase family Biochem 
Bwphys Res Commun , 204 930-936 
Lu, J , Li, Q , Xie, Η , Chen, Ζ -J , Borovitskaya, A E , MacLaren, Ν Κ , Notkins, A L , and Lan, M S 
(1996) Identification of a second transmembrane protein tyrosine phosphatase, IA-2/3, as an autoantigen 
in insulin dependent diabetes mellitus precursor of the 37 kDa tryptic fragment Proc Natl Acad Set 
USA, 93 2307-2311 
Maeda, N , Hamanaka, H , Shintani, Τ , Nishiwaki, Τ , and Noda, M (1994) Multiple receptor-like 
protein tyrosine phosphatases in the form of chondroitin sulfate proteoglycan FEBS Leu , 354 67-70 
Maeda, N , Hamanaka, H , Oohira, A , and Noda, M (1995) Purification, characterization and 
developmental expression of a brain-specific chondroitin sulfate proteoglycan, 6B4 proteoglycan/ 
phosphacan Neurosaence, 67 23-35 
Maeda, N , and Noda, M (1996) 6B4 proteoglycan/phosphacan is a repulsive substratum but promotes 
morphological differentiation of cortical neurons Development, 122 647 658 
Magistrelli G , Covini, Ν , Mosca, M , Lippoli, G , and Isacchi, A (1995) Expression of PTP35, the 
murine homologue of the protein tyrosine phosphatase related sequence 1A 2, is regulated during cell 
growth and stimulated by mitogens in 3T3 fibroblasts Biochem Bwphys Res Commun , 217 154-161 
Matozaki, Τ , Suzuki, Τ , Uchida, Τ , Inazawa, J , Anyama, Τ , Matsuda, К , Honta, К , Noguchi, Η , 
Mizuno, Η , Sakamoto, С , and Kasuga, M (1994) Molecular cloning of a human transmembrane-type 
protein tyrosine phosphatase and its expression in gastrointestinal cancers J Biol Chem , 269 2075-
2081 
Matthews, R J , Cahir, E D , and Thomas, M L (1990) Identification of ал additional member of the 
protein tyrosine-phosphatase family Evidence for alternative splicing in the tyrosine phosphatase domain 
Proc Nail Acad Sa USA, 87 4444-4448 
Maurel, Ρ , Rauch, U , Fiad, M , Margolis, R К , and Margolis, R U (1994) Phosphacan, a chondroitin 
sulfate proteoglycan of brain that interacts with neurons and neural cell adhesion molecules is an 
extracellular variant of a receptor-type protein tyrosine phosphatase Proc Nail Acad Sa USA, 
91 2512 2516 
Mauro, L J , and Dixon, J E (1994) 'Zip codes' direct intracellular protein tyrosine phosphatases to the 
correct cellular 'address' Trends Biochem Sa , 19 151 155 
Mauro, L J , Olmsted, E A , Skrobacz, В M , Mourey, R J , Davis, A R , and Dixon, J E (1994) 
Identification of a hormonally regulated protein tyrosine phosphatase associated with bone and testicular 
differentiation J Biol Chem , 269 30659 30667 
Mauro L J , Olmsted, E A , Davis, A R , and Dixon, J E (1996) Parathyroid hormone regulates the 
expression of the receptor protein tyrosine phosphatase, OST РТР, in rat osteoblast-like cells 
51 
Chapter I 
Endocrinology, 137 925-933 
Mayer, В J , Ren, R., Clark, К L , and Baltimore, D (1992) A putative modular domain present in 
diverse signalling proteins Cell, 73.629-630. 
McLaughlin, S , and Dixon, J.E. (1993) Alternative splicing gives rise to a nuclear protein tyrosine 
phosphatase in Drosophtla J. Biol. Chem., 268:6839-6842. 
Milev, Ρ , Friedlander, D.R , Sakurai, Τ , Karthikeyan, L., Fiad, M., Margolis, R.K., Grumet, Μ , and 
Margohs, R U (1994) Interactions of the chondroitin sulfate proteoglycan phosphacan, the extracellular 
domain of a receptor-type protein tyrosine phosphatase, with neurons, glia, and neural cell adhesion 
molecules J. Cell Biol , 127 1703-1715 
Milev, P., Meyer-Putthtz, В., Margohs, R К , and Margohs, R.U. (1995) Complex-type asparagine-hnked 
oligosaccharides on phosphacan and protein-tyrosine phosphatase-ζIß mediate their binding to neural cell 
adhesion molecules and tenascin J Biol Chem , 270:24650-24653. 
Milev, Ρ , Maurel, Ρ , Haring, M., Margohs, R К., and Margolis, R U. (1996). TAG-1/Axonin 1 is a high 
affinity ligand ol neurocan, phosphacan/protein-tyrosine phosphatase-ζIß, and N-CAM J Biol Chem , 
271.15716-15723 
Mishra, S., and Hamburger, A (1993). O-phospho-L-tyrosine inhibits cellular growth by activating protein 
tyrosine phosphatases. Cancer Res., 53:557-563. 
Mizuno, К , Hasegawa, К , Kaiagin, T., Ogimoto, M , Ichikawa, T, and Yakura, H. (1993) ΜΡΤΡδ, a 
putative homolog of ΗΡΤΡδ, is expressed in specialized regions of the brain and in the B-cell lineage 
Mol Cell Biol , 13 5513 5523 
Mizuno, К , Hasegawa, К , Ogimoto, M., Katagin, Τ , and Yakura, Η (1994) Developmental regulation 
of gene expression for the ΜΡΤΡδ isoforms in the central nervous system and the immune system FEBS 
Letters, 355 223-228 
Moller, N P H , Meiler, К В., Lammers, R , Kharitonenkov, A , Hoppe, E , Wiberg, F С , Sures, I , and 
Ullrich, Α. (1995) Selective down-regulation of the insulin receptor signal by protein-tyrosine 
phosphatase α and ε J Biol Chem., 270'23126-23131 
Morahan, G., Huang, D , Tan, B.D , Colman, P.G., and Hamson, L.C (1996). Markers on distal 
chromosome 2q linked to insulin-dependent diabetes mellitus Science, 272'1811-1813 
Monyama, Τ , Fujiwara, Y., Imai, E , Takenaka, M., Kawanishi, S., Inoue, Τ , Noguchi, T., Tanaka, Τ , 
Kamada, Τ , and Ueda, Ν. (1992) cDNA cloning of rat LRP, a receptor like protein tyrosine 
phosphatase, and evidence for its gene regulation in cultured rat mesangial cells. Biochem Biophys Res 
Commun , 188-34-39 
Mourey, R J , and Dixon, J.E , (1994) Protein tyrosine phosphatases- Characterization of extracellular and 
intracellular domains Curr Opm Gen. Dev , 4 31-39 
Muslin, A J , Tanner, J W., Allen, Ρ M , and Shaw, A S (1996) Interaction of 14-3-3 with signaling 
proteins is mediated by the recognition of phosphoserine Cell, 84:889-897 
Nakamura, К , Mizuno, Y, and Kikuchi, К (1996) Molecular cloning of a novel cytoplasmic protein 
tyrosine phosphatase PTPf. Biochem. Biophys Res Commun , 218 726-732 
Ng, D H W , Mam, Α., and Johnson, P. (1995). Point mutation in the second phosphatase domain of CD45 
abrogates tyrosine phosphatase activity Biochem Biophvs Res Commun , 206 302 309 
52 
general introduction 
Ng, D H W , Watts, J D , Aebersold, R , and Johnson, Ρ (1996) Demonstration of a direct interaction 
between p56'ri and the cytoplasmic domain of CD45 in vitro J Biol Chem , 271 1295-1300 
Niklmska, B.B., Hou, D., June, C , Weissman, A M , and Ashwell, J.D (1994) CD45 tyrosine 
phosphatase activity and membrane anchoring are required for T-cell antigen receptor signalling J Biol 
Chem , 14 8078-8084 
Ogata, M , Sawada, M , Kosugi, A , and Hamaoka, Τ (1994) Developmental^ regulated expression of a 
murine receptor-type protein tyrosine phosphatase in the thymus J Immunol , 153 4478-4487. 
Ogata, M , Sawada, M , Fujino, Y , and Hamaoka, Τ (1995) cDNA cloning and characterization of a 
novel receptor-type protein tyrosine phosphatase expressed predominantly in the brain 7 Biol Chem , 
270 2337-2343 
O'Grady, Ρ , Krueger, N X , Streuli, M , and Saito, H (1994) Genomic organization of the human LAR 
protein tyrosine phosphatase gene and alternative splicing in the extracellular fibronectin type-Ill 
domains J Biol Chem , 269 25193-25199 
Ohagi, S , Nishi, M , and Steiner, D F (1990) Sequence of a cDNA encoding human LRP (leukocyte 
common antigen related peptide) Nucl Acids Res , 18 7159 
Okumura, Μ , and Thomas, M L. (1995) Regulation of immune function by protein tyrosine phosphatases 
Curr Opin Immunol , 7 312-319 
Oon, S H , Hong, A , Yang, Χ , and Chía, W (1993) Alternative splicing in a novel tyrosine phosphatase 
gene (DPTP4E) of Drosophila melanogaster generates two large receptor-like proteins which differ in 
their carboxy termini J Biol Chem , 268.23964-23971 
Ostergaard, H L , and Trowbridge, I S (1990) Coclustering CD45 with CD4 or CD8 alters the 
phosphorylation and kinase activity of p56ltk J Exp Med , 172 347-350 
Ostergaard, H L , and Trowbridge, I S (1991) Negative regulation of CD45 protein tyrosine phosphatase 
activity by îonomycin in Τ cells Science, 253 1423-1425 
Ostman, A , Yang, Q , and Tonks, Ν К (1994) Expression of DEP-1, a receptor like protein-tyrosine-
phosphatase, is enhanced with increasing cell density Proc Natl Acad Sci USA, 91 9680-9684 
Pallen, С J (1993) The receptor-like protein tyrosine phosphatase a a role in cell proliferation and 
oncogenesis Sem Cell Biol , 4 403-408 
Pallen, С J , and Tong, Ρ Η (1991) Elevation of membrane tyrosine phosphatase activity in density 
dependent growth-arrested fibroblasts Proc Nail Acad Sa USA, 88 6996-7000 
Pan, M -G , Rim, С , Lu, Κ Ρ , Florio, Τ , and Stork, Ρ J S (1993) Cloning and expression of two 
structurally distinct receptor-linked protein-tyrosine phosphatases generated by RNA processing from a 
single gene J Biol Chem., 268 19284-19291 
Parsons, J Τ (1996) Integnn-mediated signalling regulation by protein tyrosine kinases and small GTP-
binding proteins Curr Opm Cell Biol , 8 146-152 
Passim, N , Langan, J D , Genovese, S , Appella, E , Sinigaglia, F , and Rogge, L (1995) The 37/40-
kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase ΙΑ 2 
Proc Natl Acad Sa USA, 92 9412-9416 
Payton, M A , Hawkes, С J , and Christie, M R (1995) Relationship of the 37,000- and 40,000-Mr tryptic 
fragments of islet antigens m insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule 
53 
Chapter I 
IA-2 (ICA512) J Clin Invest , 96 1506 1511 
Peles, E , Nativ, M , Campbell, Ρ L , Sakurai, Τ , Martinez, R , Lev, S , Clary, D О , Schilling, J , 
Bamea, G , Plowman, G D , Grumel, M , and Schlessmger, J (1995) The carbonic anhydrase domain 
of receptor tyrosine phosphatase 0 is a functional ligand for the axonal cell recognition molecule 
comactin Cell, 82 251-260 
Perkins, L A , Larsen, I , and Pernmon, N (1992) corkscrew encodes a putative protein tyrosine 
phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso Cell, 
70 225-236 
Pixley, F J , Lee, P S W , Domínguez, M G , Einstein, D В , and Stanley, E R (1995) A heteromorphic 
protein-tyrosine phosphatase, ΡΤΡφ, is regulated by CSF 1 in macrophages J Biol Chem 270 27339 
27347 
Ponting, С Ρ , and Phillips, С (1995) DHR domains in syntrophins, neuronal NO synthase and other 
intracellular proteins Trends Biochem Sci , 20 102 103 
Pot, D A , Woodford, Τ A , Remboutsika, E , Haun, R S , and Dixon, J E (1991) Cloning, bacterial 
expression, purification, and characterization of the cytoplasmic domain of rat LAR, a receptor-like 
protein tyrosine phosphatase J Biol Chem , 266 19688-19696 
Pot, D A , and Dixon, J E (1992) Active site labeling of a receptor like protein tyrosine phosphatase J 
Biol Chem , 267 140-143 
Pulido, R , Krueger, N X , Serra Pages, С , Saito, H , and Streuli, M (1995a) Molecular characterization 
of the human transmembrane protein-tyrosine phosphatase δ J Biol Chem , 270 6722-6728 
Pulido, R , Serra-Pages, С , Tang, M , and Streuli, M (1995b) The LAR/PTPô/ΡΤΡσ subfamily ot 
transmembrane tyrosine phosphatases Multiple human LAR, ΡΤΡδ, and ΡΤΡσ isotorms are expressed in 
a tissue-specific manner and associate with the LAR interacting protein LIP 1 Proc Natl Acad Sci 
USA, 92 11686 11690 
Rabin, D U , Pleasic, S M , Shapiro, J A , Yoo-Warren, Η , Oles, J , Hicks, J M Goldstein, D E and 
Rae, Ρ M M (1994) Islet cell antigen 512 is a diabetes specific islet autoantigen related to protein 
tyrosine phosphatases J Immunol , 152 3183-3188 
Rechsteiner M , and Rogers, S W (1996) PEST sequences and regulation by proteolysis Trends Biochem 
Sa , 21 267-271 
Ross, S E , Schraven, В , Goldman, F D , Crablree, J , and Koretzky, G A (1994) The association 
between CD45 and lek does not require CD4 and CD8 and is independent ot Τ cell receptor stimulation 
Biochem Biophys Res Commun , 198 88 96 
Sahin, M , and Hockfield, S (1993) Protein tyrosine phosphatases expressed in the developing rat brain J 
Neurosa , 13 4968 4978 
Sahin, M , Dowlmg, J J , and Hockfield, S (1995) Seven protein tyrosine phosphatases are differentially 
expressed in the developing rat brain J Comp Neurol 351617 631 
Sakurai, Τ , Friedlander, D R , and Gnimet, M (1996) Expression of polypeptide variants ot receptor type 
protein tyrosine phosphatase β the secreted form, phosphacan, increases dramatically during embryonic 
development and modulates glial cell behavior in vitro J Neurosa Res , 43 694 706 
Sap, J , D'Eustachio, Ρ , Givol, D , and Schlessmger, J (1990) Cloning and expression ot a widely 
54 
general introduction 
expressed receptor tyrosine phosphatase Proc Natl Acad Set t/5/4, 87 6112-6116 
Sap, J , Jiang, Υ -Ρ , Friedlander, D , Grumet, M , and Schlessinger, J (1994) Receptor tyrosine 
phosphatase R-ΡΤΡ-κ mediates homophilic binding Mol Cell Biol , 14 1-9 
Schaapveld, R Q.J , van den Maagdenberg, A M J M , Schepens, J Τ G , Olde Weghuis, D , Geurts van 
Kessel, A , Wiennga, В , and Hendriks, W J A J (1995) The mouse gene Plprf encoding the leukocyte 
common antigen-related molecule LAR cloning, characterization, and chromosomal localization 
Genomics, 27 124-130 
Schaapveld, R Q J , Schepens, J Τ G , Robinson, G W , Attema, J , Oerlemans, F Τ J J , Fransen, 
J A M , Sireuli, M , Wieringa, B , Hennighausen, L , and Hendriks, W J A J (1996) Impaired 
mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase 
activity Dev Biol , in press 
Schmidt, A , Rutledge, S J , Endo, N , Opas, E E , Tanaka, Η , Wesolowski, G , Leu, С Τ , Huang, Ζ , 
Ramachandaran , Rodan, S В , and Rodan, G A (1996) Protein-lyrosine phosphatase activity regulates 
osteoclast formation and function Inhibition by alendronate Proc Natl Acad Sci USA, 93'3068 3073 
Schraven, В . Kirchgessner, H , Gaber, В , Samstag, Y, and Meuer, S (1991) A functional complex is 
formed in human Τ lymphocytes between the protein tyrosine phosphatase CD45, the protein tyrosine 
kinase p56hk and pp32, a possible common substrate Eur J Immunol , 21 2469-2477 
Sdiraven, В , Schirren, A , Kirchgessner, Η , Siebert, В , and Meuer, S С (1992) Four CD45/p56lllt-
associated phosphoproleins (pp29 pp32) undergo alterations m human Τ cell activation. Eur J 
Immunol , 22 1857-1863 
Schraven, В , Schoenhaut, D , Bruyns, E , Koretzky, G , Eckerskorn, С , Wallich, R , Kirchgessner, Η , 
Sakoratas, Ρ , Labkovsky, Β , Ratnofsky, S , and Meuer, S (1994) LPAP, a novel 32 kDa 
phosphoprotein that interacts with CD45 in human lymphocytes J Biol Chem 269 29102 29111 
Seimiya, H , Sawabe, Τ , Inazawa, J , and Tsuruo, Τ (1995) Cloning, expression and chromosomal 
localization ot a novel gene tor protein tyrosine phosphatase (PTP-U2) induced by various differentiation-
inducing agents Oncogene, 10 1731-1738 
Serra-Pages, С Saito, H , and Streuli, M (1994) Mutational analysis of proprotem processing, subunit 
association, and shedding of the LAR transmembrane protein tyrosine phosphatase J Biol Chem , 
269 23632 23644 
Serra Pages, С , Kederscha, N L , Fazikas, L , Medley, Q , Debanl, A , and Streuli, M (1995) The LAR 
transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein со localize at focal 
adhesions EMBO J , 14 2827 2838 
Sgroi, D , Varki, A , Braesch Andersen, S , and Slamenkovic, I (1993) CD22, a В cell-specific 
immunoglobulin superfamily member, is a sialic acid-bindmg protein J Biol Chem , 268 7011-7018 
Sharma, E , and Lombroso, Ρ J (1995) A neuronal protein tyrosine phosphatase induced by nerve growth 
factor J Biol Chem . 270 48-53 
Sharma, E , and Lombroso, Ρ J (1995) A neuronal protein tyrosine phosphatase induced by nerve growth 
tactor J Biol Chem , 270 23234 
Shaw, G (1996) The pleckstrin homology domain an intriguing multifunctional protein module Bioessays, 
18 35 46 
55 
Chapter I 
Shitara, К , Yamada, H., Watanabe, K., Shimonaka, M., and Yamaguchi, Y (1994) Brain-specific 
receptor-type protein-tyrosine phosphatase RPTP/3 is a chondroitin sulfate proteoglycan in vivo J Bio! 
Chem., 269:20189-20193 
Simon, Μ Α., Bowtell, D D.L., and Rubin, G.M (1989). Structure and activity of the sevenless protein a 
protein tyrosine kinase receptor required for photoreceptor development in Drosophiia. Proc Natl Acad 
Sa. USA, 86:8333-8337. 
Skaraes, W С , Moss, J E . , Hurtley, SM., and Beddington, R.S Ρ (1995). Capturing genes encoding 
membrane and secreted proteins important for mouse development. Proc Natl. Acad Sci USA, 
92 6592-6596 
Solimena, M , Dirkx Jr, R , Hermel, J -M , Pleasic Williams, S., Shapiro, J A , Caron, L., and Rubin, 
D.U (1996) ICA 512, an auloantigen of type I diabetes, is an intrinsic membrane protein ol 
neurosecretory granules. EMBOJ., 15:2102-2114. 
Songyang, Ζ., Shoelson, S.E , McGlade, J , Oliver, P., Pawson, T., Bustelo, X R , Barbacid, Μ , Sabe, 
H.. Hanafusa, H., Yi, T., Ren, R., Baltimore, D , Ratnofsky, S., Feldman, R A , and Cantley, L C 
(1994). Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, 
and Vav Mol. Cell Biol., 14:2777-2785 
Sorby, M , and Ostman, A. (1996). Protein-tyrosine phosphatase-mediated decrease of epidermal growth 
factor and platelet-derived growth factor receptor tyrosine phosphorylation in high cell density cultures 
J. Biol Chem., 271:10963-10966. 
Southey, M.G , Findley, D.M , and Kemp, Β E (1995). Regulation of membrane-associated tyrosine 
phosphatases in UMR 106 06 osteoblast-like cells Biochem J , 305-485-490 
Spertim, F , Wand, A.V Τ , Chatila. Τ , and Geha, R S (1994) Engagement of the common leukocyte 
antigen CD45 induces homotypic adhesion of activated human Τ cells J Immunol , 153 1593-1602 
Stamenkovic, I , Sgroi, D., Aruffo, A , Sy, M S , and Anderson, Τ (1991) The В lymphocyte adhesion 
molecule CD22 interacts with leukocyte common antigen CD45RO on Τ cells and a2-6 sialyltransferase, 
CD75,on В cells Cell, 661133 
Stitt, T N . , Conn, G , Gore, M , Lai, С , Bruno, J , Radziejewski, С , and Mattson, К (1995) The 
autocoagulation tactor Protein-S and its relative, Gas6, are ligands for the TYRO 3/AXL family of 
receptor tyrosine kinases. Cell, 80 661-670. 
Stoker, A.W. (1994). Isoforms of a novel cell adhesion molecule-like protein tyrosine phosphatase are 
implicated in neural development. Mech. Dev , 46:201-217. 
Stover, D.R., and Walsh, K.A. (1994). Protein-tyrosine phosphatase activity of CD45 is activated by 
sequential phosphorylation by two kinases. Mol. Cell. Biol., 14:5523-5532. 
Streuh, M., Krueger, N X , Hall, L R , Schlossman, S.F., and Saito, H (1988) A new member of the 
immunoglobulin superfarmly that has a cytoplasmic region homologous to the leukocyte common antigen 
J Exp Med , 168 1553-1562. 
Streuh, M , Krueger, N.X , Tsai, A.Y M , and Saito, Η. (1989) A family ot receptor-linked protein 
tyrosine phosphatases in humans and Drosophiia Proc. Natl Acad Sa USA, 86 8698-8702. 
Streuh, M , Kmeger, N X., Thai, Τ , Tang, M , and Sano, H (1990) Distinct functional roles of the two 
intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and 
56 
general introduction 
LAR EMBO J , 9 2399-2407 
Streuli, M , Krueger, Ν Χ , Ariniello, Ρ D , Tang, Μ , Munro, J M , Blattler, W.A , Adler, D Α , 
Disteche, С M , and Sano, Η (1992) Expression of the receptor-linked protein tyrosine phosphatase 
LAR proteolytic cleavage and shedding of the CAM-like extracellular structure EMBO J , 1Γ897-907 
Streuh, M (1996) Protein tyrosine phosphatases in signaling Curr Opm Cell Biol , 8 182-188 
Stuckey, J A , Schüben, H L , Fauman, E В , Zhang, Ζ -Y , Dixon, J E , and Saper, M A (1994) 
Crystal structure of Yersinia protein tyrosine phosphatase at 2 5 À and the complex with tungstate 
Nature, 370 571-575 
Su, J Batzer, A , and Sap, J (1994) Receptor tyrosine phosphatase R-PTP-a is tyrosine-phosphorylated 
and associated with the adaptor protein Grb2 J Biol Chem , 269 18731-18734 
Sun, H , and Tonks, Ν К (1994) The coordinated action of protein tyrosine phosphatases and kinases in 
cell signaling Trends Biochem Sri , 19 480-485 
Tahiti, К , Smith, D R , Goh, H S , and Pallen, С J (1995) Increased mRNA expression of the receptor­
like protein tyrosine phosphatase or in late stage colon carcinomas Cancer Leu , 93 239-248 
Takeda, A , Wu, J J , and Maizel, A L (1992) Evidence tor monomenc and dimenc forms of CD45 
associated with a 30-kDa phosphorylated protein J Biol Chem , 267 16651-16659 
Takeda, A , Maizel, A L , Kitamura, К , Ohta, Τ , and Kimura S (1994) Molecular cloning of the 
CD45-associated 30-kDa protein J Biol Chem , 269 2357-2360 
Tan, X , Stover, D R , and Walsh, К A (1993) Demonstration of protein tyrosine phosphatase activity in 
the second ot two homologous domains of CD45 J Biol Chem , 268 6835-6838 
Tashian, R E (1989) The carbonic anhydrases widening perspectives on their evolution expression and 
lunclion Bioasays. 10 186 192 
Thomas, M L , Barclay, A N , Gagnon, J , and Williams, A F (1985) Evidence from cDNA clones that 
the rat leukocyte common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 
80,000 Mr Cell, 41 83 93 
Thomas, Ρ E , Wharram, В L , Goyal, M , Wiggins, J E , Holzman, L B , and Wiggins, R С (1994) 
GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase 
Identification, molecular cloning, and characterization in rabbit J Biol Chem , 269 19953-19962 
Tian, S S , Tsoulfas, Ρ , and Zinn, К (1991) Three receptor-linked protein tyrosine phosphatases are 
selectively expressed on central nervous system axons m the Drosophila embryo Cell, 67 675-685 
Tian, S -S , and Zinn, К (1994) An adhesion molecule like protein that interacts with and is a substrate 
tor a Drosophila receptor-linked protein tyrosine phosphatase J Biol Chem , 269 28478 28486 
Tonks, Ν К , Diltz, C D , and Fischer Ε Η (1988a) Purification of the major protein tyrosine 
phosphatases of human placenta J Biol Chem , 263 6722 6730 
Tonks, Ν К , Charbonneau.H , Diltz, С D , Fischer, Ε Η , and Walsh, К A (1988b) Demonstration that 
the leukocyte common antigen CD45 is a protein tyrosine phosphatase Btochemtsiry, 27 8696 8700 
Tonks, N К , Diltz, С , and Fischer, Ε Η (1990) CD45, an integral membrane protein tyrosine 
phosphatase J Biol Chem . 265 10674 10680 
Tonks, N K, Yang Q , Flint, A J , Gebbink, M F В G , Franza Jr , B R , Hill, D E , Sun, H , and 
Brady-Kalnay, S (1992) Protein tyrosine phosphatases The problems of a growing family Cold Spring 
57 
Chapter i 
Harb Symp Quant Biol , 57 87 94 
Tracy, S , van der Geer, Ρ , and Hunter, Τ (1995) The receptor like prolein-tyrosine phosphatase, 
RPTPa, is phosphorylated by protein kinase С on two serines close to the inner face of the plasma 
membrane J Biol Chem , 270 10587 10594 
Trowbridge, I S , Johnson, Ρ , Ostergaard, Η , and Hole, N (1992) Regulation and structure function 
relationship of CD45 Bwchem Soc Trans , 20 174-178 
Tsukamoto, Τ , Takahashi, Τ , Ueda, R , Hibi, К , Saito, Η , and Takahashi, Τ (1992) Molecular 
analysis ot the protein tyrosine phosphatase γ gene in human lung cancer cell lines Cancer Res , 
52 3506 3509 
Tsuneizumi, К , Kume, Τ , Watanabe, Τ , Gebbink, M F В G , Thomas, M L , and Oishi, M (1994) 
Induction ol specific protein tyrosine phosphatase transcripts during differentiation of mouse embryonal 
carcinoma cells FEBS Lett , 347 9-12 
Valentine, M A , Widmer, M В , Ledbetter, J A , Pinault, F , Voice, R , Clark, E A Gallis, В and 
Brautigan, D L (1991) Interleukin 2 stimulates serine phosphorylation ot CD45 in CTLL 2 4 cells Eur 
J Immunol , 21 913 919 
van den Maagdenberg, A M J M , Olde Weghuis, D , Rijss, J , van de Wetering, R А С , Wieringa, В , 
Geurts van Kessel, A , and Hendriks, W J A J (1996) Assignment of the human gene lor receptor type 
protein tyrosine phosphatase IA 2 (PTPRN) to chromosome region 2q35-»q36 1 and identification ot an 
intragenic genetic marker Cytogenet Cell Genet , 73 145 148 
van Inzen, W G , Peppelenbosch, Μ Ρ , van den Brand, M W M , Tertoolen, L G J , and de Laat, S W 
(1996) The role of receptor protein tyrosine phosphatase a in neuronal differentiation ot embryonic stem 
cells Dev Brain Res , 91 304-307 
Vamum, В С , Young, С , Elliott, G , Garcia, A , Bartley, Τ D , Fndell, Y W , and Hunt, R W (1995) 
AXL receptor tyrosine kinase is stimulated by the vitamin к dependent protein encoded by growth arrest 
specific gene-6 Nature, 373 623 626 
Wagner, J , Boerboom, D , and Tremblay, M L (1994) Molecular cloning and tissue specific RNA 
processing of a murine receptor type protein tyrosine phosphatase Eur J Bwchem , 226 773-782 
Walton, К M , Martell К J , Kwak S Ρ , Dixon, J E , and Largent, В L (1993) A novel receptor type 
protein tyrosine phosphatase is expressed during neurogenesis in the olfactory epithelium Neuron 
11 387 400 
Wang, H , Yan, H , Canoll, Ρ D , Silvennoinen, О , Schlessinger, J , and Musacchio, J M (1995) 
Expression of receptor protein tyrosine phosphatase a (RPTP σ) in the nervous system of the developing 
and adult rat J Neurosa Res , 41 297 310 
Wang, Η , Lian, Ζ , Lerch, M M , Chen, Ζ , Xie, W , and Ullrich, A (1996) Characterization of PCP 2, 
a novel receptor protein tyrosine phosphatase of the MAM domain family Oncogene, 12 2555 2562 
Wary, К К , Lou, Ζ , Buchberg, A M , Siracusa, L D , Druck, Τ , LaForgia, S and Huebner, К (1993) 
A homozygous deletion within the carbonic anhydrase like domain ol the Plprg gene in murine L cells 
Cancer Res , 53 1498 1502 
Wang, Y , and Pallen, С J (1991) The receptor like protein tyrosine phosphatase ΗΡΤΡα has two catalytic 
domains with distinct substrate specificities EMBO J 10 3231 3237 
58 
general introduction 
Wasmeier С and Hutton, J С (1996) Molecular cloning of Phognn, a protein-tyrosine phosphatase 
homologue localized to insulin secretory granule membranes J Biol Chem , 271 18161 18170 
Weinberg, R A (1991) Tumor suppressor genes Science, 254 1138-1146 
Weinstein, M , Kaiasik, A , Kanety, Η , Papa, Μ Ζ , Goldman, В , and Ravia, Y (1993) Deletion of part 
of the DNA encoding the human protein tyrosine phosphatase LAR in human tumors Am J Hum 
Gen , 53(suppl ) 385 
Wiener, J R , Kems, В J , Harvey, E L , Conaway, M R , Iglehart, J D , Berchuck, A , and Bast Jr , 
R С (1994) Overexpression ot the protein tyrosine phosphatase PTP1B in human breast cancer 
association with pl85t_erb"2 protein expression J Natl Cancer Inst , 86 372 378 
Wiggins, R С , Wiggins, J E , Goyal, M , Whairam, В L , and Thomas, Ρ E (1995) Molecular cloning 
of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase characterization of the 
GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromsome 
12pl2pl3 Gewomi«, 27 175-181 
Wong, E С С , MuUersman, J E , and Thomas, M L (1993) Leukocyte common antigen-related 
phosphatase (LRP) gene structure Conservation of the genomic organization of transmembrane protein 
tyrosine phosphatases Genomics, 17 33 38 
Wu, L W , Baylink, D J , and Lau, К -H W (1996) Molecular cloning and expression of a unique rabbit 
osteoclastic phosphotyrosyl phosphatase Bwchem 7 , 3 1 6 515-523 
Yahagi Y , Tagawa, M , Tomoda, Τ , and Shirasawa, Τ (1996) Binary expresston of olfactory bulb 
protein tyrosine phosphatase in rat central nervous system developmental gene regulation in neonate 
cerebral cortex and constitutive expression in olfactory rhinencephalon Neurosa Leu , 211 125-128 
Yakura, Η (1995) The role of protein tyrosine phosphatases in lymphocyte activation and differentiation 
Cm Rev Immunol 14 311 336 
Yamada, A , Streuli, M , Saito, H , Rothstein, D M , Schlossman, S F , and Monmoto, С (1990) Effects 
of activation of protein kinase С on CD45 isoform expression and CD45 tyrosine phosphatase activity in 
Τ cells Eur J Immunol , 20 1655-1660 
Yan, Η , Grossman, A , Wang, Η , D'Eustachio, Ρ , Mossie, К , Musacchio, J M , Silvennoinen, О , and 
Schlessinger, J (1993) A novel receptor tyrosine phosphatase-σ that is highly expressed in the nervous 
system J Biol Chem , 268 24880-24886 
Yang, X , Seow, K T , Bahn, S M , Oon, S H , and Chía, W (1991) Two Drosophila receptor-like 
tyrosine phosphatase genes are expressed in a subset of developing axons and pioneer neurons in the 
embryonic CNS Cell, 67 661-673 
Yu, Q , Lenardo, Τ , and Weinberg, R A (1992) The N-terrrunal and С terminal domains of a receptor 
tyrosine phosphatase are associated by non covalent linkage Oncogene, 7 1051 1057 
Zhai Y F , Beittenmiller, Η , Wang, В , Gould Μ Ν , Oakley, С , Esselman W J , and Welsch, С W 
(1993) Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells 
neoplastically transformed by the neu oncogene Cancer Res , 53 2272 2278 
Zhai Y F , Wirth, J , Kang S , Welsch С W and Esselman, W J (1995) LAR PTPase cDNA 
iransfeclion suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells 
Mol Carcinogen , 14 103 110 
59 
Chapter I 
Zhang, J S , and Longo, F M (1995) LAR tyrosine phosphatase receptor alternative splicing is 
preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing 
extensive CAG repeats J Cell Biol , 128, 415-431 
Zhang, W -R , and Goldstein, В J (1991) Identification of skeletal muscle protein tyrosine phosphatases by 
amplification of conserved cDNA sequences Biochem Biophys Res Commun , 178 1291-1297 
Zhang, W -R , Hashimoto, N , Ahmad, F , Ding, W , and Goldstein, В J (1994) Molecular cloning and 
expression of a unique receptor-like protein tyrosine phosphatase in the leucocyte-common-antigen-related 
phosphatase family Biochem J , 302 39-47 
Zhang, W-R , Li, Ρ M , Oswald, M A , and Goldstein, В J (1996) Modulation of insulin signal 
transduction by eutopic overexpression of the receptor-type protein tyrosine phosphatase LAR Mol 
Endocrinol , 10 575 584 
Zhang, Ζ -Y , Thieme Sefler, A M , Maclean, D , McNamara, D J , Dobrusin Ε M , Sawyer, Τ К , and 
Dixon, J E (1993) Substrate specificity of the protein tyrosine phosphatases Proc Nail Acad Sa 
USA, 90 4446 4450 
Zhang, Ζ -Y Wang, Y , Wu L , Fauman E В , Stuckey, J A , Schüben, Η L Saper, M A and 
Dixon, J E (1994a) The Cys(X)Arg catalytic motif in phosphoester hydrolysis Biochemistry, 33 15266-
15270 
Zhang, Ζ -Y , Wang, Y , and Dixon, J E (1994b) Dissecting the catalytic mechanism of protein tyrosine 
phosphatases Proc Nail Acad Sa USA, 91 1624 1627 
Zhang, Ζ -Y , Palfey, В A , Wu, L , and Zhao, Y (1995) Catalytic function ol the conserved hydroxyl 
group in the protein tyrosine phosphatase signature motif Biochemistry, 34 16389 16396 
Zheng, X M , Wang, Y , and Pallen, С J (1992) Cell transformation and activation of pp60"' r by 
overexpression of a protein tyrosine phosphatase Nature, 359 336-339 
Zheng, Χ M and Pallen, С J (1994) Expression of receptor like protein tyrosine phosphatase a in rat 
embryo fibroblasts activates mitogen activated protein kinase and с Jun J Biol Chem 269 23302 
23309 
Zigmond S H (1996) Signal transduction and actin filament organization Curr Opm Cell Biol , 8 66 73 
Zinn, К (1993) Drosophila protein tyrosine phosphatases Sem Cell Biol , 4 397 401 
Zondag, G С M , Koningslein, G M , Jiang, Y Ρ , Sap, J , Moolenaar, W H , and Gebbink, M F В G 
(1995) Homophilic interaction mediated by receptor tyrosine phosphatases μ and к J Biol Chem , 
270 14247-14250 
60 


Chapter II 
The Mouse Gene Ptprf Encoding the Leukocyte Common Antigen-
Related Molecule LAR: Cloning, Characterization, and Chromosomal 
Localization 
Roel Q.J. Schaapveld, Arn M.J.M, van den Maagdenberg, Jan T G Schepens, Daniël 
Olde Weghuis, Ad Geurts van Kessel, Bé Wieringa, and Wiljan J.A.J Hendriks 
Genomics, 27:124-130(1995) 
Chapter II 
The Mouse Gene Ptprf Encoding the Leukocyte Common Antigen-Related Molecule 
LAR: Cloning, Characterization, and Chromosomal Localization 
Roel Q J. Schaap veld, Am M J M van den Maagdenberg, Jan Τ G Schepens, Daniel 
Olde Weghuis', Ad Geurts van Kessel*, Bé Wieringa, and Wiljan J A.J Hendriks 
Departments of Cell Biology & Histology, and 'Human Genetics, 
University of Nijmegen, The Netherlands 
Summary 
The human receptor-like protein tyrosine phosphatase Leukocyte common Antigen-Related 
molecule (LAR, gene symbol PTPRF) closely resembles cell adhesion molecules, which 
suggests that it may be involved in the regulation of phosphotyrosine levels through cell-cell 
or cell-matrix interactions. To obtain a better understanding of LAR function, we have 
characterized the mouse Ptprf gene as a first step towards site-directed mutagenesis studies 
in vitro and m vivo. The cytoplasmic region of the mouse LAR (mLAR) protein is encoded 
by eleven exons that span only 4.5 kb of genomic DNA Compared to the known exon-intron 
structures of other mammalian receptor-like protein tyrosine phosphatase genes, such as 
Ptpra (encoding LRP) and Ptprc (coding for Ly-5), the Ptprf gene part encoding the 
cytoplasmic region of mLAR contains not only smaller, but also fewer introns. Sequence 
analysis of both phosphatase domains of mLAR and its homologs ΜΡΤΡδ and mRPTPa 
revealed a higher evolutionary conservation of the second, C-terminal domain in comparison 
to the first domain Fluorescence in situ hybridization was used to map the Ptprf gene to 
region C6-D1 on mouse Chromosome 4 
Introduction 
Protein tyrosine phosphorylation is recognized as an important reversible reaction controlling 
many aspects of cellular function, including growth and differentiation, cell cycle control, 
and cytoskeletal integrity (Tonks et al., 1992; Mourey and Dixon, 1994). The role of protein 
tyrosine kinases (PTKs) in these processes and the induction of their activity has been 
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extensively studied, but the recent identification and characterization of many protein tyrosine 
phosphatases (PTPases) suggests that dephosphorylation of signal transduction proteins is also 
a crucial event in signal transduction (Fischer et al , 1991, Brady-Kalnay and Tonks, 1994) 
To date more than 30 PTPases have been identified (Mourey and Dixon, 1994) Sequence 
comparisons have revealed that there are two major classes of PTPases (for review see Tonks 
et al , 1992, Mourey and Dixon, 1994), namely (ι) those found in the cytoplasm or nucleus 
that contain only one tyrosine phosphatase domain and (n) membrane-bound, receptor-like 
PTPases (RPTPases) that have two tandemly repeated catalytic domains There also exist 
intermediate forms such as HPTP/3 (Krueger et al, 1990) and PTP-SL (Hendriks et al , 
1995) that are transmembrane proteins with only one catalytic domain 
The RPTPases can be subdivided into five types based on the structure of their 
extracellular segments (Mourey and Dixon, 1994) Type I represents the CD45 family, which 
is comprised of multiple isoforms arising from differential splicing of the RNA of a single 
gene Type II members (e g LAR, ΗΡΤΡδ, RPTPa, RPTPji, RPTPK) are characterized by 
the presence of multiple immunoglobulin (Ig) and fibronectin (FN) type Ill-like domains 
Type III carry multiple FN-III domains (e g HPTP/3), while type IV members (e g ΗΡΤΡα, 
HPTPf) possess small glycosylated segments Finally, type V members (e g HPTP£, 
ΗΡΤΡγ) have an amino-terminal motif with homology to carbonic anhydrase 
The extracellular region of the type II RPTPases resembles that of cell adhesion molecules 
(CAMs) such as N-CAM (Edelman and Crossin, 1991) Recently, homophilic adhesive 
properties have been attributed to RPTP/* and RPTPK (Gebbink et al , 1993, Brady-Kalnay 
et al , 1993, Sap et al , 1993) In combining cell adhesion motifs at the cell surface with 
intracellular phosphatase activity, these RPTPases may be invloved in the control of cell 
growth, motility and differentiation in a direct response to cell-cell interaction 
The cytoplasmic region of most type II RPTPases contains two tandem phosphatase 
domains of approximately 260 amino acid residues each, but it is not clear at present whether 
both domains are enzymatically active in vivo or exhibit different substrate specificities 
Structure function relationships have only been established for phosphatase domains expressed 
in bacteria and therefore outside their natural context Although site-directed mutagenesis 
studies have shown the significance of the 'signature sequence' (I/V)HCXAGXXR(S/T)G for 
tyrosine phosphatase activity of the first, transmembrane proximal phosphatase domain 
(Mourey and Dixon, 1994), it remains to be determined whether the distal phosphatase 
domain also exhibits catalytic activity (Wang and Pallen, 1991, Tan et al., 1993), or plays 
only a regulatory role in modulating the activity of the first domain (Streuh et al , 1990, Pot 
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et al., 1991; Krueger and Saito, 1992). However, in vitro studies are inadequate to address 
such questions because specific inhibitors of PTPases are not yet at hand and substrates and 
ligands are unknown. 
To initiate studies into the role of LAR domains in an organismal context, we set out to 
isolate structural and genomic mouse LAR (mLAR) DNAs Here we describe the 
organization of the Ptprf gene region encoding the cytoplasmic part of mLAR. Compared 
with known exon-intron structures of other mouse PTPase genes, such as Ptpra (Wong et al., 
1993) and Ptprc (Saga et al., 1988), the Ptprf gene exhibits a more compact structure. 
Comparison of both phosphatase domains of mLAR with closely homologous sequences 
of ΜΡΤΡδ (Mizuno et al., 1993) and mRPTPa (Ogata et al., 1994) revealed a higher 
evolutionary conservation of the second, C-terminal domain compared to the proximal 
'catalytically active' domain. 
Finally, we report the chromosomal localization of the Ptprf gem to region C6-D1 of 
mouse Chromosome 4. 
Materials & Methods 
Isolation of mouse LAR genomic and cDNA clones 
Cosmid clones were isolated from a mouse 129/SvEv genomic DNA cosmid library (kindly provided 
by Dr. M Hofker, University of Leiden, Leiden) using a random-primed (Feinberg and Vogelsiein, 
1983) 1 5 kb EcoRl-Sall human LAR (hLAR) cDNA fragment (positions 4444-5933, Streuli et al, 
1988) as a probe Hybridizations were carried out according to Church and Gilbert (1984) and filters 
were washed for 5, 10, and 30 min at 65°C in 0.25 M sodium phosphate/1% SDS/1 mM EDTA 
Positive clones were purified by subsequent rounds of low density screening 
The same hLAR cDNA probe was used to screen an oligo dT-primed mouse brain cDNA library 
in XZAPII (Stratagene) Filters were washed three times for 30 mm at 65 °C in 2 χ SSC/0 2 % SDS 
Positive phages were plaque-purified and inserts were rescued as pBluescript SK plasmids according 
to the manufacturers protocol 
Sequence analysis 
Nested deletion mutants of cDNA clone mLAR#9 were generated using Exonuclease III (Promega) 
and nucleotide sequences were determined using the double-stranded DNA dideoxy sequencing 
method (Hattori and Sakaki, 1986) A 6 5 kb Ssil-BamHl Piprf genomic fragment was used for exon-
ìntron determination according to the shotgun sequencing strategy of Deininger (1983) Briefly, 
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fragments of around 500 bp were generated by sonication, blunt-ended using Klenow (Boehnnger) 
and subcloned into the Sma\ site of vector pGEM4 (Promega) Clones, grown in microtiter plates, 
were replica plated onto nitrocellulose filters and screened with the mLAR cDNA#9 insert. Thirty 
positive clones were used for sequence determination (Hattori and Sakaki, 1986) 
DNA sequence gel readings were recorded, compared, edited, and assembled using the IGSUITE 
5 35 package (Intelhgenetics Ine , Moutain View, California). Sequences were aligned using the GCG 
Wisconsin programs PILEUP and LINEUP (Devereux et al., 1984) Evolutionary reconstruction was 
done using the program FITCH supplied in the phylogeny inference package PHYLIP (distributed by 
Dr J Felsenstein, University of Washington, Seattle) FITCH uses distance matrices to construct 
trees without allowing negative branch length (Fitch and Margoliash, 1967) 
Fluorescence in situ hybridizanon 
Fluorescence in situ hybridization was performed on mouse strain 129-derived E14 embryonic stem 
cell (Handyside et al., 1989) metaphase spreads for the regional localization of the Ptprf gene, using 
mouse cosmid #5 as a probe. Biotinylated cosmid DNA was dissolved in 10 μ\ hybridization solution 
containing 2 x SSC, 10% dextran sulphate, 1% Tween-20, and 50% formamide The probe mixture 
was heat-denatured at 80°C for 10 minutes, followed by incubation at 37°C to allow re-annealing of 
highly repetitive sequences Hybridization of this probe to heat-denatured chromosome spreads, under 
a cover slip, was carried out overnight at 37°C Hybridizing probe was detected 
immunohistochemically using fluorescein isothiocyanate conjugated to avidin-D (Suijkerbuijk et al., 
1991) Images of metaphase preparations were captured by a cooled high-performance CCD camera 
(Photometries) coupled to a Macintosh II computer Separate images of both mLAR hybridizing 
signals and DAPI-counterstained chromosomes were transformed into pseudocoloured images using 
image analysis software. 
Results & Discussion 
Isolation and characterization of the mLAR-encoding Ptprf gene 
We are currently investigating the biological role of LAR and the functions of the tyrosine 
phosphatase domains in the LAR signal transduction pathway using reverse genetic 
approaches As a first step we isolated and characterized mouse LAR genomic and cDNA 
clones, with special emphasis on the region encoding the phosphatase domains 
A 1.5 kb EcoW-Saft hLAR cDNA probe encoding both phosphatase domains (Streuli et 
al., 1988) was used to isolate cosmid clones, two of which, #5 and #11, repeatedly showed 
stronger hybridization signals under more stringent washing conditions. These clones were 
67 
Chapter II 
characterized further. Southern blot and restriction enzyme analyses revealed these two clones 
to overlap and span some 50 kb of the mouse Ptprf locus, as shown in Fig 1 We assume 
that the other, more weakly hybridizing cosmid clones contained either Ptprf pseudogenes 
or genes with homology to Ptprf, such as Ptprd (encoding ΜΡΤΡδ, Mizuno et al., 1993) or 
Ptprs (coding for mRPTPa, Ogata et al., 1994). 
A ) #11 
#5 
5 . E E E E 3 . 
Β Β Β Η Β Β Β Н Н В В В 
В) 
129 Ptprf locus 
Ssll Н Е НЕ В ВдШ 
1 2 
1 kb 
P Q R S T U V W X Y Ζ 
Η ними к -
cys cys 
Figure 1. Schematic representation ot the Ptprf IOLUS (A) and exon-intron structure ol the region ol the gene 
encoding the phosphatase domains of the mLAR protein (B) A) Thick solid bars indicate the positions of the 
cosmid clones relative to the Ptprf locus A hatched bar marks the SstVBglW fragment that is shown in more 
detail in panel В В, BamHI.E, £coRI,H, Wmdlll В) Introns (thin lines) and exons (tilled boxes) are drawn 
to scale Exons are numbered Ρ thru Ζ The region encoding the two phosphatase domains are indicated by 
brackets and numbered 1 and 2, respectively. Cys indicates the position of the codon for the conserved cystein 
residue within the signature sequence of each phosphatase domain 3' UTR, 3' untranslated region 
We compared genomic and cDNA sequences to position exon-intron boundaries within the 
Ptprf gene. To this end, ten cDNA clones were isolated from a XZAPII mouse brain cDNA 
library using the hLAR cDNA probe mentioned above End-in sequencing and comparison 
with the cognate positions in hLAR (Streuli et al., 1988), rat LAR (rLAR, Pot et al., 1991), 
and fragments of mLAR (Hendriks et al., 1995) revealed that three clones contained genuine 
mLAR cDNAs The other cDNA clones contained mLAR homologous sequences In Fig 
2, the sequence of the largest mLAR cDNA clone, mLAR#9, is depicted alongside the 
deduced amino acid sequence. 
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ATG CC* GAC CAC CCC CCC АТС 21 
M R Ο H Ρ Ρ 1 (1306) 
CCC АТС ACT GAC CTG GCA GAC ДАТ ATT GAG CGC CTC AAA GCC AAC GAT GGG СГС AAG TTC TCC CAG GAG TAT GAG 96 
P I T 0 L A O N I E R L K A M 0 G L K F S Q E Y 6 (1331) 
іЕжоп Ρ 
TCC ATT GAC CCT GGA CAG CAG TTC АСА TGG GAG ДАТ TCC AAC TCG GAG GTG AAC AAG CCC AAG AAC CGC TAT CCA 171 
S I D P G O O F T U E H S M S E V M I C P K H R Y A (1356) 
іЕяоп Q 
AAT GTC ATT GCC TAT GAC CAT TCT C U GTC CTC CTC ACC TCC ATT GAT GGT GTT CCT GGG AGT GAC TAC АТС AAT 2(6 
И I A Y D H S R V L L Г S t D G V P G S D T I И (1M1) 
GCC AAC TAC ATT GAT GGC TAC CGA AAG CAG AAT GCC TAC АТС GCC АСА CAA GGT CCG CTG CCC GAG ACC ATG GGC 321 
A M Y I D G T R K Q H A T I A T O G P L P E T H G ( 1 ( 0 6 ) 
GAT ITC TGG AGG ATG GTG TGG GAA CAG CCC АСА GCC АСА GTG GTC ATG ATG « С ACÛ СТА GAG GAG AAA TCC CGfl 396 
D F W R H V U E Û R T A T V V M M T R L E E K S R ( H Î D 
іЕиоп H 
GTG AAG TUT GAT CAG ТАГ TGG CCA GTC CCT GGC АСГ GAG ACC TAT GGC CTC АТГ CAG GTG ACC CTG GTG GAC ACT (71 
V K C D Q Y U P V R G T E T Y G L Î O V T L V D T (1(56) 
іЕнол S 
GTG GAG TTG GCC АСА TAC ACC ATG CGC ACC TTT GCC CTC CAT AAG AGT K G TCC AGT GAG AAG CG Τ GAG CTG CCT 5(6 
V E L A T Y T H R T F A L H I C S G S S E K R E L R ( U B I ) 
CAG П С CAG TTC ATB GCC TGG CCA GAC CAC GCC GTT CCT GAG TAC CCC ACT CCC АТС TTG GCC TTC СТО АСА CGG 621 
tìFQFHAUPOHGVPETPTPlLAFLRR (1 )06) 
іЕжоп Τ 
GIC AAC GCC IGT AAC CtA СТА GAT GCG GGG CCC ATG GTG GTG CAT IGC AGT GCG GGT GTG GGG CGC АСА GGC TGC 696 
V ï A C H P L O A G F - H V V H C S A G V G R T G С (1531) 
ITC АТС GTC AIC GAC GCA ATG CTG GAG CGT ATG AAG CAC GAG AAG ACG GIT GAC AIC TAT GGC CAC GTG ACG TGC 771 
F I V I D A N L E R H I C H E K T V D I Y G H V r c (1556) 
ATG CGC ICA CAA AGG AAC TAC ATG GTG CAG ACC GAG GAC CAG TAT GTG TTC АТС CAC GAG GCC CTG СТА GAG GCT №6 
H R S Û R M Y H V O T E D Q Y V F 1 H E A L L E A (1581) 
GCC AIG TCC CGA CAC ACC GAG GTG CTC GCT CGG AAC CTC TAT CCC CAC АТС CAG AAG СТА GGC CAA GTG CCT CCC 921 
A H C G H T E V L A R 4 L Y A H ] Q C L G Q V P P (1606) 
lExon U 
GCG GAG AGC GTC ACG GCC ATG GAA С П GAG ITC AAG TTC CTG GCC AAC TCC AAG GCC CAC ACG TCG CGC MT GTC 996 
G E S V T A H E L E F K L L A N S K A H T S R F V (1631) 
AC1 GCC AAC CTG CCC TGC AAC AAG TIC AAG AAC CGC C A GTG AAC AIC AIG CCC IAT GAG CTG ACC CGA GIG TGC 1(171 
S A H L P C H E F K H R L V N I H P Y E L T R V C (1656) 
lE«on V 
HG CAA CCC АТС CGT GGI GTG GAG GGC TCA GAC TAC АТС AAT GCC AGC TTT CIA GAI GGC TAC АСА CAG CAG AAG 11(6 
L O P [ H C V E G S D Y I X A S F L D C T R O Q « ( І б а і ) 
GCC TAC ATA GCT АСА CAG GGG CCT CTG GCA GAG AGC ACC GAG GAC TTC TGG CGC ATG TTA TGG GAG CAC AAT TCC 1221 
A T [ A T a G P L A E S T E D F W R H L U E H N S (1706) 
іЕяоп W 
ACC АТС АТС GTC ATG CTG ACC AAG CTT CGG GAG ATG GGC AGG GAG AAA TCT CAC CAG TAC TGG CCA CCA GAG CGC 1296 
T l I V M L T K L R E M G R E Í C H Q Y U P A E R (1731) 
TCC GCr CGC TAT CAG TAC TTC GTT GTT GAC CCG AIG GCT GAG TAC AAC ATG CCC CAG TAT ATT CTG CGT GAA TTC 1371 
S A R Y O Y F V V D P H A E Y H H P Q Y | L R E F (1756) 
ΙΕκοη X 
AAA GTC АСА GAC GCC CGG GAI GGG CAG TCA AGG АСА АТС CGA CAG ITC CAG TTT АСА GAC TCG CCA GAG CAA GGA H 4 6 
K V T D A R D G Û S R T I R O F Q F T D U P Ê O G (1781) 
GTA CCC AAA АСА GGT GAA GGC TIC АТС GAC TTC АТС GCG CAG GTG CAC AAG АСА AAG GAG CAG TTT GGC CAG GAT 1521 
V P K T G E G F I O F I G Û V H K T ï E O F G O O (1806) 
іЕяоп V 
CGC CCC АТС ACG GTG CAC TGC AGT GCT CCT GTG GGC CGC ACC CGT GTG TTC АТС ACC CTG AGC ATT GTC CTG GAG 1596 
G Ρ Ι Τ V H C S A G V G R T G V F 1 Г L S 1 V L E (1831) 
CGC ATG CGC TAT GAG GGT GTG GTT CAC ATG TTC CAG ACC GTG AAG ACC CTC CGC АСА CAC CGC CCT GCA ATG GTC 1671 
R M R Y E G V V D M F O T V I T L f t T Q R P A H V (1856) 
i £ x o n Ζ 
CAG АСА GAG GAC CAA TAC CAG CTG TGC TAC CGT GCG GCC CTG GAA TAC CIC GGC AGC TTI CAT CAC TAT GCA ACG 17(6 
Q T E O O Y Q L C T R A A L E T L G S F D H T A T (1B81) 
ІАД CTACIGCTCCCCTCTCCTCCGACGCTCCCCCGCGGCTCCGGAGGGACCCAGCTCCICTCAGCCATACCAACCAICGTCCAGCCCICCTGCACGGA 1B(( 
rGCTGTTGCCGGCAGAGCACAGCCCACTGGGATCACAGCATTTCCCCGAACATTGCCACACCAGTCAGAGAGCCCAGAACACCTGGCCAAGTAGGCCGA 19(3 
CTGGCAGCCTGGCTCTGGGCCCTCGTCCACCCGGCCAAGTGGAGCCCCGCTTCAAGCTCTCTGnCAGCTCCGCCTTCTCATGCTTCTCATGGGCTGGG 20(2 
AAAACGGGGCAAAGCCCCCACTTTTTATACACTAGGCGGGGTACACTGCGGGGTCCTACCCTCTTCCTCCGACTTTGCTTTTGCAGGTCTTTCACTGCA 21(1 
GATGCGCCTCCTGTGCGACTTGGGACTTGTrTCTTTTCCTTTTTGAGTTCACGTTGGATCC 2202 
Figure 2. Definition oí the exon intron boundaries within the partial mLAR cDNA sequence 
Exon intron boundaries are indicated by arrows at the first nucleotide ot each exon The 3' UTR sequence is 
given up to the BamHl sue as indicated in Fig 1 Numbers to the right indicate nucleotides as present in clone 
mLAR#9 and in brackets, amino acids according to the numbering system of Streuh et al (1988) Regions 
which exhibit 100% identity with previously published PCR derived mLAR fragments (Hendriks et al , 1995), 
are shown on a grey background Underlined sequences indicate the 'active site' signature motif 
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All three mLAR cDNAs ended in an Α-rich stretch in the 3' untranslated region (3' UTR) 
also found in the hLAR mRNA message (position 6900, Streuli et al., 1988). Screening of 
the mouse cDNA library with a more 3' UTR hLAR probe (Sall-EcoRl, positions 5933-7700, 
Streuli et al., 1988), yielded additional clones which terminated at the genuine 
polyadenylation site as predicted from hLAR sequence data (not shown) We therefore 
conclude that clone mLAR#9 represents a mLAR cDNA in which the reverse transcription 
reaction started at the Α-rich stretch within the 3' UTR. 
i 1 il i 1 
LRP l 12 13 17 18 19 20 21 22 
Ly-5 £ 20 
/ // / / / ƒ / 
21 23 25 26 
mLAR 
ι v ^ 7 7 7 
/ / / / / 
L L-
27 28 29 30 31 33 34 
/ / / / / / / 
Figure 3. Comparison of exon segmentation as observed in the Pipra, Plprc, and Ptprf genes within the region 
encoding the phosphatase domains of RPTPases LRP (Wong et al , 1993), Ly 5 (Saga et al , 1988), and 
mLAR, respectively Dashed lines indicate identical boundaries Downward arrows indicate introns present in 
Ptpra and Plprc but missing in the Ptprf gene The upward arrow points to an intron present in Ptprf but absent 
in Ptpra and Ptprc Exon numbers for LRP and Ly-5 are according to the literature 
Southern blot analysis using cDNA clone mLAR#9 as a probe revealed that the sequence 
encoding the mLAR cytoplasmic region resided in a 6 5 kb Sstl-BamHi genomic fragment. 
Sequence analysis showed both phosphatase domains to be encoded by eleven exons 
contained within a 4 5 kb EcoRl-BamH\ fragment (Fig. 1). The most 3' exon contains the 
last 22 codons for the protein and the entire 3'UTR of the mRNA The intron lengths in the 
gene segment shown in Fig 1 vary from only 80 bp up to 0 5 kb Comparison of the 
deduced organization of the Ptprf gene with that of the Ptpra and Ptprc RPTPase genes 
(encoding for LRP and Ly-5, respectively, Wong et al., 1993, Saga et al., 1988), revealed 
conspicuous differences (Fig. 3) Whereas the genomic organization of the first phosphatase 
domain is similar but not identical to the second domain in all three PTPase family members, 
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both mLAR phosphatase domains together are encoded by only eleven exons, in contrast to 
the seventeen (spanned within ~ 34 kb) and sixteen exons (spanned within ~ 27 kb) for LRP 
and Ly-5, respectively. This finding is at variance with the conclusions of Wong et al. 
(1993), who postulated that all RPTPases exhibit a similar genomic organization of the region 
encoding the phosphatase domains. Our results show clear differences in the gene structure 
of RPTPases. We propose that an ancestral gene originally contained a single tyrosine 
phosphatase domain encoded by at least nine exons. This may have been duplicated later to 
produce RPTPases with two phosphatase domains. Subsequently, several intron losses may 
have occurred for both the phosphatase domains as well as for the various types of 
RPTPases. One intron (between exon Ρ and Q), still present in the Ptprf gene has been 
removed from the PtpralPtprc ancestor. In the Ptprf gene, five introns have been removed 
that are still present in the other two RPTPase genes (Fig. 3). The reason why the gene 
structure of the Ptprf gene is so much more compact than other RPTPase genes remains, 
however, obscure for the moment. 
Figure 4. Chromosomal localization of the Ptprf gene. 
Unique hybridizing signals of cosmid mLAR#5 were recorded in more than 30 metaphase spreads (right panel). 
Positively imaged chromosomes were counterstained with DAPI for the identification of the individual 
chromosomal sub-bands (left panel). 
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Chromosomal localization of the Ptprf gene 
Mouse cosmid clone mLAR#5 was used as a probe for fluorescence in situ hybridization in 
order to determine the chromosomal localization of the Ptprf locus Alignment to G banded 
chromosome images showed the Ptprf gene to localize within the region C6-D1 of mouse 
Chromosome 4 (Fig 4) Based on data on evolutionary conservation ot chromosome 
segments in man and mouse (Lyon and Kirby, 1993), this is in agreement with the 
localization of the PTPRF gene within the p32-33 region of human Chromosome 1 (Streuli 
et al , 1992) This localization is distinct from those of the Ptprd and Ptprs loci, which have 
been assigned to the region around the b locus on mouse Chromosome 4 (Mizuno et al , 
1993) and distal mouse Chromosome 17 (Yan et al , 1993), respectively Together with RNA 
in situ hybridization data, which reveal different expression patterns tor mLAR, ΜΡΤΡό, and 
mRPTPa (R Q J Schaapveld, J Τ G Schepens, and W J A J Hendriks, unpublished 
results), these mapping data are in agreement with Mizuno et al (1993) and demonstrate that 
mLAR, ΜΡΤΡδ, and mRPTPa are indeed separate entities 
Homology to other receptor-like PTPases 
The mLAR cDNA sequence presented here is nearly identical to rat (Pot et al , 1993) and 
human LAR (Streuli et al , 1988) the overall homology at the amino acid level is 99 6% and 
98 2%, respectively The homology (up to 90% at the amino acid level) to other type II 
RPTPases, ΜΡΤΡδ and mRPTPa (Mizuno et al , 1993, Ogata et al , 1994), which also 
contain two catalytic domains, a single transmembrane domain and, extracellularly, eight FN 
III and three Ig-hke domains, is also striking Indeed, we also isolated clones representing 
ΜΡΤΡδ and mRPTPa by screening both the genomic and cDNA libraries at low stringency 
(not shown) Nucleotide sequence alignment of the phosphatase domains was used to gain 
insight into their evolutionary history A phylogenetic tree, as depicted in Fig 5, suggests 
that a common ancestor for ΡΤΡδ and RPTPa diverged from the LAR lineage most probably 
before the time of mammalian radiation These results suggest that the mutation rate for LAR 
is lower than those of both ΡΤΡδ and RPTPa, reflecting the maintenance of selective pressure 
on the LAR lineage and the adaptation to new roles in growth and development for ΡΤΡδ and 
RPTPo 
In addition, the homology between these three proteins is more conserved in phosphatase 
domain 2 than in domain 1 This is not seen for the other, more distant, members of the type 
II RPTPases (ι e RPTP^, RPTPK), or among type IV (e g ΗΡΤΡα HPTPc) and type V 
(e g HPTPf, HPTP7) RPTPases (Jiang et al , 1993, Krueger et al , 1990, Krueger and 
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Saito, 1992; Kaplan et al., 1990). Further studies on the biological significance of each 
individual phosphatase domain in RPTPases are now in progress. 
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Figure 5. A proposed phylogenetic tree of the phosphatase domains 1 and 2 of the human, rat, and mouse 
PTPases LAR, ΡΤΡδ, and RPTPa Nucleotide sequences encoding the region which starts immediately after 
the sequence DFWRM(I/V)W(E/D) and ends before the stretch HCSAG(V/I)GR were used for both domains 
of mLAR (accession number Z37988), rLAR (M60103), hLAR (Y00815), mPTPÒ (D13905), hPTPÍ (X54133), 
mRPTPa (D28530), rPTPa (A49104), and hRPTPa (S78080) This unrooted tree was constructed on the basis 
ot a distance matrix created according to the Kimura 2-parameter model (Kimura, 1980) with a 
transition/transversion ratio of 2, using the program FITCH and performing global rearrangements to verify the 
obtained topology Changes in sequence input order did not alter the tree topology The scale for branch lengths 
(bottom) represents the expected underlying number of changes per site 
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Summary 
Receptor-like protein tyrosine phosphatases (RPTPases) comprise an extracellular ligand-
binding region, a transmembrane domain, and as a rule two cytoplasmic tyrosine 
phosphatase domains In vitro studies using the cytoplasmic parts of RPTPases and 
artificial substrates have suggested that the first, membrane proximal phosphatase domain 
exhibits catalytic activity, whereas the second, C-terminal phosphatase domain may 
regulate the phosphatase activity of the first domain Further studies, however, are 
hampered by the fact that RPTPase-specific hgands and substrates still remain to be 
identified Moreover, the complexity of transmembrane signalling is difficult to mimiek in 
vitro To circumvent these problems, the individual functions of the two phosphatase 
domains in RPTPases can be studied m vivo by means of homologous recombination in 
mouse embryonic stem (ES) cells Here, we decnbe the use of 'double replacement' gene 
targeting in mouse embryonic stem cells to generate cell and animal models for studying 
the individual role of both phosphatase domains of the RPTPase Leukocyte common 
Antigen-Related molecule LAR In addition, exploiting the process of gene conversion, 
LAR-negative ES cells were generated to analyse structure-function relationships of LAR 
mutants on a null background 
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Introduction 
Receptor-like protein tyrosine phosphatases 
Protein-tyrosine phosphatases (PTPases) are the natural antagonists of the well-known 
protein tyrosine kinases (PTKs) and play an important role in the control of diverse 
cellular signalling pathways, cell growth, and differentiation (Fischer et ai, 1991; Tonks 
et ai, 1992; Mourey and Dixon, 1994). The identification of many distinct PTPase 
genes, and the discovery of multiple isoforms resulting from alternative splicing and post-
translational modifications, have revealed a suprising degree of complexity in this 
multiprotein family. On the basis of their overall structures, two classes of PTPases can 
be distinguished, namely: (i) those found in the cytoplasm and the nucleus that have only 
one tyrosine phosphatase domain and (n) membrane-bound, receptor-like PTPases 
(RPTPases) that have an extracellular ligand-binding region, a transmembrane domain, 
and, with a few exceptions, two repeated cytoplasmic phosphatase domains (Fig 1) 
extracellular intracellular 
ss ss ss NUUÜ~B 
"Ig" 
— С лп 
С РТР1в 
"РТР" 
Figure 1. Structural organization ot the two distinct PTPase classes, as illustrated by PTP1B (Tonks et al , 
1988) and LAR (Slreuli el al , 1988) Dashed lines indicate the plasmamembrane Ig, Immunoglobulin like 
domain, FN-III, fibronectin type III repeat; PTP, protein tyrosine phosphatase domain; N, amino terminus, 
C, carboxy-terminal end 
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One of the best studied RPTPases is the Leukocyte common Antigen Related molecule 
LAR (Streuli et al , 1988) LAR is composed of two cytoplasmic phosphatase domains, a 
transmembrane segment, and an extracellular region which shares homology to 
immunoglobulin (Ig)-like and fibronectin type III (FN-III) domains (Fig 1) Such an 
arrangement of these extracellular motifs is commonly found in cell adhesion molecules 
like N-CAM (Edelman and Crossin, 1991) It is tempting to speculate that LAR may play 
a role in cell adhesion, through ligand-mediated dephosphorylation of intracellular 
substrates 
LAR is expressed on the cell surface as a complex of two non-covalently associated 
subumts derived from the same pro protein (Streuli et al , 1992, Yu et al , 1992) The 
-200 kDa precursor is cleaved within the cell at a paired basic amino acid site by a 
subtihsin-like endoprotease to generate 150 kDa and 85 kDa fragments (Fig 1) The N 
linked glycosylated 150 kDa fragment represents the amino terminus of the protein, and is 
shed from the cell membrane during growth Whether this shedding has an effect on the 
intracellular phosphatase activity remains to be investigated The 85 kDa fragment 
contains the transmembrane segment and the two phosphatase domains of approximately 
260 amino acid residues each In vitro site directed mutagenesis studies have suggested 
that the first phosphatase domain in RPTPases exhibits catalytic activity, for which a 
cysteine residue in the 'signature sequence' (I/V)HCXAGXXR(S/T)G is essential 
(reviewed m Mourey and Dixon, 1994) It is still a point of controversy whether the 
second, C-terminal phosphatase domain has only a regulatory function in modulating the 
substrate specificity of the first domain (Streuli et al , 1990, Pot et al , 1991, Krueger 
and Saito, 1992), or has catalytic activity by itself (Wang and Pallen, 1991, Tan et al , 
1993) This problem is difficult to address because of the complexity of transmembrane 
signalling Furthermore, extracellular ligands and downstream substrates, that are specific 
for a single RPTPase, are currently not known Therefore, we set out to study the loss of 
function of the two individual phosphatase domains of LAR in vivo by means of gene 
targeting using homologous recombination in mouse embryonic stem (ES) cells 
Gene targeting by homologous recombination 
Gene targeting, the homologous recombination of chromosomal DNA sequences with 
newly introduced DNA sequences (Thomas and Capecchi, 1987), is now widely used to 
study gene function in vivo (for review see Koller and Smithies, 1992) Pluripotent ES 
cells, containing the desired genomic alteration, are microinjected into blastocysts and 
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subsequently transferred into pseudo-pregnant foster mothers These ES cells can 
contribute to the germhne of the resulting chimaeric mice, which then can transmit the 
mutated allele to their offspring In this way, mutations can be transferred from the 
culture dish to the whole animal Subsequent inbreeding can give rise to mice carrying the 
mutation in both alleles, allowing the analysis of the mutation in the heterozygous and 
homozygous state 
Thusfar, gene inactivation is the major application of gene targeting, and more than a 
hundred different so-called knock out mice have been created and studied Since 
phenotypic alterations in null mutants are often very complex or embryomcally lethal, 
gene function may be better understood by introducing subtle mutations in functional 
domains of a protein while leaving the remainder of the protein intact To date, three 
procedures have been described to introduce specific mutations in the genome, namely (1) 
the 'hit and run' or 'in-out' procedure (Hasty et al , 1991, Valanuus and Smithies, 
1991), (n) a one-step recombination strategy using the Cre loxP recombination system 
(Gu et al , 1993), and (in) the 'double replacement', 'two-step', or 'tag-and exchange' 
strategy (Askew et al , 1993, Gondo et al , 1994, Stacey et al , 1994, Wu et al , 1994) 
This latter procedure requires two rounds of homologous recombination using 
replacement type targeting vectors In the first step, a cassette containing both a positive 
and a negative selectable marker is introduced into the gene locus to mark the region of 
interest by selection for the positive selectable marker In the second step, using the 
negative selectable marker to enrich for recombinants, the cassette is replaced again by 
the original endogenous sequences carrying any desired subtle mutation (see also Fig 2) 
This procedure can be used to generate cell lines and subsequently mice in which either 
the LAR phosphatase domains 1 or 2, or both, are inactivated 
Materials & methods 
'Double replacement' targeting at the LAR locus 
The isolation and characterization of mouse 129 genomic LAR sequences were described 
previously (Schaapveld et al , 1995) A 7 5 kb ВатШ-EcóRl fragment just upstream of the exons 
encoding the cytoplasmic phosphatase domains was subcloned into pBluescnpt KS+ (Stratagene) 
From this, the 3' segment was subcloned as a 3 2 kb Pstl Sail fragment into a modified pGEM3 
vector having a Xhol linker inserted in the Sma\ site, resulting in pLAR5' From the 4 5 kb 
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ВатШ clone just 448 bp downstream the stop-codon of LAR, the 5' 2 3 kb ВатШ-Bglll 
fragment was subcloned into the BamHl-s'ite of pLAR5', generating pLAR5'-3' Finally, a 
hygromycin phosphotransferase/thymidine kinase fusion gene (HyTK, Lupton et al., 1991) or a 
neomycin phosphotransferase expression cassette (Neo, van Deursen el al , 1991) were inserted as 
a Xhol fragment into the Sa/I-site of pLAR5'-3' for step 1 or step 2, respectively Prior to 
electroporation, targeting constructs (pLARHyTK or pLARNeo) were linearized using the unique 
X/ioI-site from the introduced linker 
E14 ES cells were cultured on irradiated SNLH9 feeder cells as described (van Deursen and 
Wiennga, 1992) Exponentially growing ES cells were collected and mixed with 20 /ig of 
linearized pLARHyTK (step 1) or pLARNeo (step 2), electroporated at 250 V/500 ¿iF (Gene 
Pulser, Biorad), and plated at 5.106/9 cm dish onto irradiated feeder cells Selection was applied 
24 h later using 300 ¿¿g/ml Hygromycin В (HygroB, ICN) for step 1 or 300 ^g/ml G418 
(Gibco/BRL) whether or not in combination with 0.2 μΜ l-[2 deoxy, 2-fluoro-ß-D-
arabinofuranosyl] 5-iodo-uracil (FIAU, Bristol Myers Squibb) for step 2 After 9-11 days of 
selection, drug resistant ES clones were picked, expanded, and used for genotyping 
Production of homozygous mutant ES cells 
HygrB7G4187FIAUs ES clones were plated at 1.105 cells/9 cm dish onto 0 1 % gelatin in the 
presence of Leukemia Inhibiting Factor (LIF, 1,000 U in CHO conditioned medium) to keep them 
pluripotent Selection was applied 24 h later using 0-2 mg/ml G418 in combination with 0-0 2 μΜ 
FIAU After 8-13 days of selection, ES clones were picked and expanded for further analysis 
Genotyping 
Genomic DNA from individual ES cell clones was extracted and analyzed by Southern blot 
analysis as described (Steeghs et al., 1995). Initial screening was performed using a 3'-flanking 
probe (a Sau3A fragment derived from a 2 5 kb ВатШ fragment just downstream of the 4.5 kb 
ВатШ clone mentioned above) Positive clones were also analyzed with a 5'-flanking probe (a 
1 0 kb ВатШ-ХЬаХ fragment representing the 5' end of the 7.5 kb ВатШ-ЕсоШ fragment 
mentioned above), a 1 8 kb EcoRI-Hindlll fragment from the HyTK cassette, a 0.8 kb Pstl 
fragment from the Neo cassette, and a 1 8 kb ВатШ mouse LAR cDNA fragment comprising all 
exons encoding both cytoplasmic phosphatase domains (pos. 420-2202, Schaapveld et al., 1995) to 
check for proper homologous recombination. 
RNA analysis 
A RT-PCR reaction using LAR-specific primers was designed to check for expression of both 
LAR phosphatase domains in wildtype ( + / + ), heterozygous ( + /-), and homozygous mutant (-/-) 
ES cells Total RNA from the diverse clones was isolated using RNAzol В (Cinna/Biotecx), 
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according to the manufacturers protocol 2 μg of RNA was reverse transcribed using random 
hexamers (2 μg, Pharmacia) and Superscript reverse transcriptase (100 U, Gibco/BRL) One-tenth 
of the cDNA was subsequently analyzed by PCR (Hoffmann-La Roche) using Taq polymerase and 
the LAR-specific primers LAR5s (5'-GAG CTG CGT CAG TTC CA-3', sense), located 129 bp 
upstream of the codon for the conserved cysteine residue in the first phosphatase domain and 
LAR2as (5'-GAC TTG CTC AGG TAG GGC-3', antisense), located 532 bp downstream of the stop-
codon of LAR, resulting in a 1,745 bp amplicon Each cDNA preparation was tested with a ß-
Actin PCR to ensure the integrity of the cDNA synthesis The ß-Actin primers (1)5' GCT AT/CG 
AGC TGC CTG ACT G 3' (sense) and (2) 5' GAG GCC AGG ATG GAG CC-3' (antisense) detect a 
338 bp amplicon The PCR cycle profile consisted of 94'С for 1 min, 50'С for 1 min (ß-Actin 
58°C) and 72'C for 3 min (ß-Actin 1 min), for 35 cycles, and was performed in a programmable 
thermocycler (Perkin-Elmer Cetus) Each 50 μΐ reaction contained 10 mM Tris-HCl (pH 8,3), 50 
mM KCl, 2 5 mM MgCl2 (ß-Actin 1 5 mM MgCl2), 0 01% BSA, 1 mM dNTPs, 50 ng of each 
primer, and 1 U Taq polymerase In addition to template minus (-cDNA) controls, reverse 
transcriptase-minus (-RT) controls were included One-fifth of the reaction products was separated 
on 1 % (LAR) or 2% (ß-Actin) agarose gels and visualized by ethidium bromide staining 
To ensure LAR double knock-out ES cells were really negative, the LAR-specific PCR 
products were transferred to nylon membrane (Biotrace, Gelman Sciences) in 0 4 N NaOH and 
analyzed by hybridization to the mLAR cDNA probe encompassing the exons encoding both 
phosphatase domains 
Generation of a LAR polyclonal antiserum 
The 1 8 kb BamHl LAR cDNA fragment was subcloned into the bacterial expression vector 
pGEX-3X (Pharmacia) The construct was introduced into E coli strain DH5a and expression of 
fusion protein was induced by 0 1 mM IPTG The expressed fusion protein was isolated using 
standard protocols (Sambrook et al , 1989) followed by preparative SDS-PAGE and electroelution 
(Biotrap, Schleicher & Schuell) A New Zealand white rabbit was immunized intraperitoneal^ 
with -250 μg fusion protein in the presence of Freund's complete adjuvants and boosted for three 
times (~250 μg fusion protein with incomplete Freund's adjuvants) with three weeks intervals 
Two weeks after the last boost serum (aLAR-cyt) was collected 
Immunoprectpitation and immunoblotting 
Wildtype and double knock-out ES cells were plated at 2 lOVwell on a 6-well dish 48 h later 
cells were washed with PBS containing 1 mM СаС1
д
, incubated for 10 min on ice in 1 ml NP-40 
lysis-buffer (50 mM Tris-HCl, pH 8 0, 150 mM NaCl, 5 mM EDTA, 1% NP-40, 10 μg/ml 
Leupeptin, 10 μg/m] Aprotinin, 1 mM PMSF, 1 mM Na3V04, and 10 mM NaF), and scraped 
After centrifugation, the supernatants were precleared with CL2B-Sepharose beads (Pharmacia) 
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and incubated O/N with aLAR-cyt (1:100) and GammaBind plus Sepharose beads (Pharmacia) 
Immune complexes were washed four times with modified lysis-buffer (0.1% NP-40), transferred 
to a new tube, and washed one more time Immunoprecipitates were released from the beads by 
boiling for 5 min in SDS sample buffer, resolved on a 8% SDS-PAGE gel, and blotted to a 
nitrocellulose filter The immunoblot was blocked for 1 h with 1% BSA (Sigma) in TBST (10 mM 
Tris, pH 8.0, 150 mM NaCl, and 0.05% Tween-20), probed O/N with aLAR-cyt (1:1000) in 
TBST, washed three times with TBST, incubated for 1 h with Prot A/G-PO (1:10,000, Pierce), 
washed again, and developed using chemihimimscence (NEN-DuPont) 
Results 
Targeting of the RPTPase LAR gene 
The relevant segments of the structural and genomic murine LAR DNAs were isolated 
using a human LAR cDNA clone as a probe (Schaapveld et al., 1995) A replacement-
type targeting vector was constructed in which a dominant positive/negative selection 
marker, a hygromycin phosphotransferase-thymidine kinase (HyTK) fusion gene (Lupton 
et al., 1991), was flanked by 3.2 and 2.3 kb of endogenous LAR genomic segments to 
provide the necessary homology for targeted integration Upon homologous 
recombination, the HyTK cassette replaces a 4.5 kb genomic segment containing all exons 
encoding the cytoplasmic part of LAR (Fig 2, step 1) 
Figure 2. Disruption of the LAR gene by 'double replacement' targeting 
A recombination event replaces the genomic sequences comprising both phosphatase domains by the HyTK 
fusion cassette (step 1) The resulting HygroBVFIAU' homologous recombinant cell line is then used in a 
second round of targeting (step 2) in which either the HyTK fusion cassette (A) or the LAR phosphatase 
domains of the remaining wild-type allele (B) are replaced by the Neo gene Hatched bars represent the 
endogenous LAR genomic segments and the grey arrows symbolize the selection cassettes Small grey bars 
indicate the 5'- and З'-diagnostic probes, and the solid bars I and II mark the genomic segments encoding 
the phosphatase domains 1 and 2, respectively. B, BamHl; V, £coRV; E, EcoRl 
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The targeting construct was introduced into E14 ES cells by electroporation and 272 
Hygromycin В resistant (HygroBr) clones were screened for homologous recombination 
by Southern blot analysis using 5'- and З'-diagnostic probes derived from genomic 
sequences flanking the targeting vector region. Using the З'-probe, ten clones were found 
to display the diagnostic £coRV fragment, indicative of a targeting event. Eight out of the 
ten clones also revealed the proper ВатШ digestion pattern with the 5'-probe, 
demonstrating correct homologous recombination at both ends (Fig. 3). Unfortunately, 
these cell lines were unsuitable for germline transmission, probably due to high 
expression of the thymidine kinase fusion protein in germ cells (Braun et al., 1990; 
Ramirez-Solis et al., 1993). However, they can serve as starting cell lines for the 
introduction of inactivating point mutations in the phosphatase domains by a second 
recombination step. 
Í· 
Mw(kb) — 
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Figure 3. Screening for homologous recombinants. 
Southern blot autoradiograms of ±10 /ig genomic DNA from individual HygroB' ES clones. The 3'-
flanking probe reveals the diagnostic 12.0 kb fragment in EcoRV digested DNA (left panel), indicative of 
targeting at the LAR locus. Use of a 5'-flanking probe on BamHl digested DNA (right panel) is necessary 
to confirm correct homologous recombination (clone G6 is a result of an integration event at the LAR 
locus). 
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To test the feasabihty of this 'double replacement' strategy and to obtain germline 
transmission of a LAR null allele for the generation of LAR knock-out mice, one of the 
targeted ES cell lines (E14.F4) was again transfected, but now with a gene targeting 
vector in which all exons encoding the cytoplasmic part of LAR were replaced by the 
neomycin phosphotransferase (Neo) gene (Fig 2, step 2) Applying different 
combinations of the selective agents HygroB, G418 and l-[2 deoxy, 2-fluoro-ß-D-
arabinofuranosyll 5-iodo-uracil (FIAU) resulted in 1) G4187FIAUr ES cells, in which the 
HyTK cassette is exchanged for the Neo cassette, and 2) G4187HygroBr ES cells, in 
which both LAR alleles are targeted (Table 1, Fig 4) Highly chimaenc mice were 
generated upon injection into blastocysts of either 'replacement' clones or 'double knock-
out' clones Chimaeras resulting from the replacement clones were tested in a breeding 
program and germline transmission of the desired genotype has been obtained (Schaapveld 
et al , manuscript in preparation), demonstrating that a second round of homologous 
recombination in the E14 F4 cell line is possible without affecting the germline 
competence This opens the way for the introduction of inactivating point mutations in 
each of the two LAR phosphatase domains using a replacement-type targeting vector 
carrying the mutated genomic segment 
Table 1. Targeting of the LAR gene in E14 F4 cells (step 2) 
Selection 
G418 & HygroB 
G418 
G418 & FIAU 
# clones 
screened 
185 
189 
17 
Targeting 
events 
3 
2 
2 
Homologous 
recombinants 
1 (DK) 
2 (DK & RC) 
2(RC) 
DK = Double Knock out RC = Replacement Clone 
As mentioned above, cell lines were also obtained in which both LAR alleles were 
inactivated as a result of the second replacement step Such a double knock-out cell line 
may be a useful tool to assess the function of a gene, especially when the mutation is 
lethal in early development Other groups have used double knock-out cell lines, 
generated by two consecutive rounds of targeting with two different vectors, to study 
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genes involved in cell growth and differentiation (te Riele et al., 1990; Mortensen et al. 
1991). 
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Figure 4. Detection of 'replacement' and 'double knock-out' clones. 
Southern blot autoradiograms of ± 10 /ig genomic DNA from individual clones resulting from the second 
round of targeting in the E14.F4 cell line (see Fig. 3). In DNA digested with Bamiü (upper panel), the 5'-
flanking probe reveals the diagnostic 8.6 kb and/or 10.5 kb fragments indicating targeting at the LAR locus. 
Replacement (BC2, CAI, and CA7) and double knock-out (A1G9, and BE6) cell lines are shown. Use of a 
З'-flanking probe on EcoRV digested DNA (lower panel) reveals the 12 kb diagnostic fragment for both 
events. Screening with HyTK and Neo probes was necessary to discriminate between integration (A1C10, 
and A2C9) and recombination events (data not shown). 
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Production of LAR double knock-out ES cells 
Recently, a method has been described that requires only a single targeting construct to 
generate double knock-out cell lines (Mortensen et al , 1992) It is based on the 
phenomenon that cells heterozygous for a given locus can be rendered homozygous by 
mitotic recombination or gene conversion Since cells bearing two copies of a Neo gene 
are more resistant to G418, homozygous cells can be generated from a heterozygous cell 
line (containing only one copy of the Neo gene) by cultunng in sublethal concentrations 
of G418 We tested this approach by taking advantage of the presence of the HyTK fusion 
cassette and the Neo gene in the LAR double knock out HygroB7G4187FIAUs cell line, 
E14 BE6 This cell line was cultured not only in the presence of a high G418 
concentration, but also in the presence of FIAU As a result, only cells that mutate or 
delete the HyTK cassette and at the same time increase their neomycin phosphotransferase 
levels will survive Gene conversion resulting in the replacement of the HyTK allele by a 
copy of the Neo allele will have both these effects In this way, we were able to generate 
double knock-out cell lines containing two copies of the Neo gene (Table 2, Fig 5) 
Table 2. Use of high G418 concentrations to generate homozygous mutant ES cells 
Selection # Clones % Homozygous 
G418 (mg/ml) FIAU (μΜ) picked (# analyzed) 
10 0 2 19 14 (7) 
15 0 2 15 16(12) 
2 0 0 2 2 - (0) 
Next we investigated the consequences of double replacement gene targeting and gene 
conversion at the RNA level in these double knock out cell lines Total absence of LAR 
transcripts containing sequences encoding both phosphatase domains was analyzed by RT-
PCR using mouse LAR specific primers, followed by Southern blot analysis using a 
mouse LAR cDNA probe encoding both phosphatase domains Double knock-out cell 
lines containing two copies of the Neo gene (CI) or one copy of the HyTK fusion cassette 
and one copy of the Neo gene (BE6) show total absence of LAR mRNA, whereas 
heterozygote cell lines containing only one copy of the Neo gene (CAI) or only one copy 
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of the HyTK fusion cassette (F4) still show expression of LAR (Fig. 6). 
Mw (kb) 
probe: 5' flanking 
Figure 5. Detection of gene conversion events in LAR-negative ES cells. 
Southern blot autoradiograms of ± 10 /ig genomic DNA from individual clones surviving high concentration 
of G418. In DNA digested with BamWl the 5'-flanking probe reveals the two diagnostic 8.6 kb fragments 
indicating loss of the HyTK cassette by gene conversion using the Neo allele as template (cell lines CI, and 
C8). 
LAR 
1745bp 
^ &&#*<?£? & 
ß-Actin 
338 bp ^^ ^^ ^ ^^ ^^ ^ ^^ ^^ ^ 
Figure 6. Detection of RNA expression in LAR-negative ES cells. 
RT-PCR analysis followed by Southern blot analysis of individual clones generated by the various ways 
described above. Double knock-out cell lines (CI, and BE6) show complete absence of LAR expression 
(upper panel). RT-minus and cDNA-minus controls were included to show specificity of the RT-PCR. ß-
Actin primers were used as a control for the cDNA synthesis (ethidium bromide picture, lower panel). 
Amplicon sizes are shown on the left. 
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To confirm the absence of the LAR phosphatase domains at the protein level, protein 
lysates of the double knock-out cell lines were prepared, and analyzed by 
immunoprecipitation followed by Western blot analysis. A rabbit polyclonal antiserum 
raised against a GST-LAR fusion protein containing both phosphatase domains failed to 
detect the 85 kD subunit of LAR (Streuli et al., 1992) in the double knock-out cell line 
(Fig. 7). This demonstrates the efficient inactivation of both LAR alleles in ES cells by 
initially targeting a single allele followed by selection of double knock-outs. 
Mw(kD)H ± *
4 X 
2 0 0 -
97 
66 
P85 LAR 
Figure 7. Absence of the LAR phosphatase doamins in double knock-out ES cells. 
Protein lysates of wildtype (E14, +/ + ) en double knock-out (CI, -/-) ES cells were prepared and analyzed 
by immunoprecipitation followed by Western blot analsyis, using a rabbit polyclonal antiserum against both 
phosphatase domains of mouse LAR. P85 LAR represents the 85 kD subunit of LAR containing both 
phosphatase domains. Protein size markers are indicated on the left. 
In Conclusion 
Using replacement-type targeting vectors we have shown various ways of generating cell 
and animal models to study the role of the RPTPase LAR in signal transduction. Firstly, 
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ES cell lines lacking the gene sequences essential for LAR phosphatase activity were 
generated using a double replacement strategy involving two subsequent homologous 
recombination events. Secondly, the feasabihty of selecting for gene conversion events to 
mutate the remaining allele was confirmed. Thirdly, the E14.F4 line that resulted from 
the first targeting step involving the HyTK positive/negative selection cassette was 
succesfully used for a second round of homologous recombination without the loss of 
germline competence. 
We have observed homologous recombination events involving the region that spans 
both phosphatase domains of LAR at an average frequency of about 1 in 50 clones for 
both steps 1 and 2 An insertion rather than a replacement mutation was seen in 20% of 
our clones. In agreement with others, this underlines the necessity of using probes not 
only from both sides of the targeted locus, but also probes for the selectable markers and 
the deleted region, to screen for genuine homologous recombination events However, 
this frequency of lllegtimate targeting events may not be general and might depend on 
intrinsic properties of the locus under study. 
Future experiments will be aimed at the reconstitution of the LAR-negative ES cell 
line with wild-type human LAR as well as with several mutants Generated cell lines can 
then be used to study the role of LAR in cell proliferation and differentiation by 
analyzing, for example, their cell growth properties, phosphotyrosine protein patterns, 
and the LAR phosphatase activity itself during ES cell differentiation The strategies and 
techniques used here to create LAR' models are generally applicable and provide a 
unique means to study many Orphan' signal transduction molecules 
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Summary 
The LAR receptor-like protein tyrosine phosphatase is comprised of two intracellular 
tyrosine phosphatase domains and a cell adhesion molecule-like extracellular region 
containing three lmmunoglubulin-hke domains in combination with eight fibronectin type-
III-like repeats This architecture suggests that LAR may function in cellular signalling by 
the regulation of tyrosine phosphorylation through cell cell or cell-matrix interactions We 
used gene targeting in mouse embryonic stem cells to generate mice lacking sequences 
encoding both LAR phosphatase domains Northern blot analysis of various tissues 
revealed the presence of a truncated LAR mRNA lacking the cytoplasmic tyrosine 
phosphatase domains and indicated that this LAR mutation is not accompanied by obvious 
changes in the expression levels of one of the LAR-like receptor tyrosine phosphatases 
PTP5 or ΡΤΡσ LAR' mice develop and grow normally and display no appreciable 
histological tissue abnormalities However, upon breeding we observed an abnormal 
neonatal death rate for pups from LAR' females Mammary glands of LAR' females 
were incapable of delivering milk due to an impaired terminal differentiation of alveoli at 
late pregnancy As a result, the glands failed to switch to a lactational state and showed a 
rapid involution postpartum In wildtype mice, LAR expression is regulated during 
pregnancy reaching maximum levels around day 16 of gestation Taken together, these 
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findings suggest an important role for LAR mediated signalling in mammary gland 
development and function 
Introduction 
Protein tyrosine phosphorylation, a key event in signal transduction, is a post-translational 
modification controlled by the agonistic or antagonistic action of protein tyrosine kinases 
(PTKs) and protein tyrosine phosphatases (PTPases, Mourey and Dixon, 1994, Sun and 
Tonks, 1994) The PTPases comprise a diverse family of receptor like and cytoplasmic-
type enzymes including multiple isoforms resulting from alternative splicing and post 
translational modifications (for review see Saito, 1993) 
Receptor-like PTPases (RPTPases) contain one or two homologous PTPase domains, a 
transmembrane segment, and diverse combinations of domains with possible ligand-
binding properties in the extracellular part For example, the closely related RPTPases 
ΡΡΤΡμ and PTP/c mediate cell-cell interactions in a homophihc, but not heterophilic 
manner (Brady Kalnay et al , 1993, Gebbink el al , 1993, Sap et al , 1994, Zondag et 
al , 1995) In RPTP/3 the extracellular moiety binds to a non-related cell-surface protein, 
the neuronal recognition molecule contactin (Peles et al , 1995) It has not been clarified 
if and how such interactions modulate tyrosine phosphatase activity and whether 
RPTPases play a role early in signal transduction or later in adaptation or response 
cessation (Ninfa and Dixon, 1994) 
Although LAR was among the first RPTPases to be identified (Streuli et al , 1988) and 
has been studied extensively at the cellular level, its physiological function remains 
elusive LAR is composed of two cytoplasmic phosphatase domains in tandem, a 
transmembrane segment, and an extracellular part which shares homology to 
immunoglobulin (Ig) like and fibronectin type III (Fn-III) domains, commonly found m 
cell adhesion molecules (Edelman and Crossin, 1991) This architecture suggests a 
physiological function for LAR in cellular signalling by tyrosine dephosphorylation as a 
response to cell-cell or cell-matrix interactions Recently, an intracellular LAR-interacting 
protein (LIP 1) was identified, which binds to the second PTPase domain and colocalizes 
with LAR to the ends of focal adhesions most proximal to the cell nucleus, suggesting a 
role for LAR in disassembly of focal adhesions (Serra Pages et al , 1995) 
LAR has a broad tissue distribution, and is expressed on the cell surface as a complex 
of two noncovalently associated subumts of 150 kDa and 85 kDa resulting from cleavage 
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of the pro-protein (Streuli et al., 1992; Yu et al., 1992) The N-linked glycosylated 150 
kDa fragment is shed during growth Whether this shedding, which is PMA-inducible 
(Serra-Pages et al., 1994), has an effect on the intracellular phosphatase activity remains 
to be established The 85 kDa fragment contains a short ectodomain, the transmembrane 
segment, and the two PTPase domains of -280 amino acid residues each Two closely-
related family members do exist that show a similar intracellular processing and cell 
surface expression, namely the LAR-like RPTPases ΡΤΡδ and ΡΤΡσ (Pulido et al , 
1995a; Y an et al., 1993) 
In vitro site-directed mutagenesis studies suggested that the first, membrane-proximal 
phosphatase domain of LAR exhibits catalytic activity whereas, the second, membrane 
distal phosphatase domain may have only a regulatory function in modulating the 
substrate specificity of the first domain (Pot et al., 1991; Streuli et al, 1990). However, 
the extracellular ligand(s) and downstream substrate(s) of LAR have not been identified 
Therefore, we set out to study the consequences of the loss of LAR PTPase function in 
vivo by means of gene targeting using homologous recombination in mouse embryonic 
stem (ES) cells. Characterization of the resulting LAR' mice points to a role for LAR 
PTPase activity in mammary gland development during pregnancy 
Materials & Methods 
Generation of LAR deficient mice 
The isolation and characterization of mouse 129 genomic LAR sequences were described 
previously (Schaapveld et al., 1995) A 7 5 kb BamHl-EcoR\ fragment just upstream of the exons 
encoding the cytoplasmic phosphatase domains was subcloned into pBluescript KS+ (Stratagene) 
From this, the 3' segment was subcloned as a 3.2 kb Pstl-Sall fragment into a modified pGEM3 
vector having a X/ioI-lmker inserted in the Smal-site, resulting in pLAR5' From the 4 5 kb 
BamH\ clone just 448 bp downstream the stop-codon of LAR, the 5' 2 3 kb BamHl-Bglll 
fragment was subcloned into the flamHI-site of pLAR5', generating pLAR5'-3'. Finally, a 
neomycin phosphotransferase expression cassette (Neo) (van Deursen et al , 1991) was inserted 
into the Sa/I-site of pLAR5'-3'. Prior to electroporation, the targeting construct (pLARNeo) was 
linearized using the unique Xhol-site from the introduced linker 
E14 ES cells were cultured on irradiated SNLH9 feeder cells as described (van Deursen and 
Wieringa, 1992). Exponentially growing ES cells were collected and mixed with 20 μg of 
linearized pLARNeo, electroporated at 250 V/500 μ¥ (Gene Pulser, Biorad), and plated at 5 χ 106 
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per 9 cm dish onto irradiated feeder cells Selection was applied 24 hours later using 300 Mg/ml 
G418 (Gibco/BRL) After 9-11 days of selection, G418 resistant ES clones were picked and 
expanded 
Genomic DNA from individual ES cell clones was extracted and analyzed by Southern blot 
analysis as described (Steeghs et al , 1995) Initial screening was performed using a 3'-flanking 
probe (a 5a«3A fragment derived from a 2 5 kb ВатШ fragment just downstream of the 4 5 kb 
Bam\\\ clone mentioned above) Positive clones were also analyzed with a 5' flanking probe (a 
1 0 kb BamHl-Xbal fragment representing the 5' end of the 7 5 kb ВатШ-ЕсоШ fragment 
mentioned above), a 0 8 kb Pstl fragment from the Neo cassette, and a 1 8 kb ВатШ mouse 
LAR cDNA fragment comprising all exons encoding both cytoplasmic phosphatase domains 
(Schaapveld et al , 1995) to check for proper homologous recombination 
Three correctly targeted ES cell clones that also displayed the correct number of 40 
chromosomes (CAI, CA7, and BC2) were used for injection into C57BL/6 recipient blastocysts 
and implanted into the uterine horns of pseudopregnant (C57BL/6 χ CBA/Ca)Fl foster mothers 
(Bradley, 1987) Resulting male chimaeras were mated with C57BL/6 females to check for 
germhne transmission DNA obtained from tail biopsies ot agouti offspring and subsequent 
generations was screened for the presence of the mutant LAR allele by Southern blot analysis 
and/or polymerase chain reaction (PCR, Hoffmann-La Roche) 
Genotyping 
A PCR reaction using four primers was designed to discriminate between wildtype (LAR+ +), 
heterozygous (LAR+/), and homozygous mutant (LAR') mice The wildtype allele was detected 
as a 542 bp amplicon using the primers LAR5s (5'-GAG CTG CGT CAG TTC CA-3', sense), 
located 129 bp upstream of the codon for the conserved cysteine residue in the first phosphatase 
domain, and LAR4as (5' GAC AGG CTT CCC ACG AC-3', antisense), a genomic primer located 
410 bp downstream of the same cysteine codon The mutant allele was detected as a 394 bp 
amplicon using the primers Neo3' (5'-CTA TCG CCT TCT TGA CGA GTT 3', sense), located 25 bp 
upstream of the stop codon in the Neo cassette, and LAR2as (5' GAC TTG CTC AGG TAG GGC 
3 , antisense), located 532 bp downstream of the stop-codon of LAR The PCR cycle profile 
consisted of 94'C for 1 minute, 59'C for 1 minute and 72"C for 1 minute, for 35 cycles, and 
was performed in a programmable thermocycler (Perkin-Elmer Cetus) Each 50 μ\ reaction 
contained 10 mM Tns-HCl (pH 8 3), 50 mM KCl, 2 5 raM MgCl2, 0 01% BSA, 0 01% gelatin, 
0 05% NP 40, 0 05% Tween-20, 1 mM dNTPs, 100 ng genomic DNA, 100 ng of each primer, 
and 1 U Taq polymerase One-fifth of the reaction products was separated on 2% agarose gels and 
visualized by ethidium bromide staining 
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Breeding of mice 
Mice were kept at the Central Animal Facilty of the University of Nijmegen in a standard room 
with a day/night rhythm of 06 00/18 00 hours at a temperature of 21 'C and a humidity of 50-
60% Males were housed together with four females in a macrolon type I cage and fed ad libitum 
Upon pregnancy, females were separated to give birth to their pups The first, second, and third 
litter of each female was counted and pups were observed every day Experiments were performed 
on F2 mice with a 129 χ C57BL/6 hybrid genetic background Breeding results were statistically 
analyzed using MANOVA (SPSS) and Student's t test 
RNA analysis 
Poly(A)+ RNA from kidney, brain, heart, liver, and lung (pooled from four three-months-old 
male LAR+/+, LAR+', and LAR' mice, respectively) was isolated as described previously 
(Hendriks et al , 1995) For Northern blot analysis, 3 /¿g of each sample was fractionated on a 
1% (w/v) agarose/2 2 M formaldehyde gel, transferred to a Hybond N+ membrane (Amersham), 
and linked by UV-radiation (UV Stratalinker 1800, Stratagene) Blots were subsequently probed 
with the 1 8 kb BarnW mouse LAR cDNA fragment described above, a 162 bp £coRI fragment 
from mouse LAR cDNA#9 upstream of the deleted region (Schaapveld et al , 1995), a 1 1 kb 
Xhol fragment from the Neo cassette, and mouse cDNA probes (Schaapveld et al , 1995) spanning 
the phosphatase domains of the LAR-hke RPTPases ΡΤΡδ (pos 2486 3815, Mizuno et al 1993) 
and ΡΤΡσ (pos 4518-3' UTR, Ogata et al , 1994), respectively In addition, a rat 1 3 kb Pstl 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA probe (Fort et al , 1985) was used to 
enable comparison of RNA loading Hybridization signals on autoradiograms were analyzed on a 
GS-670 imaging densitometer (Bio Rad) Hybridized probes were stripped for 10 mm in boiling 
0 lxSSC/0 1% SDS Removal of probes was checked by exposing filters overnight between 
hybridizations 
For analysis of LAR expression during mammary gland postnatal development, the first 
inguinal glands of 3-4 wildtype mice were collected (pregnancy staged by detection of vaginal 
plug) and RNA was prepared according to Chomzynski and Sacchi (1987) Total RNA (20 μg) 
was separated on a 15% formaldehyde-agarose gel, transferred to Nylon membrane (GeneScreen 
Plus) and hybridized with the LAR, ΡΤΡδ, ΡΤΡσ and GAPDH probes described above and with 
a 28S rRNA probe Phosphor image analysis was performed using a Model GS-363 Molecular 
Imager System (Bio-Rad) and Molecular Analyst software (Bio Rad) to quantify the relative 
expression levels 
Analysis of milk protein expression was essentially done as described previously (Robinson et 
al , 1995) Briefly, the first inguinal glands of non lactating LAR' and wildtype mice at 18 5 
days of pregnancy and at parturition were collected and RNA isolated For hybridizations 
oligonucleotide probes specific for WDNM1, WAP, /3 casein, and α-lactalbumin were used 
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Histological analysis 
Various tissues from 7, 14, and 21 weeks old mice (male and females) were dissected, fixed in 
buffered formaldehyde, dehydrated, and embedded in paraffin Sections of 6 μπι thickness were 
stained with haematoxyhn-eosin according to standard histological procedures Brains were 
analyzed using parasagittal and coronal sections stained with cresyl violet 
For analyses of mammary glands only female mice with a known history (2-3 litters) regarding 
neonatal death were used At the appropiate time point during pregnancy mice were anaesthetized 
with Avertin (Aldrich) and glands were taken surgically Mice were subsequently allowed to 
recover and to give birth to their pups At partunton and the appropiate time point during the 
lactation period mice were sacrificed by cervical dislocation 
For histological analyses of mammary glands, the right first inguinal mammary glands were 
dissected, fixed and embedded in paraffin as described above 5 μπι sections were stained with 
haematoxylin eosin or used for immunohistochemical detection of WAP protein as described 
earlier (Robinson et al , 1995) Mammary glands were also frozen in liquid N2 and embedded in 
Tissue-Тек O C T Compound (Miles) Serial cryostat-sections of 10 μπι were stained with oil-red 
О to enable detection of lipid vesicles, or with haematoxyhn-eosin 
For whole mount preparations of mammary glands the left second thoracic and first inguinal 
mammary fat pads were dissected, mounted on glass slides, fixed, and stained with Delafield's 
haematoxylin or carmine as described (Edwards et al , 1988) Subsequently, they were made 
transparant by immersing in methyl salicylate, analyzed using a dissecting microscope, and 
photographed As controls for mouse strain-specific differences, mammary glands from 129, 
C57BL/6, and (129 χ C57BL/6)F1 females were included in the analysis 
Milk protein analysis 
Milk collection was done essentially as described (Simons et al , 1987) At day 2 of lactation (day 
of birth of pups is taken as day 0), female mice were separated from their pups and 2 h later 
injected intrapentoneally with 1 or 2 1 U oxytocin (Intervet) After 10 minutes milk collection 
was started 
Results 
Targeted deletion of the LAR phosphatase domain gene sequences 
To study LAR function in an organismal context we used gene targeting by homologous 
recombination in ES cells to produce LAR' mice A replacement-type targeting vector 
was constructed in which a positive selection marker, a 1 1 kb neomycin 
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phosphotransferase expression cassette (Neo), is flanked by 3.2 and 2.3 kb of endogenous 
LAR genomic segments (Schaapveld et al., 1995) which provide the necessary homology 
for targeted integration. Upon correct homologous recombination, a 4 5 kb genomic 
segment containing all exons encoding the phosphatase domains of LAR, is replaced by 
the Neo cassette in the same transcriptional orientation (Fig. 1A). This event results in a 
shorter Ватт fragment (12.0 to 8.6 kb) and EcoRV fragment (20.5 kb to 12.0 kb) 
spanning the 5' and 3' regions of homology, respectively This targeting construct was 
introduced into E14 ES cells by electroporation and 365 G418 resistant clones were 
screened for homologous recombination Southern blot analysis using 5'- and 3'-
diagnostic probes derived from genomic DNA flanking the targeting vector region 
revealed a targeting frequency of about 1 in 50 clones Three cell lines displaying correct 
homologous recombination and a normal karyotype were injected into blastocysts. 
Chimaeric males derived from all three cell lines were mated with C57BL/6 females and 
shown to transmit the ES cell genome. Offspring carrying the desired mutation were then 
sibling mated and used to produce heterozygous and homozygous mutant mice in a mixed 
129 χ C57BL/6 background 
Figure 1. Disruption of the LAR gene by homologous recombination 
(A) LAR protein structure showing the relevant functional domains Ig, Immunoglobulin-like domains. Fn-
III, fibronectin type-III-hke domains, PTP, tyrosine phosphatase domains 1 and 2 The LAR cDNA probes 
as used tor Northern blot analysis (see Fig 2) are indicated by solid bars Below, a schematic diagram of 
the relevant part ot the mouse genomic LAR locus and the targeting strategy are shown. Hatched bars in 
pLARNeo represent the fragments homologous to endogenous LAR genomic segments and the gray arrow 
symbolizes the neomycin phosphotransferase selection cassette Small gray bars indicate the 5'- and 3'-
diagnostic probes, and the solid bars 1 and 2 mark the genomic segments encoding the phosphatase domains 
1 and 2, respectively B, BamHl; E, EcoRI: V, EcoRV; P, Pstl. 
(B) Southern blot analysis of tail DNA from wildtype ( + / + ), mice heterozygous ( + /-), and mice 
homozygous (-/-) for the mutant LAR allele The LAR 5'- and З'-flanking probes (panels A and B) reveal 
the mutant diagnostic 8.6 kb BamHl and 12 0 kb EcoRV fragments next to the wildtype 12 0 kb BamHl and 
20 5 kb EcoRV fragments, respectively Hybridization with a LAR cDNA probe encompassing both 
phosphatase domains confirms the total absence of these sequences in LAR' mice (panel C) A Neo cDNA 
probe reveals the absence of additional integrations of the targeting vector (panel D) 
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To verify the presence of the correct replacement mutation in our lines, offspring born 
from Fl heterozygote crosses were genotyped by Southern blot (Fig IB) or PCR analysis 
of genomic DNA isolated from tail biopsies The 5' and 3' flanking probes revealed the 
correct targeting of the LAR locus (Fig IB, panels A and Β) A LAR cDNA probe 
encompassing both phosphatase domains (Schaapveld et al , 1995) failed to detect the 
wildtype 12 0 kb BamHl fragment in DNA isolated from homozygous mutant mice, as 
anticipated (Fig IB, panel C) Using the neomycin resistance gene as a probe, only the 
12 0 kb EcoRV fragment and no additional integrations of the targeting construct were 
detected (Fig IB, panel D) 
The mutant LAR allele was identified in 145 heterozygous (LAR+ , 49 7%) and 68 
homozygous (LAR , 23 3%) mice out of a total of 292 mice tested Thus, the mutant 
allele segregated essentially according to Mendelian laws, indicating that the removal of 
the LAR PTPase domains is not lethal 
The mutant LAR allele produces a truncated mRNA 
To investigate the consequences of LAR gene targeting at the RNA level, poly(A) RNA 
was isolated from several tissues and analyzed by Northern blot analysis (Fig 2) Using 
the mouse LAR cDNA encompassing both LAR PTPase domains as a probe, no wildtype 
LAR mRNA was detected in LAR mice (Fig 2, panel A) The faint signals present in 
the LAR' brain isolate are due to cross hybridization to the highly homologous RPTPase 
ΡΤΡσ (Schaapveld et al , 1995, see also below) Total absence of LAR mRNA containing 
the PTPase domains was confirmed by RT-PCR using mouse LAR specific primers and 
poly(A)+ RNA isolated from various tissues (data not shown) In mRNA isolated from 
wildtype brain, an additional mRNA isoform of - 6 5 kb is seen along with the 
ubiquitously expressed messenger of — 8 kb 
The mutant LAR allele is expected to give rise to shorter transcripts that contain the 
sequences encoding the LAR extracellular region and ending at the poly(A) addition site 
present in the Neo cassette Indeed both an EcoRI mouse LAR cDNA fragment located 
just upstream of the deleted region and the neomycin resistance gene probe detect a - 5 5 
kb mRNA (Fig 2, panel В and C) In brain a ~4 kb transcript is also found in LAR+ 
and LAR' mice that likely encodes a shorter LAR isoform lacking extracellular region 
sequences (O'Grady et al , 1994, Zhang and Longo, 1995) The truncated transcnpt(s) in 
the LAR' mice, if translated at all, encode(s) a mutated LAR molecule that lacks PTPase 
activity 
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Figure 2. Northern blot analysis of poly(A)+ RNA isolated from various tissues from LAR+/+, LAR+ , and 
LAR mice using different probes: (A) A mouse LAR cDNA encompassing both PTPase domains of LAR; 
(В) A mouse LAR cDNA EcoRl fragment upstream of the deleted region (ALAR); (C) A Neo cDNA Xho\ 
fragment; (D) A mouse ΡΤΡδ cDNA; (E) A mouse ΡΤΡσ cDNA clone; and (F) A rat GAPDH cDNA Pstl 
fragment is used to verify the integrity of the RNA loaded. The positions of the 28S and 18S ribosomal 
bands are indicated on the right. 
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Histological analysis of LAR mutant mice 
Mice lacking the LAR PTPase domains had normal weight, behaved normally and 
appeared healthy upon veterinary inspection We then performed an extensive histological 
survey to look for possible consequences of the absence of functional LAR at the tissue 
and cellular level A wide variety of tissues, including brain, kidney, adrenal, liver, lung, 
heart, stomach, colon, ileum, duodenum, testis, uterus, pancreas, muscle, spleen, thymus 
and mammary gland were isolated from 6, 14, and 21 week old male and female mice, 
sectioned and stained with haematoxyhn-eosin In addition, serial parasagittal and coronal 
sections of brain were stained with cresyl violet This analysis revealed no significant 
differences between LAR+ +, LAR+', and LAR mice (data not shown) 
Expression of LAR-like RPTPases 
The LAR-like RPTPases, ΡΤΡδ (Mizuno et al , 1993) and ΡΤΡσ (Ogata et al , 1994 
Wagner et al , 1994), are -90% identical to LAR at the amino acid level for both 
PTPase domains (Schaapveld et al , 1995), exhibit similar in vitro PTPase activity and all 
three interact with the LAR-interacting protein, LIP 1, suggesting similar functions in 
various tissues (Pulido et al , 1995b) To determine whether ΡΤΡδ and/or ΡΤΡσ could 
compensate for LAR function in the LAR' mice, we performed Northern blot analysis 
using mouse cDNA probes encompassing the cytoplasmic regions of ΡΤΡδ and ΡΤΡσ 
(Schaapveld et al , 1995) Signal quantitation by densitometry revealed no significant 
difference in mRNA levels of ΡΤΡδ or ΡΤΡσ in LAR' mice compared with LAR+ and 
LAR+/+ mice (Fig 2, panels D and E), and the expression distribution of the tissue 
specific alternative mRNA isoforms was consistent with data published elsewhere (Mizuno 
et al , 1993, Ogata et al , 1994, Wagner et al , 1994) This finding cannot rule out any 
redundancy at the enzymatic level, and ultimately crosses between LAR-, ΡΤΡδ-, and 
ΡΤΡσ negative mice will be needed to reveal a potential overlap in function between these 
RPTPase subfamily members 
Increased neonatal mortality for pups from LAR' females 
Unexpectedly upon interbreeding LAR' males and females normal-sized litters were 
obtained, but many of the pups died within 1-3 days after birth To substantiate this 
finding, an extensive breeding program was performed in which four possible intercrosses 
were examined (Fig 3) We observed an increased neonatal death rate for pups from 
LAR' mothers (>50%) compared to pups from LAR+/+ mothers (<10% 
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t(27,48) = 5 13, p<0.001), independent of the male genotype and litter size 
(F(2,30)=0 08, p=0 921) This reduced survival rate was a consistent finding for all 
three independently derived LAR knock-out lines (originating from ES cell lines CAI, 
CA7, and BC2) and comparable results were observed for the second and third litters 
from the same LAR"' females (data not shown). Ongoing studies using female mice that 
result from multiple backcrosses onto C57BL/6 background point to full penetrance in 
C57BL/6 mice with respect to the neonatal death. Thus, most likely the heterogeneity of 
the genetic background (hybrid 129 χ C57BL/6) explains the variable penetrance that was 
observed using F2 animals. 
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Figure 3. Increased neonatal mortality for pups ot LAR female mice 
Upon breeding, LAR' témales show normal fertility and give birth to normal-sized litters However, 
>50% of the pups die within 1-3 days after birth compared to only <10% in the case of LAR"* females 
The ratio death/bom (%) are indicated reflecting the lack of complete penetrance of the phenotype 
Comparable results were found for second and third litters (data not shown). Diagram represents the sum of 
results with mice derived trom the CAI and BC2 ES cell clones. 
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At autopsy, pups born from LAR females which died at day 1-3 postpartum appeared 
smaller compared with pups of the same age born from wildtype mice As indicated by 
the absence of a white coloured belly, no milk was found in their stomachs Because milk 
ingestion failed despite multiple attempts to suckle the mothers' nipple, we attribute the 
neonatal death to a defect in the lactating capacity of the LAR ' mothers rather than to a 
behavioural abnormality of neonates To validate this observation, one day old LAR' 
pups from LAR' parents without white bellies were swapped to lactating wildtype 
mothers These pups survived demonstrating that their suckling capacity was normal In 
contrast, one day old healthy looking LAR+/+ pups from wildtype parents were accepted 
by LAR' mothers and did suckle their nipples, but dehydrated and died within 5 days 
(data not shown) 
To investigate a possible milk production defect in LAR' mothers in more detail, the 
quantity of the milk produced by these mice was analyzed In contrast to lactating 
LAR+/+, LAR+', or LAR' mothers from which normal amounts of milk (20-50 μ\) could 
be readily obtained already at postpartum, we never obtained more than 2-3 μ\ milk from 
LAR' mothers whose pups died within 1-3 days Neither the injection of higher doses of 
oxytocin (2-5 I U ) nor the intensive massaging of the mammary glands helped to increase 
milk production (data not shown), suggesting that the lactational defect in LAR' mice 
may be due to a general lack of milk protein synthesis or impaired milk secretion 
Regulation of LAR expression during pregnancy 
To determine whether LAR has a role in mammary gland development and function, we 
examined LAR mRNA expression in mammary glands isolated from female mice at 
various stages during postnatal development LAR expression is already present in 
mammary glands of virgin females as determined by RT PCR (data not shown) Northern 
blot analysis of total RNA isolated from glands of wildtype females at various stages 
during pregnancy (P9-18) and at parturition (LI) revealed that LAR expression during 
pregnancy is developmentally regulated (Fig 4) LAR expression is evident at day 9 of 
gestation, increases five-fold during mid-pregnancy and reaches maximum levels at day 
16 Since GAPDH expression might vary during pregnancy, as was found during lactation 
(Buhler et al , 1993), the variations in the amount of RNA loaded was also assessed by 
hybridizing the blot with a 28S rRNA cDNA probe The obtained LAR expression profile 
is consistent with a role for LAR during mammary gland development at late pregnancy 
The expression pattern of the LAR-like RPTPases was also investigated ΡΤΡδ transcripts 
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are undetectable, but ΡΤΡσ is expressed, although at very low levels, during mammary 
gland development (Fig. 4). Compared to LAR, a twenty-fold longer exposure time was 
needed for ΡΤΡσ signals to become visible. 
Pregnancy Lact. 
" Ч — : — ι day 9 11 14 16 18 J_ 
LAR 
PTPò 
*»« ^^ш ^ ^ · 
^ І У 
E ж :хч лж: • - ^ 
ΡΤΡσ 
GAPDH Μ Μ Μ Μ Μ Μ 
28S 
Figure 4. Regulation of LAR expression during postnatal development of wildtype mammary gland. 
Total RNA isolated from mouse mammary gland at various stages during pregnancy (P) and at parturition 
(L, lactating) was analyzed by Northern blotting. The blot was subsequently hybridized with cDNA probes 
for mouse LAR, ΡΤΡδ, ΡΤΡσ, rat GAPDH, and 28S RNA (28S). The numbers indicate the stage of 
gestation (in days) at which the mammary glands were dissected. 
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Impaired terminal differentiation of mammary alveoli in non-lactating LAR'' females 
To examine whether the lactational defect found in LAR'" female mice could result from 
an impaired mammary gland development, we histologically analyzed mammary glands 
from virgin, late pregnant, postpartum, lactating, and involuting female mice. We termed 
LAR'" females 'non-lactating' if they consistently showed for two or three successive 
litters that their pups would die within 1-3 days after birth. LAR"' females which were 
indistinguishable from wildtype mice regarding the percentage of surviving pups per litter 
were considered as 'lactating' LAR"'" mice. We observed no significant difference in the 
number of ducts per unit volume of fat pad in glands of virgin LAR+/+, LAR+', and 
lactating LAR'" females (data not shown). Extensive alveolar development was observed 
during lactation in LAR+/+, LAR+', and LAR'" females which could lactate (Fig. 5, 
panel B; and data not shown). The lumina were extended and contained secretion. In 
contrast, less extended alveoli with filled lumina were found in the exceptional case of a 
non-lactating LAR' female which pups survived until day 7 postpartum (Fig. 5, panel A). 
Figure 5. Histological analysis of mammary tissue from post-partum non-lactating LAR' (A) and LAR+' 
(B). The former litters of the LAR"' female died within the first three days after birth, but this time the 
litter was nursed very poorly and the last pups died at day 7. For the ~50% of females that show the non-
lactating phenotype, this was the only exception for which we could monitor a lactational state. The fat pad 
of the LAR ' mice is not completely filled and the alveoli are overall smaller than those in hemizygous and 
wildtype mice (not shown). The epithelial cells in the LAR"'" mice do not have a secretory phenotype as 
witnessed by their cuboidal appearance and flattened apical side (arrow in A). In contrast, milk is visible in 
the hemizygous mice, both as proteinacious luminal content and as intracellular secretory products (arrow in 
B). Bar, 200 μτη. 
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The alveolar development in LAR' females without the ability to lactate appears 
incomplete, and the epithelial cells in the alveoli do not have the secretory phenotype and 
apparently milk production and/or secretion coupled with the formation of an extended 
lumen was abrogated in non-lactating mice 
The development of mammary glands from non-lactating LAR' females up to late 
pregnancy (day 18-20) parallels that of wildtype glands, as determined by whole mount 
analysis (data not shown) Thus, ductal outgrowth and branching is not overtly impaired 
The formation of the lobuloalveolar structures was examined in more detail by 
histological analysis using haematoxyhn-eosin (Fig 6, panels A and B) or oil-red О 
staining (data not shown) of mammary glands at late pregnancy Only minor differences 
in lumen size and alveoli cluster formation were observed between wildtype and non-
lactating LAR' glands However, clear differences in the morphology of secretory 
epithelial cells and luminal contents were evident While intraluminal secretions were 
visible in glands from wildtype mice (Fig 6, panel A), the LAR' epithelial cells 
contained large secretory vesicles and lipid droplets indicating an impaired secretion (Fig 
6, panel B) 
At parturition, enlarged alveoli with extended lumina were clearly visible in wildtype 
glands (Fig 6, panel C) In contrast, the number and size of alveoli in non-lactating 
LAR were reduced, and local interstitial fibrosis and congestion of secretion could be 
observed (Fig 6, panel D) Whole mount analysis of mammary glands isolated from non-
lactating LAR' mothers at parturition showed an advanced state of involution (Fig 7, 
panels C-F) Although there is unavoidable variation in the moment of tissue collection, 
the involution state is at least comparable with that of glands isolated from wildtype mice 
two days after the removal of their pups (Fig 7, panel A) and in some cases already 
resembles complete involution as observed for wildtype mice at two weeks following 
weaning of the pups which had been nursed for three weeks (Fig 7, panel B) 
To test whether altered expression of milk protein genes could explain the failure of 
non lactating LAR' females to switch to the lactational state, RNA was isolated and 
probed for WDNM1, WAP, (3-casein, and cn-lactalbumin transcript levels by Northern 
blot analysis No differences were apparent between non-lactating LAR' and wildtype 
mice (data not shown) Also, immmunohistochemical staining for WAP expression did 
not point to altered milk protein synthesis (data not shown) Moreover, the protein and 
triglycerides content of the few microliters that incidentally could be obtained from non-
lactating mice is comparable to that of wildtype and lactating LAR' mice (data not 
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shown). 
Pups did recognize, attach, and bite the nipple of their mothers, but in about half of 
the LAR"'" females alveolar development which is characteristic for late pregnancy was 
not attained and milk secretion was not initiated. Moreover, the transition to involution 
and apoptosis of alveolar epithelium occured more readily in these mice, even before milk 
secretion started. These findings suggest an impaired development of mammary alveoli in 
LAR ' females at late pregnancy: the failure of the alveoli to acquire secretory activity is 
paralleled by a rapid involution at parturition. 
Figure 6. Aberrant development at late pregnancy resulting in impaired functional differentiation at 
parturition in LAR' mammary glands. Haematoxylin-eosin staining of mammary glands at late pregnancy 
(day 18.5; A and B) and at parturition (C and D) from a wildtype female (A and C) and a non-lactating 
LAR' female (B and D). Only minor differences in lumen size and alveoli cluster formation can be 
observed at late pregnancy. Tissues from wildtype mice contain more intraluminal secretion (arrow in A). In 
contrast, secretion appears more intracellular in non-lactating LAR"' glands as indicated by the high content 
of lipid droplets in epithelial cells (arrow in B). Impaired functional differentiation is clearly visible in 
glands from non-lactating LAR' females at parturition. The number and size of alveoli are reduced. 
Furthermore, signs of local interstitial fibrosis (arrow in D) and congestion of secretion are visible. Bar, 30 
μτη. 
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Figure 7. Rapid involution postpartum in LAR' females. 
Whole mount mammary glands were dissected, fixed, stained with carmine, cleared with methyl salicylate, 
and photographed. An advanced state of involution is observed in mammary glands from non-lactating 
LAR mothers at parturition (C-F). For comparison, a mammary gland from a wildtype mother dissected 2 
days after removal of pups at parturition (A) and an involuted mammary gland 2 weeks after weaning of 
pups which were nursed for 3 weeks (B) are shown. Bar, 350 μτη. 
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Discussion 
To address the biological role of LAR PTPase activity in growth and development we 
generated mice lacking expression of the LAR PTPase cytoplasmic region The LAR 
mice are viable, grow, and behave normally Furthermore, histological analysis of a wide 
variety of tissues at different ages did not reveal structural abnormalities, consistent with 
a previous report on the generation of LAR-deficient mice using a gene trap-based method 
capturing the N-terminal signal sequence and generating a 0-galactosidase fusion protein 
(Skarnes et al , 1995) However, our current detailed analysis reveals that LAR has a 
function during mammary gland differentiation We observed an increased neonatal 
mortality for pups from LAR ' mothers, independent of the litter size and the genotype of 
the male or the offspring The pups suckled the nipples of their mother, but failed to 
ingest milk, became dehydrated and died Swapping experiments demonstrated that the 
increased neonatal death was due to a lactational defect of the LAR ' mothers rather than 
to an abnormal behaviour of neonatal pups Due to genetic background heterogeneity this 
phenotype displayed a 50% penetrance in the F2 hybrid 129 χ C57BL/6 mice that were 
used in this study, which might explain why it was not detected by Skarnes et al (1995) 
Interestingly, also in Drosophila the inactivation of CAM-like RPTPases resulted in 
phenotypes with a limited penetrance (Desai et al , 1996, Krueger et al , 1996) To map 
potential modifier loci, it will be necessary to cross the LAR allele into different genetic 
backgrounds Regarding ductal outgrowth and branching in wildtype mammary glands, 
we did not observe significant background differences between mouse strain 129, 
C57BL/6, the F2 hybrid 129 χ C57B1/6, and F4 mice on C57BL/6 background, although 
the ductal system at the virgin state in 129 mice is less developed 
Development of the mammary gland progresses gradually during puberty and 
pregnancy, and acquires full function during lactation (for review see Daniel and 
Silberstein, 1987) In several natural mouse mutants, as well as transgenic and knock-out 
mice this process is affected (Gallahan et al , 1996, Jhappan et al , 1992, 1993, Kordon 
et al , 1995, Li et al , 1994, 1996a,b, Robinson et al , 1996, Sicinski et al , 1995) For 
example, in transgenic mice expressing TGFa under the control of the mouse WAP gene 
promoter mammary development and differentiation proceeds during pregnancy, but the 
secretory cells do not establish and/or maintain a functional slate characterized by milk 
secretion (Robinson et al , 1996, Sandgren et al , 1995) A similar phenotype was 
observed in mice which contain a non-functional mCSFl (Pollard and Henmghausen, 
1994) or inhibin ßB gene (Vassalli et al., 1994) The high amounts of intracellular fat 
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droplets at late pregnancy is also seen in 'milenios' transgenic mice (Robinson et al , 
1995) In non-lactating LAR' mice a normal epithelial cell proliferation up to late 
pregnancy is observed, but histological sections of glands at late pregnancy showed a 
more intracellular storage of secretion products in comparison with the intraluminal 
secretion in wildtype glands At parturition, mammary glands showed signs of fibrosis 
and congestion of secretion, and a regression of alveolar structures as is seen normally at 
a progressed stage of involution following weaning of the pups Taken together, these 
observations suggest that LAR function is evoked relatively late in mammary gland 
development and that most likely the LAR' phenotype is a combination of a loss of 
alveolar cells around parturition and the inability of the remaining alveoli to undergo 
secretory differentiation 
Complex molecular interactions are involved in the regulation of lactation (Rillema, 
1994) The initiation of lactation following parturition involves many endocrine changes, 
of which the reduced influence of sex steroid hormones appears to be the most important 
(for review see Daniel and Silberstein, 1987, Rillema, 1994) Hormonal influences at the 
level of some milk protein gene promoters are mediated by the mammary gland-specific 
transcription factor MGF/Stat5 (Wakao et al , 1994) Regulation of milk protein 
expression via regulation of Stat5 activity also requires the basement membrane (Sympson 
et al , 1994, Talhouk et al , 1992) which provides signals via interaction with epithelial 
cells through cell surface receptors (Streuli et al , 1995) Mice lacking Stat5a show 
reduced mammary lobuloalveolar outgrowth and fail to lactate due to an impaired 
terminal differentiation (Liu et al , 1997) The phenotype becomes apparent during mid 
pregnancy and is reflected by a marked reduction in WAP transcript levels LAR deficient 
mice show signs of abnormal mammary gland development al a later stage, shortly before 
parturition, and no reduction in WAP levels could be observed It remains to be 
investigated whether or not LAR and STAT5a signalling pathways are intertwined at 
some stage of mammary gland development 
LAR is expressed in brain and could perhaps play a role in the regulation of the 
appropriate hormone balance needed for proper mammary gland development and 
function However, at the moment it is not known if LAR is specifically localized to 
regions in the brain that are involved in the hormonal regulation of lactation and further 
studies will be required to address this issue LAR is predominantly expressed in 
epithelial cells and localized at regions of association of these cells and the basement 
membrane (Streuli et al , 1992) Consistent with this is the recent finding of co-
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localization of LAR and its interacting protein LIP 1 at focal adhesions and its proposed 
role in disassembly of focal adhesions (Serra-Pagès et al , 1995) In view of the 
developmental regulation of LAR expression in the mammary gland during pregnancy and 
the phenotypic consequences of the ablation of LAR PTPase activity, these data point to 
an important role for LAR in cell-matrix interactions that are crucial for mammary gland 
development and function 
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Summary 
Insulin binding to the α-subunit of the insulin receptor results in phosphorylation and thus 
activation of its intracellular /3-subumts Subsequent inactivation by dephosphorylation is 
achieved by protein tyrosine phosphatases (PTPases, protein-tyrosine-phosphate 
phosphohydrolase, EC 3 1 3 48) The cell adhesion molecule-like PTPase LAR has been 
implicated in the inactivation of the insulin receptor on the basis of in vitro studies Our 
aim was to test this involvement by studying the insulin response in mice that are 
deficient in LAR signalling (LAR') Post-prandial LAR' and age-matched control male 
mice were subjected to an insulin tolerance test Blood samples were obtained 120 and 5 
min pre-dose and at 30 min intervals for 2 h post-dose enabling calculation of the 
Aglucose-AUC LAR' mice showed no difference in pre-dose plasma glucose levels or 
insulin concentrations compared to wildtype controls, nor in their response to insulin 
Adipocytes isolated from the epididymal fat pad were used to determine the ED50 for 
insulin in a hpogenesis assay for both control and LAR' mice Again, no significant 
difference for both groups was observed In addition, basal insulin receptor tyrosine 
kinase activity in soleus muscles did not differ significantly between LAR' and control 
mice As our data provide no evidence for increased insulin signalling in absence of I AR 
tyrosine phosphatase activity, we conclude that PTPase family members other than LAR 
must be involved 
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Introduction 
Insulin plays a pivotal role in metabolic and cellular processes like the control of blood 
glucose levels, glycogen synthesis, and the regulation of a variety of enzymes and 
transport systems (White and Kahn, 1994) Binding of insulin to the α-subunit of the 
insulin receptor (IR) results in phosphorylation and thus activation of the intracellular ß-
subunits (White et al , 1988) Subsequently, several intracellular substrates become 
tyrosine phosphorylated such as the Insulin Receptor Substrates 1 and 2 (1RS 1, IRS-2), 
and She (Pronk et al , 1993, Sun et al , 1991, 1995) IRSI functions as a multisite 
docking protein for other signalling molecules like growth factor receptor binding protein 
2 (GRB-2), the adaptor protein Nek, and the p85a regulatory subunit of 
phosphatidyl inositol 3 kinase (PI З'-kinase) via interaction with their Src homology 2 
(SH2) domains, leading to the aforementioned various cellular responses mediated by 
insulin (for review see Myers et al , 1994, White and Kahn, 1994) 
Dephosphorylation of the IR and its phosphorylated substrates can be achieved by 
protein tyrosine phosphatases (PTPases), which may act as either positive or negative 
regulators in the insulin signalling cascade However, little is known about the identity of 
the PTPases involved, and their regulation and specificity Various PTPases, such as the 
cytosohc PTP1B, SHP-1 (also known as SHPTP1, SHP, HCP, and PTP1C) and SHP-2 
(also known as SHPTP 2, SHPTP-3, PTP1D, Syp, and PTP2C) and the receptor-hke 
PTPases (RPTPases) CD45, LAR, RPTPa, and RPTPe are all capable of 
dephosphorylating the insulin receptor in vitro (Adachi et al , 1996, Goldstein, 1993, 
Hashimoto et al , 1992a, 1992b, Kenner et al , 1996, Kulas et al , 1995, 1996a, Maller 
et al , 1995, Uchida et al , 1994), but data on in vivo reactions are scarce 
It has been suggested that SHP-2 is a positive regulator of insulin signalling Binding 
of SHP-2 to the activated IR results in reduced SHP-2 PTPase activity towards the IR 
(Karitonenkov et al , 1995, Maegawa et al , 1993, 1994, Staubs et al , 1994, Ugi et al , 
1994), whereas binding to tyrosine phosphorylated IRS-1 leads to activation of SHP 2 
(Kuhne et al , 1993, Pluskey et al , 1995, Sugimoto et al , 1994, Ugi et al , 1994) It 
may therefore be responsible for the dephosphorylation of IRS-1 (Kuhné et al , 1994, 
Noguchi et al , 1994, Ugi et al , 1996) In addition, it acts as a positive regulator in 
insulin-induced activation of the p21ras-MAPK pathway (Hausdorff et al , 1995, Milarski 
and Saltiel, 1994, Noguchi et al , 1994, Xiao et al , 1994, Yamauchi et al , 1995) and in 
the insulin-mediated dephosphorylation of Focal Adhesion Kinase (pl25FAK) and paxillin 
which is accompanied by a reduction of actin stress fibers (Knight et al , 1995, Ouwens 
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et al , 1996, Yamauchi et al , 1995) However, recently, Arrandale et al (1996) showed 
that mice expressing reduced levels of SHP-2 retain their acute metabolic responses to 
insulin, suggesting a minor role for SHP-2 in insulin signalling 
Several findings support the candidancy of the cell adhesion molecule-like RPTPase 
LAR as a negative regulator of insulin signalling For example, LAR expression is 
increased in adipose tissue of obese human subjects (Ahmad et al , 1995, Ahmad and 
Goldstein, 1995) Also, LAR has been found to be active against the autophosphorylated 
IR in vitro, preferentially dephosphorylating the phosphotyrosine residues that have been 
implicated in the regulation of the receptor kinase (Hashimoto et al , 1992a) Antisense 
inhibition of LAR leads not only to increased ligand-dependent IR activation, but also to 
increased insulin-dependent PI З'-kinase activity (Kulas et al , 1995, 1996b) Conversely, 
overexpression of membrane-bound LAR decreased the tyrosine phosphorylation of the IR 
upon insulin stimulation (Zhang et al , 1996) Finally, upon chemical cross-linking on the 
surface of rat hepatoma cells the IR and LAR could be co-immunoprecipitated (Zhang et 
al , 1996) In these cells LAR may influence the phosphorylation status of the insulin 
receptor and its substrates IRS-1 and IRS-2 (Li and Goldstein, 1996) To further 
substantiate the indirect evidence from these in vitro and cell culture-based studies, we 
have generated mice lacking LAR tyrosine phosphatase activity (Schaapveld et al , 1997) 
and used these mice to test the involvement of LAR in insulin signalling in vivo 
Materials & Methods 
Generation of LAR knock-out mice 
The generation and phenotypic analysis of mice lacking LAR tyrosine phosphatase activity is 
described elsewhere (Schaapveld et al , 1997) For all experiments only male mice were used 
The strain, genotype, and age of the mice are indicated with each experiment All animals were 
screened for viruses, including MHV, using enzyme-linked immunosorbent assays (ELISA) and 
trained for handling over three days prior to each experiment to avoid stress 
Plasma glucose and insulin levels 
Plasma glucose and insulin levels were measured in fasted (18 h on water only) and fed LAR 
(F3(129 χ C57BL/6), n=12, 38-44 wks old) and age matched control mice (C57BL/6, n=10. 43 
wks old) Post-prandial mice (fed ad libitum) were subjected to an insulin tolerance test (ITT) by 
s с injection of 1 U human insulin (Actrapid, Novo Nordisk) per kg body weight Blood samples 
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were collected for determination of post-prandial levels of insulin and glucose at 120 min and 5 
min pre-dose and at 30 min intervals for 2 h post-dose, enabling calculation of the Aglucose 
AUC
m
 (AUC, area under curve) (Brand et al , 1996, Tai, 1994) 
Whole blood and plasma glucose levels were measured on a glucose autoanalyzer (immobilized 
glucose oxidase method, EBIO, Eppendorf, Germany) using 10 μΙ blood samples diluted into 500 
μΐ EBIO analysis buffer For the determination of fasting and post-prandial plasma insulin levels, 
blood was collected into chilled hepannized tubes containing Aprotmin, centnfuged at 4"C and 
plasma was stored at -20°C Insulin was assayed using an ELISA consisting of GP114 and PO 
conjugated GP116 anti-insulin antibodies (C Binder, В Dinesen, and M Decken, Novo Nordisk, 
personal communication) and a 2 1 mixture of rat insulin I and II (Novo Nordisk) as standard Rat 
and mouse insulin I and II are identical 
Lipogenesis/Glucose uptake assay 
Adipocytes isolated from epididymal fat pad (Livingston et al , 1984) were used to determine the 
EÜ50 for insulin in 2 months old LAR' (F3(129 χ C57BL/6), n=4) and control (F6(129 χ 
C57BL/6) χ C57BL/6), n=4) mice, and 4 months old LAR' (F3(129 χ C57BL/6), n=4) and 
control (C57BL/6, n=4) mice For 3H-glucose incorporation measurements, ahquots of pooled fat 
cells (2 χ 105 cells/ml) were incubated for 2 h at 37" С in the presence of varying concentrations 
of insulin (K41100, Novo Nordisk), with or without adenosine (a well-known insulin sensitizer, 
105 M final concentration), and with or without bisperoxovanadium 1,10-phenanthroline 
(bpV(phen), a non-specific PTPase inhibitor, 105 M final concentration) (Novo Nordisk) 
A toluene-based scintillation fluid was added directly to the cells and after vortexing the 3H-
labeled lipid was allowed to separate into the fluid phase Samples were then counted in a 
scintillation counter (Packard) 
Insulin receptor tyrosine kinase (IRTK) activity 
After sacrificing the mouse by cervical dislocation, M Soleus were quickly excised from both 
hindlimbs, freeze clamped, and stored at -80'C until analyzed Muscles were homogenized on ice 
in solubilization buffer (20 mM Hepes, 8 mM EDTA, 0 2 mM Na3V04, 10 mM Na4P207, 2 5 
шМ PMSF, 1 mg/ml aprotmin, 2 5 mg/ml benzamidine, 2 5 ¿tg/ml pepstatin, 2 5 μg/ml 
leupeptin, 160 mM NaF, 2 mM dichloro-acetic acid, 1% Triton X-100, pH 7 4) using a Potter-
Elvehjelm homogemzer After 20 mm at 4'C, the samples were processed and basal IRTK 
activity was measured as described previously (Hansen et al , 1996) 
Statistical analysis 
Statistic analysis was performed using the Students' t-test (on pooled data from LAR' vs 
wildtype controls) or ANOVA All values are mean±SEM For the hpogenesis assay a four 
131 
Chapter V 
parameter estimation of E D ^ , basal, maximal response, and the slope of the linear part of the 
curve is performed. 
Results 
As LAR has been implicated in insulin signal transduction, we examined the loss of 
function of LAR with respect to the insulin response. Insulin plays a pivotal role in the 
metabolic processes that regulate plasma glucose levels. Therefore, we determined blood 
glucose levels in response to fasting, feeding, and insulin administration (ITT). Fasting 
and post-prandial LAR ' mice showed no difference in plasma glucose levels compared to 
sex- and age-matched control animals (Table I.). There was also no significant difference 
in plasma glucose levels in response to insulin between LAR-deficient mice and wildtype 
controls (Fig. 1). 
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Figure 1. Blood glucose levels in LAR' and wildtype mice upon insulin administration 
Post-prandial LAR' (•, n=12) and wildtype ( · , n=10) mice were subjected to an insulin tolerance test 
(ITT) by s с. injection of 1 U human insulin per kg bodyweight Absolute levels (panel A) and Aglucose 
values corrected for pre-dose levels are shown (panel B) The Aglucose-AUCITT values are given in Table I 
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Although the insulin levels in the fasting LAR' animals appear higher than in the 
fasting control mice, the absence of LAR tyrosine phosphatase activity has clearly no 
influence on the in vivo insulin responsiveness and does not lead to a higher degree of 
hyperinsuhnemia in post-prandial mice However, this does not rule out the possibility of 
an insulin resistance via desensitization of insulin signalling at the post-receptor level in 
the fasted mice (Marshall and Olefsky, 1980) 
Table I. Plasma glucose and insulin concentrations and insulin tolerance in LAR ' mice 
Mice [glucose] [insulin] AAUCITT 
fasting fed fasting fed 
wildtype (n=9) 9 3±0 5 9 5±0 3 36±10 393±55 -452±93 
LAR' (n=12) 8 9+0 4 8 8±0 3 82+14 (*) 316 + 54 -344 + 38 
[glucose] in mmol/1, [insulin] in pmol/1, Aglucose-AUC,TT in min χ mmol/1 
(*)P = 0 05vs wildtype (ANOVA) 
Average weight of mice wildtype, 32 8+ 1 1 g, LAR , 28 5 + 0 7 g 
An important aspect of the regulation of plasma glucose levels is the stimulation by 
insulin of glucose uptake via glucose transporters from blood into insulin-responsive 
tissues We investigated a possible role for LAR in the insulin-stimulated translocation of 
glucose transporters and subsequent increase in hexose uptake Rates of hpogenesis in 
response to insulin were measured to evaluate the glucose metabolism in primary 
adipocytes isolated from epididymal fat pads (Fig 2, and Table II) We designed the 
assay in such a way that the different effects of either adenosine, a well known insulin 
sensitizer, or bpV(phen), a non-specific PTPases inhibitor, could be observed If LAR 
activity is necessary for turning off the insulin signal, we would expect to maintain the 
adenosine effect, but to see no effect of bpV(phen) in adipocytes isolated from LAR' 
mice Figure 2 (panels Α-D) shows that there is no significant difference in hpogenesis in 
fat cells isolated from LAR' and control mice over the complete range of insulin 
concentrations, as measured for 2 (Fig 2, panels A and B) and 4 months old mice (Fig 
2, panels С and D) It is also clear that there is no influence of loss of LAR function on 
either the adenosine, nor the bpV(phen) effect (Fig 2, and Table II) Accordingly, the 
basal hpogenesis is not higher in the LAR' mice (Fig 2) and the ED50 for insulin is not 
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significantly different for both groups of mice (Table II). 
In various reports LAR has been put forward as a key regulator of IR tyrosine 
phosphorylation and activation upon insulin stimulation (Hashimoto et al, 1992a, Kulas 
et al., 1995, 1996b; Zhang et ai, 1996). However, when the basal IR tyrosine kinase 
(IRTK) activity was determined in soleus muscle no significant difference in basal IRTK 
activity could be observed between LAR' and control mice (2.0±0.5 vs. 3.2 + 1.1). 
Further studies will be necessary to address possible differences in IRTK activity in 
response to insulin. 
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Figure 2. Insulin-stimulated 3H-glucose incorporation into lipid in epididymal adipocytes. 
Adipocytes were isolated from young (2 months of age, panels A and B) and old (4 months of age, panels 
С and D) wildtype (n=4) and LAR' (n = 4) mice Triplicate samples were incubated with varying 
concentrations insulin in the absence (•) or presence of adenosine (·) or bpV(phen) (*). 
134 
RPTPase LAR in insulin signalling 
Table II. ED50 for insulin stimulated hpogenesis m adipocytes 
young mice (n=4) old mice (n=4) 
wildtype LAR' wildtype LAR' 
Body weight (g) 
Insulin 
+ Adenosine 
+ bpV(phen) 
EDW in pM 
EDsn 
23 5+0 1 
42 
32 
17 
23 0±0 4 
62 
38 
23 
32 5±1 1 
101 
65 
47 
29 2±1 0 
103 
65 
42 
Discussion 
Over the past few years numerous reports have suggested PTPases as important regulators 
of insulin action Although the cytoplasmic PTPase SHP-2 and the transmembrane 
RPTPase LAR have been suggested as being candidate positive and negative regulators, 
respectively, their physiological relevance in the IR signal transduction has not been 
established yet 
Of the family of insulin-responsive glucose transporters (GLUT), GLUTI and GLUT4 
are considered as the most relevant in basal hexose uptake and insulin-stimulated glucose 
transport, respectively (for review see Mueckler, 1994, Stephens and Pilch, 1995) In 
response to insulin, GLUT4 translocates from a cytoplasmic pool to the plasma membrane 
where it catalyses the rate-limiting step for glucose uptake and metabolism in skeletal 
muscle and adipose tissue (Stephens and Pilch, 1995) Insulin activates hexose transport 
via a p21 ""-dependent pathway, leading to an increase in the amount of cell surface 
GLUTI Also a metabolic, p21rai-independent pathway, leading to the translocation of 
GLUT4 to the cell surface is implicated in this activity (Haruta et al , 1995, Hausdorff et 
al , 1994) This insulin-stimulated translocation of GLUT4 involves activation of PI 3'-
kinase, but may be independent of phosphorylated IRS-1 (Morns et al., 1996, and 
references therein) SHP-2 was shown to be necessary for insulin-stimulated expression of 
the glucose transporter GLUT 1, but is not required for activation of the pathway leading 
to GLUT4 translocation (Hausdorff et al , 1995) In addition, no major role for SHP-2 as 
a positive regulator in the acute in vivo metabolic actions of insulin could be demonstrated 
(Arrandale et al , 1996) However, since homozygous knock-out mice were embryonic 
lethal, these metabolic studies were performed with hemizygous mice expressing 50% of 
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the SHP-2 protein level compared to wildtype mice (Arrandale et al , 1996) Probably, as 
the divergence of the mitogenic p21ras-MAPK and metabolic signalling pathways occurs at 
or near the IR (Pang et al , 1994), SHP-2 acts as a positive mediator in insulin-induced 
mitogenesis (Arrandale et al., 1996, Hausdorff et al , 1995) 
We have used mice lacking LAR tyrosine phosphatase activity (Schaapveld et al , 
1997) to address the possible negative regulatory role of LAR in insulin signalling We 
observed no difference for LAR' mice in body weight, plasma glucose and insulin levels 
in fasting and post-prandial mice, and glucose levels after insulin injection when 
compared to wildtype control mice (Fig 1, and Table I) In addition, our results suggest 
no dominant role for LAR in the insulin induced expression and translocation of glucose 
transporters LAR' mice show no increased insulin signalling resulting in enhanced 3H-
glucose incorporation into lipids (Fig 2, and Table II) 
While the work described in this manuscript was ongoing, a physical and functional 
association of LAR and the IR was found in intact cells, suggesting a negative regulatory 
role for LAR in insulin action at the IR level (Ahmad and Goldstein, 1997) In muscle of 
LAR' mice, however, basal IRTK activity is not increased Hauguel-de Mouzon et al 
(1993) have shown for diabetic (insulinepenia) as well as for pregnant (hypennsulinemia) 
rats the association of defective liver membrane-associated PTPase activity with decreased 
IRTK autophosphorylation In addition, impairment of insulin-stimulated IRTK activity 
has been proposed as an explanation for defective insulin sensitivity and thus insulin 
resistance m vivo (Chang et al., 1994) Therefore, analysis of the IRTK activity upon 
insulin stimulation in LAR' mice will be subject of further study and may give more 
insight in a direct regulatory role for LAR at the IR Sofar, despite all previously 
published in vitro data, our data clearly show that LAR is not a major determinant in the 
negative regulation of the IR As also the levels of LAR expression in the insulin 
sensitive tissues liver and muscle show great variability (Hashimoto et al , 1992b, Longo 
et al , 1993, Pulido et al , 1995, Schaapveld et al , 1996, Streuli et al , 1992, Zhang and 
Goldstein, 1991), the involvement of other (R)PTPases in down-regulating the IR signal 
in vivo is most likely The LAR-like RPTPases RPTPô and/or RPTPc could serve this 
role and may provide a possible functional compensation for LAR in the LAR ' mice 
However, in this study we have not addressed the possible involvement of LAR in the 
dephosphorylation of a subset of phosphorylated substrates further downstream in insulin 
initiated signalling cascade(s) For example, recent data justify future studies on a 
regulatory role for LAR, like SHP-2, in insulin-induced rearrangements of the 
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cytoskeleton Activation of the IR also leads to tyrosine dephosphorylation of pl25FAK and 
paxilhn, two major components of Focal Adhesions (FAs), and the reduction of actin 
stress fibers (Ouwens et al , 1996, Pillay et al , 1995, Yamauchi et al , 1995) The small 
GTP binding protein Rho is a key regulator in the formation of these cytoskeletal 
structures for which tyrosine phosphorylation is essential (Ridley and Hall, 1994) 
Inhibiton of PTPases with vanadate mimics the stimulation of FA assembly by Rho, 
suggesting a regulatory role for PTPases in FA turnover (for review see Craig and 
Johnson, 1996) LAR has been localized to FA and sites of association of cells and the 
basement membrane (Serra-Pages et al , 1995, Streuli et al , 1992) More intriguing, 
LAR is able to bind TRIO, a protein harboring guanine nucleotide exhange factor (GEF) 
domains for Rho and Rac (Debant et al , 1996) Therefore, it is tempting to speculate that 
LAR is involved in the signalling and/or activation of Rho and Rho-mediated FA 
assembly and stress fiber formation LAR and TRIO may integrate diverse signals 
involved in cell migration, a process that requires cell-matrix and cytoskeletal 
rearrangements As antisense inhibition of LAR leads to increased activity of PI 3'-kinase 
(Kulas et al , 1995), which is an upstream regulator of Rac, and, hence, regulates 
indirectly Rho (Nobes et al, 1995), an inhibitory role for the LAR-TRIO complex 
upstream or even downstream of PI 3' kinase is not unlikely Finally, insulin and 
cytoskeletal rearrangements necessary for cell-cell and cell matrix interactions are 
required for mammary gland development and maintenance of lactation (Rillema, 1994) 
Female mice lacking LAR tyrosine phosphatase activity show a defect in terminal 
differentiation of the mammary gland epithelial cells and as a consequence are unable to 
nurse their pups (Schaapveld et al , 1997) The involvement of LAR in insulin mediated 
cytoskeletal rearrangements during mouse mammary gland development will therefore be 
subject of further studies 
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Chapter Vi 
GENERAL DISCUSSION & FUTURE PROSPECTS 
Protein tyrosine phosphorylation is now recognized as an important component of the 
control of cellular function, including growth and differentiation, cell cycle, cytoskeletal 
integrity, and cell death The net level of phosphorylation of tyrosyl residues in a target 
substrate reflects the balance between the competing action of protein tyrosine kinases 
(PTKs) and protein tyrosine phosphatases (PTPases) Since the cloning of the first PTPase 
in 1988, considerable progress has been made in identifying new members of an ever 
growing family of enzymes that rival the PTKs in their structural diversity and complexity 
(see Chapter I) Unfortunately, although it is assumed that the extensive structural 
diversity reflects a broad range of functions for the PTPase family members in vivo (Neel 
and Tonks, 1997), relatively little is known about the physiological function(s) of 
individual PTPases 
The membrane-bound, receptor-like PTPases (RPTPases) have a putative extracellular 
ligand-binding region, a transmembrane domain, and, with a few exceptions, two repeated 
cytoplasmic phosphatase domains The striking variation in the extracellular segments 
presumably reflects an equivalent diversity of hgands to which these enzymes may 
respond (see Chapter I) The study as described in this thesis is the first example of a 
mouse model to study specifically the catalytic tyrosine phosphatase function of a 
RPTPase, while leaving the possible ligand function of its extracellular part intact The 
outcome of the experiments performed justifies further studies on the role of LAR in 
signal transduction 
Through our knowledge of the mouse LAR gene and mRNA structure, the coding 
information, and the feasibility of 'double replacement' gene targeting approaches at the 
mouse LAR gene (Ptprf) locus (see Chapters II and III), tools to study the biological 
significance of each individual PTPase domain are now available As already discussed in 
Chapter III, the LAR negative ES cell lines are suitable to perform structure-function 
studies with respect to the involvement of LAR PTPase domains in early embryonic 
development and differentiation, by creating catalytic inactive and so-called 'substrate-
trapping' LAR mutants (Flint et al , 1997) Differences between wildtype and LAR' cells 
in responses to diverse extracellular matrices (ECM), growth factors and hormones, and 
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in tyrosine phosphorylation patterns may give future directions towards the identification 
of possible hgand(s) and substrate(s) The elucidation of ligand(s) and/or substrate(s) is a 
prerequisite to set up a cell biological read out system for LAR tyrosine phosphatase 
activity Once established, the study of the significance of the association of, for example, 
LIP 1 and TRIO to the second, C-terminal PTPase domain of LAR becomes possible 
Furthermore, to study the role of each individual catalytic domain, the 'double 
replacement' strategy can now be used to generate mice expressing full-length LAR with 
either a catalytic inactive first, membrane proximal, or an inactive second PTPase 
domain 
Quite unexpectedly, disruption of LAR signalling resulted m impaired mammary gland 
development during pregnancy as the sole detectable deviation from wildtype control mice 
(see Chapter IV) The discovery of this specific phenotype has now paved the way to 
study the role of LAR signal transduction m mammary epithelial cells and the possible 
involvement of LAR in breast tumongenesis Monitoring the proliferative and apoptotic 
index, and the expression of differentiation and apoptosis markers in mammary glands at 
various stages of pregnancy for both wildtype and LAR' mice may provide clues to the 
precise role of LAR signalling for survival of mammary epithelial cells in vivo In 
conjunction, study of the susceptibility of LAR' mice towards DMBA-induced mammary 
tumors is warranted, as cell survival is of high importance for tumor growth 
Mammary epithelial cell (MEC) lines can be derived from LAR' and control mice to 
investigate more precisely the involvement of LAR in diverse signal tranduction 
pathways When grown on an artificial basement membrane, called Matngel*, and m the 
presence of the proper hormones like hydrocortisone and insulin, these MECs are able to 
form three-dimensional structures representing alveolar outgrowth Using this in vitro 
system one can study the possible roles of LAR in the insulin-induced rearrangments of 
the cytoskeleton, and in the extracellular matnx-integnn pathway which, like the prolactin 
signal transduction pathway, leads to the expression of milk proteins It may even well be 
that, in analogy to what is now known for RPTK signalling (Weiss et al , 1997), LAR 
may not only be a transmembrane signal transducer of specific extracellular ligands but 
may also, directly or indirectly, participate in the signal modulation of a variety of 
stimuli More specific, LAR might have its function at the crossroad(s) of the diverse 
signalling pathways important for functional differentiation of MECs 
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As said, the specific mammary gland phenotype of the LAR'" mice was a surprising 
outcome, especially when taking into account the broad expression pattern of the 
molecule. The question now arises what the phenotype of a total LAR knock-out mouse 
will be With the data available to date this is hard to predict Observed defects could 
result from loss of the ability of LAR, as all other RPTPases, to function as a ligand, 
independent of its capacity to dephosphorylate target substrates (Neel and Tonks, 1997). 
The LAR-deficient mice made by Skarnes et al. (1995) using a gene trap-based method 
were reported as being completely devoid of LAR expression, due to an insertion of the 
/3-galactosidase reporter gene in the 5' region of the gene encoding the N-terminal Ig-like 
domains. For these mice, no defects in mammary gland development and function have 
been described, although it is known that the breeding of these mice is also hampered by 
a considerable loss of newborns (M. Streuli and D. Rotin, personal communications) It 
now appears that at least in brain this gene trap is leaky, i.e. full-length LAR transcripts 
are still detectable (Yeo et al., 1997). Leakiness of the gene trap in the mammary gland 
was not reported, but may explain that no phenotype was observed in this tissue (Skarnes 
et al., 1995). On the other hand, leakiness of the gene trap gives rise to transcripts in 
which the presence of reporter gene sequences may affect proper alternative splicing, 
resulting in a-specific phenotypic effects. 
It is of note therefore, that Yeo et al. (1997) describe an abberant morphology of the 
basal forebrain cholinergic neurons and a reduced cholinergic innervation of the dentate 
gyrus in the hippocampal region of the brains of these mice. As only a minor decrease in 
full-length LAR expression and an apparantly normal expression of the smaller brain-
specific LAR transcript was reported, the data as presented in this paper are puzzling. In 
our LAR' mice moreover, we could not detect morphological abnormalities in 
parasagittal and coronal sections of the hippocampal formation (see Chapter IV; 
Schaapveld et al., manuscript submitted). It is of course possible that, like in our case, 
the heterogeneity in genetic background obscures the phenotype displayed by the 
'Skarnes' mice. 
Why are no abnormalities resulting from the loss of LAR function observed in other 
tissues than the mammary gland? One explanation for the lack of a more general 
phenotype might be redundancy in LAR-like PTPase function. Recent data showed that 
LAR and the highly homologous RPTPases RPTPô and RPTPa undergo similar pro-
protein processing and posttranslational modifications, exhibit similar in vitro PTPase 
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activity, and that all three are capable to interact via the second PTPase domain with the 
coiled-coil protein LIP 1 (see Chapter I) Hence, it is not unlikely that these three look-a-
likes exert similar functions in various tissues At this moment it is an open question 
whether one might expect adaptations in tissue- and cell type-specific distribution or 
expression levels of RPTPô and RPTPa in LAR' mice and what mechanisms would serve 
to initiate this rewiring in the PTPase network The fact remains that we observed no 
appreciable differences in mRNA expression levels of the LAR-like RPTPases RPTP5 and 
RPTPa in the LAR' mice (see Chapter IV) In addition, our RNA in situ hybridization 
data (Schaapveld et al , manuscript submitted) indicate also no differences between 
wildtype and LAR' mice in temporal and spatial expression of these two RPTPases 
during embryonic development 
As these three RPTPases show distinct and overlapping expression patterns, it is 
important to investigate changes in PTPase activity of RPTPÔ and RPTPff in the diverse 
tissues of the LAR' mice Therefore, in analogy with experiments performed on 
Drosophila mutants, intercrossing LAR' mice with RPTPô and RPTPa knock-out mice 
may reveal redundant functions of these three closely related molecules and explain the 
specific mammary gland phenotype of the LAR' mice In addition, these studies may 
lead to the identification of modifier loci in the 129 mouse genome as discussed in 
Chapter IV, or may point to the existence of yet another member of this subclass of 
RPTPases 
This issue might also play a role in explaining the results of our studies on the 
involvement of LAR in insulin signal transduction (Chapter V) Over the past few years 
in vitro data on LAR as a negative regulator in signalling via the insulin receptor (IR) are 
piling up (see Chapter V) Our data, however, indicate no functional correlation between 
absence of LAR PTPase activity and increased insulin responsiveness At this moment, it 
is thus not clear whether other PTPases or specific isoforms thereof, including RPTP6 
and RPTPa, are more important in the downregulation of the IR signal 
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SUMMARY 
Protein tyrosine phosphorylation is now recognized as an important component of the 
control of cellular function, growth and differentiation, cell cycle, and cytoskeletal 
integrity The net level of phosphorylation of tyrosyl residues in a target substrate reflects 
the balance between the competing action of protein tyrosine kinases (PTKs) and protein 
tyrosine phosphatases (PTPases) On the basis of their overall structures, two classes of 
PTPases can be distinguished, namely (ι) those found in the cytoplasm and nucleus that 
have only one tyrosine phosphatase domain and (n) membrane bound, receptor-like 
PTPases (RPTPases) that have a putative extracellular ligand-bmding region, a trans 
membrane domain, and, with a few exceptions, two related cytoplasmic phosphatase 
domains (see Chapter I) 
One of the best studied RPTPases is the Leukocyte common Antigen-Related molecule 
LAR LAR is composed of two cytoplasmic phosphatase domains, a transmembrane 
segment, and an extracellular region which shares homology to immunoglobulin (Ig) like 
and fibronectm type III (Fn-III) domains This arrangement of extracellular motifs renders 
LAR a prototype of the cell adhesion molecule (CAM)-like RPTPases Using bactenally 
expressed proteins and artificial substrates it was shown that the first, membrane proximal 
phosphatase domain is catalytically active, whereas the second, С terminal phosphatase 
domain may regulate the phosphatase activity of the first domain 
Since LAR-specific ligands and substrates still remain to be identified, we set out to 
study the consequences of the loss of LAR PTPase function in vivo by means of gene 
targeting using homologous recombination in mouse embryonic stem (ES) cells 
As a first step towards site-directed mutagenesis studies, we used the human LAR cDNA 
as a probe to isolate mouse LAR cDNA and genomic clones (Chapter II) The 
cytoplasmic region of the mouse LAR protein is encoded by eleven exons which span 
only 4 5 kb of genomic DNA Compared to the, at that time, known exon-intron struc 
tures of other mammalian RPTPase genes, such as LRP and Ly 5 (the mouse homologs of 
RPTPa and CD45, respectively), the gene segment encoding the cytoplasmic region of 
LAR contains not only smaller, but also fewer introns The mouse LAR cDNA sequence 
was found to be nearly identical to the cDNAs for rat and human LAR Strikingly, among 
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species the second, 'catalytically inactive' domain shows a slower mutation rate than the 
first, 'catalytically active' domain In addition, the homology to the LAR-like RPTPases 
RPTPô and RPTPa is also higher in the second phosphatase domain This is not seen for 
the other more distant members of the RPTPase family The LAR gene (Ptprf) maps to a 
distinct chromosome region in mouse, C6 Dl, demonstrating that LAR, RPTPÓ, and 
RPTPa, although closely related family members, are indeed separate entities 
In Chapter III we describe the use of 'double replacement' gene targeting in mouse ES 
cells to generate cell lines lacking the gene sequences essential for LAR phosphatase 
activity We show that the use of replacement-type targeting vectors in two consecutive 
rounds of targeting does not interfere with germline competence By exploiting the 
process of gene conversion, we were also able to generate ES cells containing two 
mutated LAR alleles These double knock-out cell lines were analyzed by RT-PCR and a 
polyclonal antiserum directed against both phosphatase domains to confirm the absence of 
the LAR phosphatase domains at the RNA and protein level Loss of LAR expression is 
apparently not harmful for early cell growth Cells that had undergone two rounds of 
homologous recombination also contribute normally to development 
In Chapter IV we describe the generation of mice lacking both phosphatase domains of 
LAR Chimaeras showed germ line competence and heterozygote and homozygote 
mutants deficient in LAR tyrosine phosphatse activity develop and grow normally, do not 
show an overt phenotype, and display no appreciable tissue abnormalities at the 
histological level Northern blot analysis of various tissues revealed the presence of a 
truncated LAR mRNA lacking the part encoding the cytoplasmic signalling moiety and 
indicated that this mutation of LAR is not accompanied by changes in expression levels of 
one of the LAR-like RPTPases RPTPÔ or RPTPa However, upon breeding we observed 
an increased neonatal death rate for pups (more than 50%) from LAR' females compared 
to offspring from LAR+'+ females Later, it appeared that full penetrance of the 
phenotype was hampered by the heterogeneity of the genetic background of the mice 
Mammary glands of LAR ' females were incapable of delivering milk due to an impaired 
terminal differentiation of alveoli at late pregnancy Histological examination showed that 
the alveolar development which is characteristic for late pregnancy is not attained, the 
glands fail to switch to a lactational state, and showed a rapid involution postpartum 
Milk secretion is not initiated because the transition to involution and apoptosis of the 
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alveolar epithelium occurs more rapidly in these mice, even before milk secretion starts. 
In wild-type mice, LAR expression is regulated during pregnancy reaching maximum 
levels around day 16 of gestation. Expression of the LAR-like RPTPases RPTPô and 
RPTPa are not or hardly detectable during mammary gland development. Taken together, 
these findings point to a highly specific role for LAR-mediated signalling in mammary 
gland development and function 
In Chapter V we describe how we have used the LAR ' mice to study insulin signalling in 
the absence of LAR tyrosine phosphatase activity. In vitro studies had implicated LAR as 
a negative regulator in the signal transduction via the insulin receptor (IR). In contast to 
expectation, our in vivo data provide no evidence for differences in metabolic processes in 
response to insulin, nor for an increased tyrosine kinase activity of the IR (IRTK) in the 
absence of LAR activity. Although a more detailed study of the IRTK activity in response 
to insulin is warranted, we may conclude that PTPases other than LAR, possibly RPTPô 
and RPTPa, are involved in the downregulation of the IR signal. 
The study described in this thesis is one of the first to address the specific role of the 
catalytic segments of an RPTPase in vivo, in the proper cellular context and within the 
entire animal. Further studies, considering the ligand and extracellular receptor functions 
of LAR should complete our picture on the functioning of this PTPase family member in 
cell signalling and development. 
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SAMENVATTING 
Het '"Leukocyte common Antigen-Related molecule" LAR is het prototype van een cel 
adhesie molecuul achtig receptor-type proteine tyrosine fosfatase (RPTPase, zie Hoofdstuk 
I) LAR is opgebouwd uit twee cytoplasmatische homologe tyrosine fosfatase domeinen, 
een transmembraan domein en een extracellulair deel dat 3 immunoglobuline-achtige en 8 
fibronectine type III domeinen bevat In de intracellulaire fosfatase domeinen bevindt zich 
een onder alle PTPases geconserveerde sequentie van ongeveer 11 aminozuren (-
(I/V)HCXAGXXR(S/T)G ) waarin het cysteine residue van essentieel belang is voor de 
enzymatische activiteit Hoewel het tweede, С terminale domein deze sequentie ook 
bevat, werd met behulp van in vitro assays (gebruikmakend van bacteneel geproduceerde 
eiwitten en artificiële substraten) aangetoond dat dit tweede domein geen enzymatische 
activiteit bezit Mogelijk speelt het een rol bij de substraat-specificiteit van het eerste, 
membraan proximale domein De extracellulaire liganden en intracellulaire substraten zijn 
echter nog onbekend Dit maakt in vitro studie ter bestudering van de biologische functie 
van LAR ontoereikend 
Wij besloten in vivo het verlies van functie van beide fosfatase domeinen te 
ondezoeken, door middel van gen "targeting" middels homologe recombinatie in muizen 
embryonale stam (ES) cellen 
In Hoofdstuk II wordt beschreven hoe met behulp van het humane LAR cDNA 
genomische en cDNA klonen van muis LAR geïsoleerd werden De beide fosfatase 
domeinen van muis LAR worden gecodeerd door 11 exonen die slechts 4 5 kb van 
genomisch DNA beslaan Vergeleken met de, op dat moment bekende, exon-mtron 
structuren van andere RPTPases, LRP (muizen homoloog van RPTPa) en Ly-5 (muizen 
homoloog van CD45), bevat dit deel van het LAR gen met alleen kleinere, maar ook 
minder intronen Op aminozuur-niveau is dit gedeelte van LAR nagenoeg identiek met de 
rat en humaan LAR cDNAs, en zeer homoloog aan twee andere cel adhesie molecuul-
achtige RPTPases, RPTPa en RPTPô Opvallend is dat voor LAR tijdens de evolutie het 
tweede, "enzymatisch inactieve" fosfatase domein het meest geconserveerd blijft 
Onderlinge vergelijking van LAR, RPTPö en RPTPa laat zien dat, uniek voor deze drie 
RPTPases, de homologie ook het hoogst is in het tweede domein De bepaling van de 
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chromosomale localisatie op muis chromosoom 4, regio C6-D1, bevestigd dat we 
inderdaad de muizen homoloog van LAR gekloneerd hebben en dat drie verschillende 
genen coderen voor LAR, RPTP5 en RPTPa 
In Hoofdstuk III wordt het gebruik van "double replacement gene targeting" in muizen 
embryonale stam (ES) cellen beschreven We tonen aan dat het mogelijk is met behulp 
van replacement type" targeting vectoren en twee opeenvolgende rondes homologe 
recombinatie ES cellijnen te genereren die de genomische sequenties coderend voor de 
beide fosfatase domeinen van LAR missen Tevens wordt bevestigd dat na de eerste ronde 
van homologe recombinatie gen-conversie gebruikt kan worden om het tweede allei te 
muteren Met behulp van RT-PCR en een polyklonaal antiserum gericht tegen beide 
fosfatase domeinen van LAR wordt aangetoond dat deze "double knock-out" ES cellen het 
cytoplasmatische deel van LAR missen Deze mutatie heeft blijkbaar geen negatieve 
gevolgen voor de celgroei Cellen die beide rondes van homologe recombinatie hebben 
ondergaan behouden hun kiembaan-competentie en kunnen op normale wijze bijdragen 
aan de embryonale ontwikkeling 
De generatie van de LAR knock-out muis staat beschreven in Hoofdstuk IV Bij deze 
muizen zijn de sequenties die coderen voor beide tyrosine fosfatase domeinen van LAR 
vervangen door het neomycine fosfotransferase (Neo) gen RNA analyse maakt duidelijk 
dat deze muizen een getrunceerd LAR transcript tot expressie brengen, dat gebruik maakt 
van het polyadenylenngs signaal in de Neo cassette en geen functioneel LAR eiwit meer 
kan coderen Deze mutatie van LAR gaat niet gepaard met significante veranderingen in 
de expressieniveau's van RPTPô en RPTPa De verkregen muizen zijn levensvatbaar, 
zien er gezond uit en vertonen geen noemenswaardige histologische afwijkingen 
Echter, na verder fokken blijkt dat ongeveer 50% van de nakomelingen die afkomstig 
zijn van een homozygoot mutant vrouwtje binnen drie dagen na geboorte doodgaan Het 
blijkt dat dit percentage toeneemt tot 100% indien de bijdrage van muis 129 DNA in de 
genetische achtergrond van de muizen afneemt Door uitwisseling van nesten 
pasgeborenen kwamen we erachter dat LAR-deficiente vrouwtjes niet in staat zijn jongen 
te voeden Na uitgebreide analyse van de melkklieren blijkt dat de ontwikkeling van deze 
klieren op het einde van de zwangerschap verstoord raakt De alvéolaire epitheliale cellen 
maken wel secreet, maar deze hoopt zich op intracellulair en wordt niet afgegeven aan het 
lumen Er vindt geen terminale differentiatie plaats die op de dag van geboorte moet 
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leiden tot afgifte van melk Het gevolg is dat de hele alvéolaire structuur niet in stand 
wordt gehouden en te gronde gaat door het vervroegd in gang zetten van 
geprogrammeerde celdood Het uiteindelijke resultaat is dat het vrouwtje haar jongen niet 
kan voeden Gezien ook de regulatie van LAR expressie in de melkher tijdens de 
zwangerschap, en het feit dat expressie van RPTPô en RPTPa niet tot nauwelijks 
aantoonbaar is gedurende de melklier ontwikkeling, concluderen we dat LAR in een laat 
stadium van de zwangerschap een rol speelt in de signaaltransductie vanuit de 
extracellulaire matrix Deze is immers van belang voor de melkeiwit synthese en 
functionele differentiatie van de alvéolaire epitheliale cellen 
De experimenten zoals beschreven in Hoofdstuk V zijn een voorbeeld hoe de LAR knock 
out muizen te gebruiken voor verder onderzoek Als onderdeel van een 
samenwerkingsverband gericht op de identificatie van PTPases in insuline 
signaaltransductie werden de muizen gebruikt om de invloed van verlies van LAR PTPase 
activiteit op insuline-geinduceerde metabole processen te meten Op dit moment zijn onze 
resultaten geen bevestiging van de hypothese dat LAR als een negatieve regulator 
functioneert in de signaaltransductie via de insuline receptor Er zijn geen verschillen 
meetbaar in bloed glucose en insuline gehaltes, de insuline tolerantie is vergelijkbaar, en 
de basale tyrosine activiteit van de insuline receptor is niet veranderd Alhoewel de 
activiteit van de insuline receptor na toediening van insuline nog gemeten moet worden, 
kunnen we op dit moment slechts concluderen dat er waarschijnlijk (ook) andere PTPases, 
waaronder mogelijk RPTP6 en RPTPa, betrokken zijn bij de regulatie van het signaal dat 
door de insuline receptor wordt doorgegeven na stimulatie met insuline 
Het in dit proefschrift beschreven onderzoek is het eerste voorbeeld van een in vivo model 
om zowel in de cel als in een heel organisme de biologische implicaties van de tyrosine 
fosfatase activiteit van een RPTPase te bestuderen Verder onderzoek naar de mogelijke 
ligand(en) en de functie van het extracellulaire deel van LAR zal bijdragen tot een beter 
begrip van rol van dit RPTPase in signaal transductie en ontwikkeling 
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